Health and Social Care Information Centre

NHS Data Model and Dictionary Service

Type:Patch
Reference:1408
Version No:1.0
Subject:November 2013 Release Patch
Effective Date:Immediate
Reason for Change:Patch
Publication Date:15 November 2013

Background:

This patch updates the NHS Data Model and Dictionary in preparation for the November 2013 Release and includes:

To view a demonstration on "How to Read an NHS Data Model and Dictionary Change Request", visit the NHS Data Model and Dictionary help pages at: http://www.datadictionary.nhs.uk/Flash_Files/changerequest.htm.

Note: if the web page does not open, please copy the link and paste into the web browser.

Summary of changes:

Diagrams
ACTIVITY DIAGRAM   Changed Diagram
CANCER OUTCOMES AND SERVICES DIAGRAM   Changed Diagram
CHILD AND ADOLESCENT MENTAL HEALTH SERVICES SECONDARY USES DIAGRAM   Changed Diagram
CHILDREN AND YOUNG PEOPLE'S HEALTH SERVICE SECONDARY USES DIAGRAM   Changed Diagram
DIAGNOSTIC IMAGING DIAGRAM   Changed Diagram
HIV AND AIDS DIAGRAM   Changed Diagram
IMPROVING ACCESS TO PSYCHOLOGICAL THERAPIES DIAGRAM   Changed Diagram
MATERNITY SERVICES SECONDARY USES DIAGRAM   Changed Diagram
NATIONAL JOINT REGISTRY DIAGRAM   Changed Diagram
NATIONAL RENAL DIAGRAM   Changed Diagram
ORGANISATION DIAGRAM   Changed Diagram
PATIENT PATHWAY DIAGRAM   Changed Diagram
PERSON AND PERSON PROPERTY DIAGRAM   Changed Diagram
SYSTEMIC ANTI-CANCER THERAPY DIAGRAM   Changed Diagram
 
Data Set
CANCER OUTCOMES AND SERVICES DATA SET - HEAD AND NECK   Changed Description
 
Central Return Forms
KC53 4   Changed Description
KC53 5   Changed Description
KC53 6   Changed Description
KC53 7   Changed Description
KH12 1   Changed Description
KH12 2   Changed Description
 
Supporting Information
ABO SYSTEM   Changed Description
ANAESTHETIC SERVICE   Changed Description
BIRTH LENGTH   Changed Description
BIRTH WEIGHT   Changed Description
BLOOD PRESSURE   Changed Description
BLOOD TRANSFUSION   Changed Description
BODY MASS INDEX   Changed Description
BONE AGE   Changed Description
CERVICAL GLANDULAR INTRA-EPITHELIAL NEOPLASIA renamed from CERVICAL GLANDULAR INTRAEPITHELIAL NEOPLASIA   Changed Name, Description
CERVICAL INTRA-EPITHELIAL NEOPLASIA renamed from CERVICAL INTRAEPITHELIAL NEOPLASIA   Changed Name, Description
CLINICAL INTERVENTION DATE AND TIME   New Supporting Information
CLINICAL INTERVENTION TIME   New Supporting Information
CLINICAL INVESTIGATION   Changed Description
CONTRACEPTIVE SERVICE   Changed Description
DENTAL HAEMORRHAGE SERVICE   Changed Description
DENTAL TREATMENT   Changed Description
DIAGNOSTICS WAITING TIMES AND ACTIVITY DATA SET OVERVIEW   Changed Description
DIAGNOSTICS WAITING TIMES CENSUS DATA SET OVERVIEW   Changed Description
DIASTOLIC BLOOD PRESSURE   Changed Description
DOMINANT ARM (RETIRED) renamed from DOMINANT ARM   Changed Name, Description, status to Retired
DRY WEIGHT   Changed Description
EMERGENCY TREATMENT SERVICE   Changed Description
FACE TO FACE CONTACT COMMUNITY CARE   Changed Description
FORCED EXPIRATORY VOLUME IN 1 SECOND (ABSOLUTE AMOUNT)   Changed Description
FORCED EXPIRATORY VOLUME IN 1 SECOND (PERCENTAGE)   Changed Description
GESTATION LENGTH IN DAYS (RETIRED) renamed from GESTATION LENGTH IN DAYS   Changed Name, Description, status to Retired
HAND GRIP STRENGTH   Changed Description
HBA1C   Changed Description
HEAD CIRCUMFERENCE   Changed Description
HEART RATE   Changed Description
HEIGHT   Changed Description
HIP MEASUREMENT   Changed Description
MANTOUX TEST   Changed Description
MATERNITY MEDICAL SERVICE   Changed Description
MID ARM CIRCUMFERENCE   Changed Description
MINOR SURGERY PROCEDURE   Changed Description
NATIONAL DIRECT ACCESS AUDIOLOGY PATIENT TRACKING LIST DATA SET OVERVIEW   Changed Description
NATIONAL DIRECT ACCESS AUDIOLOGY WAITING TIMES DATA SET OVERVIEW   Changed Description
ORGANISATIONS INTRODUCTION   Changed Description
ORGANISATIONS MENU   Changed Description
PALLIATIVE CARE EPISODE   Changed Description
PATIENT PROCEDURE   Changed Description
PERCENTAGE WEIGHT LOSS   Changed Description
PERSON STOP SMOKING EPISODE   Changed Description
POST MORTEM   Changed Description
RADIOLOGY DEPARTMENT   Changed Description
RADIOTHERAPY DEPARTMENT   Changed Description
RH SYSTEM   Changed Description
SCREENING TEST   Changed Description
SERUM CHOLESTEROL LEVEL   Changed Description
SERUM CREATININE LEVEL   Changed Description
STOP SMOKING SERVICE   Changed Description
STOP SMOKING SERVICE QUARTERLY DATA SET OVERVIEW   Changed Description
SYSTOLIC BLOOD PRESSURE   Changed Description
TEMPERATURE   Changed Description
TEST OF IMMUNITY renamed from TEST OF IMMUNITY   Changed Name, Description
URINARY ALBUMIN LEVEL   Changed Description
URINE OUTPUT   Changed Description
VACCINATION SERVICE   Changed Description
VASECTOMY PERFORMED (RETIRED) renamed from VASECTOMY PERFORMED   Changed Name, Description, status to Retired
VENOUS THROMBOEMBOLISM RISK ASSESSMENT DATA SET OVERVIEW   Changed Description
VENOUS THROMBOEMBOLISM RISK ASSESSMENT TOOL   Changed Description
WAIST MEASUREMENT   Changed Description
WEIGHT   Changed Description
WHAT'S NEW: NOVEMBER 2013 renamed from WHAT'S NEW: SEPTEMBER 2013   Changed Name, Description
 
Class Definitions
ACTIVITY GROUP   Changed Attributes
CATEGORY VALUED PERSON OBSERVATION   Changed Description
CLINICAL INVESTIGATION RESULT ITEM   Changed Attributes, Description
MEASURED PERSON OBSERVATION (RETIRED) renamed from MEASURED PERSON OBSERVATION   Changed Attributes, Supertype, Name, Description, status to Retired
MEASURED PERSON OBSERVATION TYPE (RETIRED) renamed from MEASURED PERSON OBSERVATION TYPE   Changed Attributes, Relationships, Name, Description, status to Retired
MEASUREMENT VALUE TYPE (RETIRED) renamed from MEASUREMENT VALUE TYPE   Changed Attributes, Relationships, Name, Description, status to Retired
OBSERVATION MEASUREMENT VALIDATION (RETIRED) renamed from OBSERVATION MEASUREMENT VALIDATION   Changed Name, Description, status to Retired
ORGANISATION SITE BED AVAILABILITY   Changed Attributes
ORGANISATION SITE BED OCCUPANCY   Changed Attributes
OTHER PERSON OBSERVATION   Changed Description
PERSON PROPERTY   Changed Attributes, Description
PERSON PROPERTY QUALIFIER   Changed Attributes
REGISTRABLE BIRTH   Changed Attributes
UNIT OF MEASUREMENT   New Class
WARD BED AVAILABILITY   Changed Attributes
WARD OPERATIONAL PLAN   Changed Attributes
 
Attribute Definitions
ACTIVITY DATE AND TIME TYPE   Changed Description
ACTIVITY TIME TYPE   Changed Description
CANCER TREATMENT MODALITY   Changed Description
CLINICAL INTERVENTION TYPE   Changed Description
CLINICAL INVESTIGATION RESULT ITEM TYPE   New Attribute
CLINICAL INVESTIGATION RESULT VALUE   New Attribute
DELAY REASON REFERRAL TO FIRST SEEN FOR CANCER OR BREAST SYMPTOMS   Changed Description
DELAY REASON TO TREATMENT FOR CANCER   Changed Description
DOMINANT ARM CODE   Changed Description
GESTATION LENGTH IN DAYS   New Attribute
GESTATION LENGTH IN WEEKS renamed from GESTATION LENGTH   Changed Name
LARGEST METASTASIS   Changed Description
MAXIMUM DEPTH OF INVASION   Changed Description
MEASURED OBSERVATION VALUE (RETIRED) renamed from MEASURED OBSERVATION VALUE   Changed Name, Description, status to Retired
MEASURED PERSON OBSERVATION TYPE CODE (RETIRED) renamed from MEASURED PERSON OBSERVATION TYPE CODE   Changed Name, Description, status to Retired
MEASUREMENT VALUE TYPE CODE (RETIRED) renamed from MEASUREMENT VALUE TYPE CODE   Changed Name, Description, status to Retired
ORGANISATION DEPARTMENT CODE   Changed Description
ORGANISATION SITE CODE   Changed Description
PERSON PROPERTY QUALIFIER TYPE (RETIRED) renamed from PERSON PROPERTY QUALIFIER TYPE   Changed Name, Description, status to Retired
PERSON PROPERTY QUALIFIER VALUE (RETIRED) renamed from PERSON PROPERTY QUALIFIER VALUE   Changed Name, Description, status to Retired
PERSON PROPERTY RELATIONSHIP TYPE (RETIRED) renamed from PERSON PROPERTY RELATIONSHIP TYPE   Changed Name, Description, status to Retired
REHABILITATION ASSESSMENT TEAM TYPE   Changed Description
SERVICE TYPE   Changed Description
SERVICE TYPE FOR CHLAMYDIA TESTING   Changed Description
SKIN CANCER LESION NUMBER   Changed Description
TUMOUR PROXIMITY TO CARINA   Changed Description
TUMOUR SIZE   Changed Description
UNIT OF MEASUREMENT renamed from CLINICAL INVESTIGATION RESULT ITEM UNIT OF MEASURE   Changed Name, Description
 
Data Elements
ABLATIVE THERAPY TYPE   Changed Description
ABNORMALITY DETECTED (DATING ULTRASOUND SCAN)   Changed Description
ACCIDENT AND EMERGENCY ATTENDANCE CONCLUSION DATE   Changed Description
ACCIDENT AND EMERGENCY DIAGNOSIS - FIRST   Changed Description
ACCIDENT AND EMERGENCY DIAGNOSIS - SECOND   Changed Description
ACCIDENT AND EMERGENCY INVESTIGATION - FIRST   Changed Description
ACCIDENT AND EMERGENCY INVESTIGATION - SECOND   Changed Description
ACCIDENT AND EMERGENCY TREATMENT - FIRST   Changed Description
ACCIDENT AND EMERGENCY TREATMENT - SECOND   Changed Description
ALANINE AMINOTRANSFERASE CONCENTRATION   Changed linked Attribute, Description
ALBUMIN LEVEL   Changed linked Attribute, Description
ALKALINE PHOSPHATASE CONCENTRATION   Changed linked Attribute, Description
ALLELE DRB3 DONOR   Changed Description
ALLELE DRB4 DONOR   Changed Description
ALLELE DRB5 DONOR   Changed Description
ALPHA FETOPROTEIN   Changed linked Attribute, Description
ALPHA FETOPROTEIN (CEREBROSPINAL FLUID)   Changed linked Attribute
ALPHA FETOPROTEIN (MAXIMUM AT DIAGNOSIS)   Changed linked Attribute
ANTENATAL OBSERVATION (MATERNAL HEIGHT)   Changed linked Attribute, Description
ANTENATAL OBSERVATION (MATERNAL WEIGHT)   Changed linked Attribute, Description
ASPARTATE AMINOTRANSFERASE CONCENTRATION   Changed linked Attribute, Description
BASE EXCESS CONCENTRATION   Changed linked Attribute, Description
BETA2 MICROGLOBULIN LEVEL   Changed linked Attribute, Description
BETA HUMAN CHORIONIC GONADOTROPIN   Changed linked Attribute, Description
BETA HUMAN CHORIONIC GONADOTROPIN (CEREBROSPINAL FLUID)   Changed linked Attribute
BETA HUMAN CHORIONIC GONADOTROPIN (MAXIMUM AT DIAGNOSIS)   Changed linked Attribute
BICARBONATE CONCENTRATION   Changed linked Attribute, Description
BILIRUBIN CONCENTRATION   Changed linked Attribute, Description
BIRTH WEIGHT   Changed linked Attribute, Description
BLOOD BASOPHILS PERCENTAGE   Changed linked Attribute, Description
BLOOD EOSINOPHILS PERCENTAGE   Changed linked Attribute, Description
BLOOD FLOW RATE (DIALYSIS)   Changed Description
BLOOD MYELOBLASTS PERCENTAGE   Changed linked Attribute, Description
BLOOD PRESSURE AVERAGED   Changed linked Attribute, Description
BLOOD PRESSURE HIGHEST   Changed linked Attribute, Description
BLOOD PRESSURE LOWEST   Changed linked Attribute, Description
BLOOD PRESSURE SITTING   Changed linked Attribute, Description
BLOOD UREA CONCENTRATION   Changed linked Attribute, Description
BLOOD UREA CONCENTRATION (DONOR ON ADMISSION)   Changed linked Attribute, Description
BLOOD UREA CONCENTRATION (DONOR ON RETRIEVAL)   Changed linked Attribute, Description
BONE AGE (RENAL PAEDIATRIC)   Changed linked Attribute, Description
BONE MARROW BLAST CELLS PERCENTAGE   Changed linked Attribute, Description
BRESLOW THICKNESS   Changed linked Attribute, Description
CALCULATED CREATININE CLEARANCE   Changed linked Attribute, Description
CD4 CELL COUNT   Changed linked Attribute, Description
CHOLESTEROL HIGH DENSITY LIPOPROTEIN CONCENTRATION   Changed linked Attribute, Description
CHOLESTEROL LOW DENSITY LIPOPROTEIN CONCENTRATION   Changed linked Attribute, Description
CHOLESTEROL TOTAL CONCENTRATION   Changed linked Attribute, Description
COUNTRY CODE (AT ASSIGNMENT)   Changed Description
CYCLOSPORINE A 12 HOUR TROUGH LEVEL (RECIPIENT)   Changed linked Attribute, Description
CYCLOSPORINE A 2 HOUR TROUGH LEVEL C2 (RECIPIENT)   Changed linked Attribute, Description
DIALYSATE 24 HOUR CREATININE CONCENTRATION   Changed linked Attribute, Description
DIALYSATE 24 HOUR PROTEIN LOSS   Changed linked Attribute, Description
DIALYSATE 24 HOUR UREA CONCENTRATION   Changed linked Attribute, Description
DIALYSATE 24 HOUR VOLUME   Changed linked Attribute, Description
DIALYSATE CREATININE PLASMA RATIO (4 HOUR)   Changed Description
DIALYSATE EFFLUENT VOLUME (4 HOUR)   Changed linked Attribute, Description
DIALYSATE GLUCOSE END OF DWELL (4 HOUR)   Changed linked Attribute, Description
DIALYSATE GLUCOSE START OF DWELL (4 HOUR)   Changed linked Attribute, Description
DIASTOLIC BLOOD PRESSURE   Changed linked Attribute, Description
DIASTOLIC BLOOD PRESSURE (POST HAEMODIALYSIS)   Changed linked Attribute
DIASTOLIC BLOOD PRESSURE (PRE-HAEMODIALYSIS)   Changed linked Attribute
DISCHARGE READY DATE (HOSPITAL PROVIDER SPELL)   Changed Description
DISTANCE BEYOND MUSCULARIS PROPRIA   Changed linked Attribute, Description
DISTANCE FROM DENTATE LINE   Changed linked Attribute, Description
DISTANCE TO CIRCUMFERENTIAL EXCISION MARGIN   Changed linked Attribute, Description
DISTANCE TO CLOSEST NON PERITONEALISED RESECTION MARGIN   Changed linked Attribute, Description
DISTANCE TO DISTAL RESECTION MARGIN   Changed linked Attribute, Description
DISTANCE TO MARGIN   Changed linked Attribute, Description
DISTANCE TO SEROSA   Changed linked Attribute, Description
ENDOCRINE THERAPY TYPE (RETIRED) renamed from ENDOCRINE THERAPY TYPE   Changed Name, Description, status to Retired
EPISODE NUMBER   Changed Description
ESTIMATED ENERGY INTAKE   Changed Description
ESTIMATED GLOMERULAR FILTRATION RATE   Changed linked Attribute, Description
ESTIMATED POTASSIUM INTAKE   Changed Description
ESTIMATED PROTEIN INTAKE   Changed Description
FINAL EXCISION MARGIN AFTER WIDE LOCAL EXCISION   Changed Description
FORCED EXPIRATORY VOLUME IN 1 SECOND (ABSOLUTE AMOUNT)   Changed linked Attribute, Description
FORCED EXPIRATORY VOLUME IN 1 SECOND (PERCENTAGE)   Changed linked Attribute, Description
GAMMA GLUTAMYL TRANSFERASE CONCENTRATION   Changed linked Attribute, Description
GESTATION (DATING ULTRASOUND SCAN)   Changed linked Attribute, Description
GESTATION LENGTH   Changed Description
GESTATION LENGTH (AT 6 - 8 WEEK PHYSICAL EXAMINATION)   Changed linked Attribute, Description
GESTATION LENGTH (AT BIRTH)   Changed linked Attribute, Description
GESTATION LENGTH (PREGNANCY FIRST CONTACT)   Changed linked Attribute, Description
GP WRITTEN REFERRALS   Changed Description
GP WRITTEN REFERRALS BOOKED   Changed Description
GP WRITTEN REFERRALS MADE   Changed Description
GP WRITTEN REFERRALS SEEN   Changed Description
HAEMOGLOBIN CONCENTRATION   Changed linked Attribute, Description
HAEMOGLOBIN CONCENTRATION (PRE-DIALYSIS)   Changed linked Attribute
HAEMOGLOBIN CONCENTRATION (PRIOR END STAGE RENAL FAILURE)   Changed linked Attribute
HAND GRIP STRENGTH   Changed linked Attribute, Description
HBA1C CONCENTRATION (DCCT)   Changed linked Attribute, Description
HBA1C CONCENTRATION (IFCC)   Changed linked Attribute, Description
HEAD CIRCUMFERENCE (RENAL PAEDIATRIC)   Changed linked Attribute, Description
HEART RATE   Changed linked Attribute, Description
HEIGHT IN CENTIMETRES FIRST VISIT   Changed linked Attribute
HIP MEASUREMENT   Changed linked Attribute, Description
HYPOCHROMIC RED CELLS PERCENTAGE   Changed linked Attribute, Description
INVASIVE THICKNESS   Changed linked Attribute, Description
INVASIVE TUMOUR SIZE   Changed Description
ISOTOPIC GLOMERULAR FILTRATION RATE (LIVING DONOR)   Changed linked Attribute, Description
LACTATE DEHYDROGENASE CONCENTRATION   Changed linked Attribute, Description
LESION SIZE (PATHOLOGICAL)   Changed Description
LESION SIZE (RADIOLOGICAL)   Changed Description
MEASURED 24HR CREATININE CLEARANCE   Changed linked Attribute, Description
MEASURED CREATININE CLEARANCE   Changed linked Attribute, Description
MEASURED GLOMERULAR FILTRATION RATE   Changed linked Attribute, Description
MID ARM CIRCUMFERENCE   Changed linked Attribute, Description
MITOTIC RATE   Changed linked Attribute, Description
MYCOPHENOLIC ACID TROUGH LEVEL (RECIPIENT)   Changed linked Attribute, Description
NEUTROPHIL COUNT   Changed linked Attribute, Description
NON INVASIVE TUMOUR SIZE   Changed Description
NORMALISED PROTEIN CATABOLIC RATE (DIALYSIS)   Changed linked Attribute, Description
NORMALISED WEEKLY PERITONEAL CREATININE CLEARANCE   Changed linked Attribute, Description
NUMBER OF OUT-PATIENT CONVERTED UNIQUE BOOKING REFERENCE NUMBERS   Changed Description
OBSERVATION DATE (ALANINE AMINOTRANSFERASE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (ALKALINE PHOSPHATASE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (ANTENATAL)   Changed Description
OBSERVATION DATE (ASPARTATE AMINOTRANSFERASE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (BILIRUBIN CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (BLOOD GASES TEST)   Changed linked Attribute, Description
OBSERVATION DATE (BLOOD PRESSURE)   Changed linked Attribute, Description
OBSERVATION DATE (BLOOD PRESSURE PRE-HAEMODIALYSIS)   Changed linked Attribute, Description
OBSERVATION DATE (BLOOD TEST)   Changed linked Attribute, Description
OBSERVATION DATE (BLOOD UREA CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (BMI)   Changed linked Attribute, Description
OBSERVATION DATE (BONE AGE)   Changed linked Attribute, Description
OBSERVATION DATE (CALCULATED CREATININE CLEARANCE)   Changed linked Attribute, Description
OBSERVATION DATE (CHEST X-RAY)   Changed linked Attribute, Description
OBSERVATION DATE (COMBINED KTV)   Changed linked Attribute, Description
OBSERVATION DATE (CORE ANTIBODY)   Changed linked Attribute, Description
OBSERVATION DATE (CYCLOSPORINE A 12 HOUR TROUGH LEVEL)   Changed linked Attribute, Description
OBSERVATION DATE (CYCLOSPORINE A 2 HOUR LEVEL C2)   Changed linked Attribute, Description
OBSERVATION DATE (CYTOMEGALOVIRUS)   Changed linked Attribute, Description
OBSERVATION DATE (CYTOMEGALOVIRUS POLYMERASE CHAIN REACTION VIRAL LOAD)   Changed linked Attribute, Description
OBSERVATION DATE (DIALYSATE 24 HOUR CREATININE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (DIALYSATE 24 HOUR PROTEIN LOSS)   Changed linked Attribute, Description
OBSERVATION DATE (DIALYSATE 24 HOUR UREA CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (DIALYSATE 24 HOUR VOLUME)   Changed linked Attribute, Description
OBSERVATION DATE (DIALYSATE KTV)   Changed linked Attribute, Description
OBSERVATION DATE (ELECTROCARDIOGRAM)   Changed linked Attribute, Description
OBSERVATION DATE (EPSTEIN-BARR VIRUS)   Changed linked Attribute, Description
OBSERVATION DATE (ESTIMATED GLOMERULAR FILTRATION RATE)   Changed linked Attribute, Description
OBSERVATION DATE (EYE EXAMINATION)   Changed linked Attribute, Description
OBSERVATION DATE (FOOT EXAMINATION)   Changed linked Attribute, Description
OBSERVATION DATE (FULL BLOOD COUNT TEST)   Changed linked Attribute, Description
OBSERVATION DATE (GAMMA GLUTAMYL TRANSFERASE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (GRAFT CLINICAL ASSESSMENT)   Changed linked Attribute, Description
OBSERVATION DATE (HAEMOGLOBIN CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (HBA1C LEVEL)   Changed linked Attribute, Description
OBSERVATION DATE (HEAD CIRCUMFERENCE)   Changed linked Attribute, Description
OBSERVATION DATE (HEIGHT)   Changed linked Attribute, Description
OBSERVATION DATE (HEPATITIS B ANTIBODY)   Changed linked Attribute, Description
OBSERVATION DATE (HEPATITIS B ANTIGEN)   Changed linked Attribute, Description
OBSERVATION DATE (HEPATITIS B E ANTIBODY)   Changed linked Attribute, Description
OBSERVATION DATE (HEPATITIS C ANTIBODY)   Changed linked Attribute, Description
OBSERVATION DATE (HIGH DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (HUMAN IMMUNODEFICIENCY VIRUS)   Changed linked Attribute, Description
OBSERVATION DATE (HYPOCHROMIC RED CELLS PERCENTAGE)   Changed linked Attribute, Description
OBSERVATION DATE (LACTATE DEHYDROGENASE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (LOW DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (MEASURED 24 HOUR CREATININE CLEARANCE)   Changed linked Attribute, Description
OBSERVATION DATE (MEASURED CREATININE CLEARANCE)   Changed linked Attribute, Description
OBSERVATION DATE (MEASURED GLOMERULAR FILTRATION RATE)   Changed linked Attribute, Description
OBSERVATION DATE (MYCOPHENOLIC ACID TROUGH LEVEL)   Changed linked Attribute, Description
OBSERVATION DATE (NET DAILY ULTRAFILTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (NORMALISED PROTEIN CATABOLIC RATE)   Changed linked Attribute, Description
OBSERVATION DATE (NORMALISED WEEKLY PERITONEAL CREATININE CLEARANCE)   Changed linked Attribute, Description
OBSERVATION DATE (PERITONEAL DIALYSIS TOTAL WEEKLY FLUID VOLUME)   Changed linked Attribute, Description
OBSERVATION DATE (PERITONEAL EQUILIBRATION TEST)   Changed linked Attribute, Description
OBSERVATION DATE (PHOSPHATE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (PLATELETS COUNT)   Changed linked Attribute, Description
OBSERVATION DATE (PROTEIN CREATININE RATIO)   Changed linked Attribute, Description
OBSERVATION DATE (RED CELL FOLATE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (RESIDUAL RENAL CREATININE CLEARANCE)   Changed linked Attribute, Description
OBSERVATION DATE (RESIDUAL URINE OUTPUT)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM ALBUMIN CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM ALUMINIUM CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM B12 CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM BICARBONATE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM CALCIUM CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM CHOLESTEROL LEVEL)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM C-REACTIVE PROTEIN CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM CREATININE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM CREATININE KTV)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM CREATININE LEVEL)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM FERRITIN CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM INTACT PARATHYROID HORMONE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM MAGNESIUM CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SERUM POTASSIUM CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (SIROLIMUS TROUGH LEVEL)   Changed linked Attribute, Description
OBSERVATION DATE (SODIUM CONCENTRATION)   Changed linked Attribute
OBSERVATION DATE (TACROLIMUS 12 HOUR TROUGH LEVEL)   Changed linked Attribute, Description
OBSERVATION DATE (TISSUE TYPING DONOR)   Changed linked Attribute, Description
OBSERVATION DATE (TISSUE TYPING RECIPIENT)   Changed linked Attribute, Description
OBSERVATION DATE (TOTAL CHOLESTEROL CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (TRANSFERRIN SATURATION)   Changed linked Attribute, Description
OBSERVATION DATE (TRIGLYCERIDES CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (URIC ACID CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (URINARY ALBUMIN LEVEL)   Changed linked Attribute, Description
OBSERVATION DATE (URINE CREATININE CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (URINE DIPSTICK TEST BLOOD)   Changed linked Attribute, Description
OBSERVATION DATE (URINE DIPSTICK TEST PROTEIN)   Changed linked Attribute, Description
OBSERVATION DATE (URINE KTV)   Changed linked Attribute, Description
OBSERVATION DATE (URINE UREA CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (URINE VOLUME)   Changed linked Attribute, Description
OBSERVATION DATE (VARICELLA-ZOSTER)   Changed linked Attribute, Description
OBSERVATION DATE (VITAMIN D CONCENTRATION)   Changed linked Attribute, Description
OBSERVATION DATE (WAIST MEASUREMENT)   Changed linked Attribute, Description
OBSERVATION DATE (WEIGHT)   Changed linked Attribute, Description
OBSERVATION DATE (WHITE BLOOD CELL COUNT)   Changed linked Attribute, Description
OBSERVATION DATE (WHOLE BLOOD MEAN CELL VOLUME)   Changed linked Attribute, Description
OBSERVATION DATE (WHOLE BLOOD MEAN CORPUSCULAR HAEMOGLOBIN)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (BLOOD PRESSURE)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (BLOOD PRESSURE AVERAGED)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (BLOOD PRESSURE HIGHEST)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (BLOOD PRESSURE LOWEST)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (FIRST BRAINSTEM DEATH TEST)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (HEART RATE)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (ISOTOPIC GLOMERULAR FILTRATION RATE)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (SECOND BRAINSTEM DEATH TEST)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (TEMPERATURE)   Changed linked Attribute, Description
OBSERVATION DATE AND TIME (URINE OUTPUT)   Changed linked Attribute, Description
ORGANISATION CODE (CODE OF COMMISSIONER)   Changed Description
ORGANISATION CODE (PCT OF RESIDENCE)   Changed Description
PARTIAL PRESSURE CARBON DIOXIDE   Changed linked Attribute, Description
PARTIAL PRESSURE OXYGEN   Changed linked Attribute, Description
PERCENTAGE WEIGHT LOSS   Changed linked Attribute, Description
PERITONEAL DIALYSIS TOTAL WEEKLY FLUID VOLUME   Changed linked Attribute, Description
PERSON HEIGHT IN CENTIMETRES   Changed linked Attribute, Description
PERSON HEIGHT IN METRES   Changed linked Attribute, Description
PERSON OBSERVATION (HBA1C LEVEL)   Changed linked Attribute, Description
PERSON OBSERVATION (SERUM CHOLESTEROL LEVEL)   Changed linked Attribute, Description
PERSON OBSERVATION (SERUM CREATININE LEVEL)   Changed linked Attribute, Description
PERSON OBSERVATION (URINARY ALBUMIN LEVEL)   Changed linked Attribute, Description
PERSON WEIGHT   Changed linked Attribute, Description
PERSON WEIGHT (POST DIALYSIS)   Changed linked Attribute, Description
PERSON WEIGHT (PRE-DIALYSIS)   Changed linked Attribute, Description
PERSON WEIGHT (RENAL CARE)   Changed linked Attribute, Description
PHOSPHATE CONCENTRATION   Changed linked Attribute, Description
PHOSPHATE CONCENTRATION (DONOR)   Changed linked Attribute
PLATELETS COUNT   Changed linked Attribute, Description
POSITIVE END-EXPIRATORY PRESSURE   Changed linked Attribute, Description
POTASSIUM CONCENTRATION (DONOR ON ADMISSION)   Changed linked Attribute, Description
POTASSIUM CONCENTRATION (DONOR ON RETRIEVAL)   Changed linked Attribute, Description
PRESCRIBED DOSE   Changed Description
PRESCRIBED DOSE (ALEMTUZUMAB)   Changed Description
PRESCRIBED DOSE (ANTI-HUMAN T-LYMPHOCYTE GLOBULIN)   Changed Description
PRESCRIBED DOSE (ANTITHYMOCYTE GLOBULIN)   Changed Description
PRESCRIBED DOSE (AZATHIOPRINE)   Changed Description
PRESCRIBED DOSE (BASILIXIMAB)   Changed Description
PRESCRIBED DOSE (CICLOSPORIN)   Changed Description
PRESCRIBED DOSE (DACLIZUMAB)   Changed Description
PRESCRIBED DOSE (GROWTH HORMONE)   Changed Description
PRESCRIBED DOSE (MUROMONAB-CD3)   Changed Description
PRESCRIBED DOSE (MYCOPHENOLATE MOFETIL)   Changed Description
PRESCRIBED DOSE (MYCOPHENOLATE SODIUM)   Changed Description
PRESCRIBED DOSE (PREDNISOLONE OR PREDNISONE)   Changed Description
PRESCRIBED ITEM (VOLUME OF 136 GLUCOSE FLUID)   Changed Description
PRESCRIBED ITEM (VOLUME OF 227 GLUCOSE FLUID)   Changed Description
PRESCRIBED ITEM (VOLUME OF 386 GLUCOSE FLUID)   Changed Description
PRESCRIBED ITEM (VOLUME OF AMINO ACID DIALYSIS FLUID)   Changed Description
PRESCRIBED ITEM (VOLUME OF ICODEXTRIN DIALYSIS FLUID)   Changed Description
PRESCRIBED ITEM SIZE (PERITONEAL BAG)   Changed linked Attribute, Description
PRESCRIBED ITEM VOLUME USAGE PER OVERNIGHT (PERITONEAL DIALYSIS FLUID ON AUTOMATED PERITONEAL DIALYSIS)   Changed Description
PRESCRIBED TOTAL DAILY DOSE (ALEMTUZUMAB)   Changed Description
PRESCRIBED TOTAL DAILY DOSE (AZATHIOPRINE)   Changed Description
PRESCRIBED TOTAL DAILY DOSE (CICLOSPORIN)   Changed Description
PRESCRIBED TOTAL DAILY DOSE (DACLIZUMAB)   Changed Description
PRESCRIBED TOTAL DAILY DOSE (MYCOPHENOLATE SODIUM)   Changed Description
PRESCRIBED TOTAL DAILY DOSE (TACROLIMUS)   Changed Description
PRIMARY TUMOUR SIZE (RADIOLOGICAL)   Changed Description
PROCEDURE DATE (STEM CELL INFUSION)   Changed Description
PROSTATE SPECIFIC ANTIGEN (DIAGNOSIS)   Changed linked Attribute, Description
PROSTATE SPECIFIC ANTIGEN (PRE-TREATMENT)   Changed linked Attribute, Description
PROTEIN CREATININE RATIO   Changed linked Attribute, Description
RADIOTHERAPY ACTUAL DOSE   Changed Description
RADIOTHERAPY PRESCRIBED DOSE   Changed Description
RADIOTHERAPY TOTAL DOSE   Changed Description
RED CELL FOLATE CONCENTRATION   Changed linked Attribute, Description
RESIDUAL RENAL CREATININE CLEARANCE   Changed linked Attribute, Description
SATURATION PERCENTAGE   Changed linked Attribute, Description
SERUM ALBUMIN CONCENTRATION   Changed linked Attribute, Description
SERUM ALBUMIN CONCENTRATION (DONOR)   Changed linked Attribute
SERUM ALUMINIUM CONCENTRATION   Changed linked Attribute, Description
SERUM B12 CONCENTRATION   Changed linked Attribute, Description
SERUM BICARBONATE CONCENTRATION   Changed linked Attribute, Description
SERUM CALCIUM CONCENTRATION   Changed linked Attribute, Description
SERUM CALCIUM CONCENTRATION (DONOR)   Changed linked Attribute
SERUM C-REACTIVE PROTEIN CONCENTRATION   Changed linked Attribute, Description
SERUM CREATININE CONCENTRATION   Changed linked Attribute, Description
SERUM CREATININE CONCENTRATION (DONOR)   Changed linked Attribute
SERUM CREATININE CONCENTRATION (DONOR ON ADMISSION)   Changed linked Attribute
SERUM CREATININE CONCENTRATION (DONOR ON RETRIEVAL)   Changed linked Attribute
SERUM CREATININE CONCENTRATION (PRE-DIALYSIS)   Changed linked Attribute
SERUM CREATININE CONCENTRATION (PRIOR END STAGE RENAL FAILURE)   Changed linked Attribute
SERUM CREATININE KTV   Changed linked Attribute
SERUM FERRITIN CONCENTRATION   Changed linked Attribute, Description
SERUM INTACT PARATHYROID HORMOME CONCENTRATION   Changed linked Attribute, Description
SERUM MAGNESIUM CONCENTRATION   Changed linked Attribute, Description
SERUM POTASSIUM CONCENTRATION   Changed linked Attribute, Description
SERUM UREA CONCENTRATION (POST DIALYSIS)   Changed linked Attribute, Description
SERUM UREA CONCENTRATION (PRE-DIALYSIS)   Changed linked Attribute, Description
SIROLIMUS TROUGH LEVEL (RECIPIENT)   Changed linked Attribute, Description
SPLEEN BELOW COSTAL MARGIN   Changed Description
SYSTOLIC BLOOD PRESSURE   Changed linked Attribute, Description
SYSTOLIC BLOOD PRESSURE (POST HAEMODIALYSIS)   Changed linked Attribute
SYSTOLIC BLOOD PRESSURE (PRE-HAEMODIALYSIS)   Changed linked Attribute
TACROLIMUS 12 HOUR TROUGH LEVEL (RECIPIENT)   Changed linked Attribute, Description
TEMPERATURE   Changed linked Attribute, Description
TRANSFERRIN SATURATION   Changed linked Attribute, Description
TRIGLYCERIDES CONCENTRATION   Changed linked Attribute, Description
TUMOUR HEIGHT ABOVE ANAL VERGE   Changed linked Attribute, Description
URIC ACID CONCENTRATION   Changed linked Attribute, Description
URINARY ALBUMIN LEVEL TESTING METHOD   Changed Description
URINE CREATININE CONCENTRATION   Changed linked Attribute, Description
URINE KTV   Changed linked Attribute
URINE OUTPUT LAST 24 HOURS   Changed linked Attribute, Description
URINE OUTPUT LAST HOUR   Changed linked Attribute, Description
URINE UREA CONCENTRATION   Changed linked Attribute, Description
URINE VOLUME   Changed linked Attribute, Description
VIRAL LOAD COUNT   Changed linked Attribute, Description
VITAMIN D CONCENTRATION   Changed linked Attribute, Description
WAIST MEASUREMENT   Changed linked Attribute, Description
WHITE BLOOD CELL COUNT   Changed linked Attribute, Description
WHITE BLOOD CELL COUNT (HIGHEST PRETREATMENT)   Changed linked Attribute
WHITE BLOOD CELL COUNT (PERITONEAL FLUID)   Changed linked Attribute, Description
WHOLE BLOOD MEAN CELL VOLUME (DIALYSIS)   Changed linked Attribute, Description
WHOLE BLOOD MEAN CORPUSCULAR HAEMOGLOBIN (DIALYSIS)   Changed linked Attribute, Description
WHOLE TUMOUR SIZE   Changed Description
 

Date:15 November 2013
Sponsor:Richard Kavanagh, Head of Data Standards - Interoperability Specifications, Health and Social Care Information Centre

Note: New text is shown with a blue background. Deleted text is crossed out. Retired text is shown in grey. Within the Diagrams deleted classes and relationships are red, changed items are blue and new items are green.

Click here for a printer friendly view of this page.


ACTIVITY DIAGRAM

Change to Diagram: Changed Diagram

top


CANCER OUTCOMES AND SERVICES DIAGRAM

Change to Diagram: Changed Diagram

top


CHILD AND ADOLESCENT MENTAL HEALTH SERVICES SECONDARY USES DIAGRAM

Change to Diagram: Changed Diagram

top


CHILDREN AND YOUNG PEOPLE'S HEALTH SERVICE SECONDARY USES DIAGRAM

Change to Diagram: Changed Diagram

top


DIAGNOSTIC IMAGING DIAGRAM

Change to Diagram: Changed Diagram

top


HIV AND AIDS DIAGRAM

Change to Diagram: Changed Diagram

top


IMPROVING ACCESS TO PSYCHOLOGICAL THERAPIES DIAGRAM

Change to Diagram: Changed Diagram

top


MATERNITY SERVICES SECONDARY USES DIAGRAM

Change to Diagram: Changed Diagram

top


NATIONAL JOINT REGISTRY DIAGRAM

Change to Diagram: Changed Diagram

top


NATIONAL RENAL DIAGRAM

Change to Diagram: Changed Diagram

top


ORGANISATION DIAGRAM

Change to Diagram: Changed Diagram

top


PATIENT PATHWAY DIAGRAM

Change to Diagram: Changed Diagram

top


PERSON AND PERSON PROPERTY DIAGRAM

Change to Diagram: Changed Diagram

top


SYSTEMIC ANTI-CANCER THERAPY DIAGRAM

Change to Diagram: Changed Diagram

top


CANCER OUTCOMES AND SERVICES DATA SET - HEAD AND NECK

Change to Data Set: Changed Description

Cancer Outcomes and Services Data Set Overview

The Mandatory, Required, Optional or Not included in the COSDS Message (M/R/O/X) column indicates the recommendation for the inclusion of data.

  • M = Mandatory: this data element is mandatory and the technical process (e.g. submission of the data set, production of output etc) cannot be completed without this data element being present
  • R = Required: NHS business processes cannot be delivered without this data element
  • O = Optional: the inclusion of this data element is optional as required for local purposes
  • X = Not included in the COSDS Message: Cancer Registries obtain the data from another source, or the item is submitted under another Standard and is included here for reference only.

For guidance on submission of the data set, see the Cancer Outcomes and Services Data Set Submission Requirements.

For guidance on the XML Schema constraints, see the Cancer Outcomes and Services Data Set XML Schema Constraints.

PRE-TREATMENT ASSESSMENT - HEAD AND NECK

To carry pre-treatment assessment details for Head and Neck cancer.
One occurrence of this group is permitted.
M/R/O/XData Set Data Elements
ROBSERVATION DATE (HEIGHT)
RPERSON HEIGHT IN METRES
ROBSERVATION DATE (WEIGHT)
RPERSON WEIGHT
RCANCER DENTAL ASSESSMENT DATE
RCARE CONTACT DATE (DIETICIAN INITIAL)
RSURGICAL VOICE RESTORATION COMMUNICATION METHOD (PLANNED POST OPERATIVE)

POST TREATMENT ASSESSMENT - HEAD AND NECK

To carry post treatment assessment details for Head and Neck cancer.
Multiple occurrences of this group are permitted.
M/R/O/XData Set Data Elements
MCLINICAL STATUS ASSESSMENT DATE (CANCER)
RPERSON HEIGHT IN METRES
RPERSON WEIGHT
RPRIMARY TUMOUR STATUS
RNODAL STATUS
RMETASTATIC STATUS
RSURGICAL VOICE RESTORATION COMMUNICATION METHOD (PRIMARY)
RSPEECH AND LANGUAGE ASSESSMENT DATE

PATHOLOGY: GENERAL - HEAD AND NECK

To carry general pathology details for Head and Neck cancer.
Multiple occurrences of this group are permitted.
M/R/O/XData Set Data Elements
MINVESTIGATION RESULT DATE
RSERVICE REPORT IDENTIFIER 

PATHOLOGY: VARIOUS - HEAD AND NECK

To carry pathology details for various Head and Neck cancer. 
One occurrence of this data group is permitted per pathology report where applicable.
M/R/O/XData Set Data Elements
RMAXIMUM DEPTH OF INVASION
RBONE INVASION INDICATION CODE
RCARTILAGE INVASION INDICATION CODE
RANATOMICAL SIDE (NECK DISSECTION)

PATHOLOGY: SALIVARY TUMOUR - HEAD AND NECK

To carry pathology salivary tumour details for Head and Neck cancer.
One occurrence of this data group is permitted per pathology report where applicable.
M/R/O/XData Set Data Elements
MHISTOLOGICAL TUMOUR GRADE (SALIVARY)
RMACROSCOPIC EXTRAGLANDULAR EXTENSION INDICATION CODE

PATHOLOGY: GENERAL AND SALIVARY TUMOUR - HEAD AND NECK

To carry general pathology and salivary tumour details for Head and Neck cancer.
One occurrence of this data group is permitted per pathology report where applicable.
M/R/O/XData Set Data Elements
MANATOMICAL SIDE (POSITIVE NODES)
RLARGEST METASTASIS (LEFT NECK)
RLARGEST METASTASIS (RIGHT NECK)
REXTRACAPSULAR SPREAD INDICATION CODE

top


KC53 4

Change to Central Return Form: Changed Description

Central Return Form Guidance
 

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.
  • Part B: Cervical Screening Programme - Number of Women Invited
  • Part B of KC53 requires age-banded data on the number of women invited for screening, The number invited relates to Screening Test Invitations with an APPOINTMENT DATE OFFERED between 1 April and 31 March. This date does not necessarily relate to a due date in the year - e.g. the Screening Test could be set to take place outside this period. Where a woman is invited on more than one occasion in the year, the last invitation is recorded on KC53.

    A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER where the APPOINTMENT CLASSIFICATION CODE is National Code 06 'Screening Test'.

    A Screening Test is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 28 'Screening Test'.
    Age of woman at 31 March (column 1)
  • Part B of KC53 requires age-banded data on the number of women invited for screening, The number invited relates to Screening Test Invitations with an APPOINTMENT DATE OFFERED between 1 April and 31 March. This date does not necessarily relate to a due date in the year - e.g. the Screening Test could be set to take place outside this period. Where a woman is invited on more than one occasion in the year, the last invitation is recorded on KC53.

    A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER for a Screening Test.

    A Screening Test is a CLINICAL INTERVENTION where CLINICAL INTERVENTION TYPE is National Code 28 'Screening Test'.
    Age of woman at 31 March (column 1)
  • The age bands are derived from the PERSON BIRTH DATE.

    Under 20 (line 0001)
    20-24 (line 0002)
    25-29 (line 0003)
    30-34 (line 0004)
    35-39 (line 0005)
    40-44 (line 0006)
    45-49 (line 0007)
    50-54 (line 0008)
    55-59 (line 0009)
    60-64 (line 0010)
    65-69 (line 0011)
    70-74 (line 0012)
    75 & over (line 0013)
    Call (column 2)
  • A count of the number of women invited for their first screen i.e. those who have never been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

    Routine recall (column 3)
  • A count of the number of women invited for screening in the year as a result of a routine recall for screening. These women will have had a previous negative result and been recalled after the usual interval (3 to 5 years). The INVITATION TYPE of the Screening Test Invitation will have the classification Routine recall.

    Surveillance (column 4)
  • A count of the number of women invited for early screening because of a previous abnormal screening result or following treatment for cervical abnormalities. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than three years for surveillance.

    Abnormality (column 5)
  • A count of the number of women invited for early screening because their last smear showed some abnormality and a repeat was advised. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than three years because of abnormality.

    Inadequate smear (column 6)
  • A count of the number of women invited for screening because their last smear was inadequate. The INVITATION TYPE of the Screening Test Invitation will have either the classification Repeat in less than three years because of inadequate smear, or the classification Technical recall (inadequate test).

    Target age group (line 0014)
  • This counts the number of women in the Screening Programme aged between 20 and 64 on 31 March (sum of lines 0002 to 0010).

    A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 06 'Screening Programme'.

    Total all ages (line 9999)
  • This is the total for all age groups counted in lines 0001 to 0013 for each INVITATION TYPE.

top


KC53 5

Change to Central Return Form: Changed Description

Central Return Form Guidance
 

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website.
  • Part C1: Cervical Screening Programme - Number of Women Tested - by Age
  • Part C1 of KC53 requires data on the women screened in the year, by invitation or opportunistically. The number screened relates to Screening Tests with a Screening Test Date between 1 April and 31 March. Where a woman is screened more than once in the year, for whatever reason, her INVITATION TYPE at her first Screening Test Date in the review period is to be recorded.

    A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'. Screening Test Date is the same as attribute ACTIVITY DATE where ACTIVITY DATE TYPE is National Code 'Screening Test'.

    Call (column 2)
  • A count of the number of women screened in the year as a result of a first call for screening within 12 months of the original invitation. These women will not have been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

    A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER where the APPOINTMENT CLASSIFICATION CODE is National Code 'Screening Test'.

    Routine recall (column 3)
  • A count of the number of women screened in the year as a result of a first call for screening within 12 months of the original invitation. These women will not have been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

    A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER for a Screening Test.

    Routine recall (column 3)
  • A count of the number of women screened in the year as a result of a routine recall for screening within 12 months of the recall invitation. These women will have had a previous negative result and been recalled after the usual interval (3 to 5 years). The INVITATION TYPE of the Screening Test Invitation will have the classification Routine recall.

    Surveillance (column 4)
  • A count of the number of women screened in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years for surveillance.

    Abnormality (column 5)
  • A count of the number of women screened in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. These women will usually have had a recent mildly abnormal smear. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years because of abnormality.

    Inadequate smear (column 6)
  • Enter the number of women screened in the year as a result of a technical recall within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have either the classification Repeat in less than 3 years because of inadequate smear or the classification Technical recall (inadequate test).

    While recall suspended (column 7)
  • A count of the number of women screened in the year who were suspended from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall suspended'.

    A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'.

    While recall ceased (column 8)
  • A count of the number of women screened opportunistically in the year who were ceased from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall ceased'.

    Not Invited by Programme (column 9)
  • A count of the number of women screened opportunistically during the year. This includes all women whose Recall Status was "No action", "GP not informed", "GP informed", "ZZZ GP" and those women whose Recall Status was "Final non-responder" where the initial invitation was generated more than 12 months ago. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'not invited by programme'.

    Target age group (line 0014)
  • This counts the number of women in the Screening Programme aged between 20 and 64 on 31 March (sum of lines 0002 to 0010).

    Total all women (line 9999)
  • This is the total for all age groups counted in lines 0001 to 0013 for each INVITATION TYPE or women who have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE recorded.

top


KC53 6

Change to Central Return Form: Changed Description

Central Return Form Guidance
 

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website
.
  • Part C2: Cervical Screening Programme - Number of Women Tested - by Result
  • Part C2 of KC53 requires data on the women aged 20 - 64 screened in the year, by invitation or opportunistically. The number screened relates to Screening Tests with a Screening Test Date between 1 April and 31 March. Where a woman is screened more than once in the year, for whatever reason, her INVITATION TYPE at her first Screening Test Date in the review period is to be recorded.

    A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'. Screening Test Date is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TYPE is National Code 'Screening Test Date'.

    Call (column 2)
  • A count of the number of women screened in the year as a result of a first call for screening within 12 months of the original invitation. These women will not have been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

    A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER where the APPOINTMENT CLASSIFICATION CODE is National Code 'Screening Test'.

    Routine recall (column 3)
  • A count of the number of women screened in the year as a result of a first call for screening within 12 months of the original invitation. These women will not have been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

    A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER for a Screening Test.

    Routine recall (column 3)
  • A count of the number of women screened in the year as a result of a routine recall for screening within 12 months of the recall invitation. These women will have had a previous negative result and been recalled after the usual interval (3 to 5 years). The INVITATION TYPE of the Screening Test Invitation will have the classification Routine recall.

    Surveillance (column 4)
  • A count of the number of women screened in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years for surveillance.

    Abnormality (column 5)
  • A count of the number of women screened in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. These women will usually have had a recent mildly abnormal smear. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years because of abnormality.

    Inadequate smear (column 6)
  • Enter the number of women screened in the year as a result of a technical recall within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have either the classification Repeat in less than 3 years because of inadequate smear or the classification Technical recall (inadequate test).

    While recall suspended (column 7)
  • A count of the number of women screened in the year who were suspended from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall suspended'.

    A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'.

    While recall ceased (column 8)
  • A count of the number of women screened opportunistically in the year who were ceased from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall ceased'.

    Not Invited by Programme (column 9)
  • A count of the number of women screened opportunistically during the year. This includes all women whose Recall Status was "No action", "GP not informed", "GP informed", "ZZZ GP" and those women whose Recall Status was "Final non-responder" where the initial invitation was generated more than 12 months ago. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'not invited by programme'.

    Result of test
  • This is classified by the following CYTOLOGY RESULT TYPES:
    Inadequate (cat. 1) (line 0001)
    Negative (cat. 2) (line 0002)
    Borderline changes (cat. 8) (line 0003)
    Mild dyskaryosis (cat. 3) (line 0004)
    Moderate dyskaryosis (cat. 7) (line 0005)
    Severe dyskaryosis (cat. 4) (line 0006)
    Severe dyskaryosis/?invasive carcinoma (cat. 5) (line 0007)
    ?Glandular neoplasia (cat. 6) line 0008)

    Total women tested aged 20-64 (line 9999)
  • This counts the number of women in the Screening Programme aged between 20 and 64 on 31 March (sum of lines 0001 to 0008).

    A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 'Screening Programme'.

top


KC53 7

Change to Central Return Form: Changed Description

Central Return Form Guidance
 

KC53: Adult Screening Programmes: Cervical Screening

This return is in development by the NHS Cancer Screening Programme, therefore the information should not be used.
For the latest version of the form and further details, please see the Health and Social Care Information Centre website
.
  • Part C3: Cervical Screening Programme - Number of Tests - by Result
  • Part C3 of KC53 requires data on all tests in the review period, not limited to the target age group 20 - 64, by invitation or opportunistically. The number screened relates to Screening Tests with a Screening Test Date between 1 April and 31 March. Where a woman is screened more than once in the year, for whatever reason, her INVITATION TYPE at her first Screening Test Date in the review period is to be recorded.

    A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'. Screening Test Date is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TYPE is National Code 'Screening Test Date'.

    Call (column 2)
  • A count of the number of tests in the year as a result of a first call for screening within 12 months of the original invitation. These women will not have been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

    A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER where the APPOINTMENT CLASSIFICATION CODE is National Code 'Screening Test'.

    Routine recall (column 3)
  • A count of the number of tests in the year as a result of a first call for screening within 12 months of the original invitation. These women will not have been screened before. The INVITATION TYPE of the Screening Test Invitation will have the classification First call.

    A Screening Test Invitation is an APPOINTMENT associated with an APPOINTMENT OFFER for a Screening Test.

    Routine recall (column 3)
  • A count of the number of tests in the year as a result of a routine recall for screening within 12 months of the recall invitation. These women will have had a previous negative result and been recalled after the usual interval (3 to 5 years). The INVITATION TYPE of the Screening Test Invitation will have the classification Routine recall.

    Surveillance (column 4)
  • A count of the number of tests in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years for surveillance.

    Abnormality (column 5)
  • A count of the number of tests in the year as a result of a non-routine recall for screening within 12 months of the recall invitation. These women will usually have had a recent mildly abnormal smear. The INVITATION TYPE of the Screening Test Invitation will have the classification Repeat in less than 3 years because of abnormality.

    Inadequate smear (column 6)
  • Enter the number of tests in the year as a result of a technical recall within 12 months of the recall invitation. The INVITATION TYPE of the Screening Test Invitation will have either the classification Repeat in less than 3 years because of inadequate smear or the classification Technical recall (inadequate test).

    While recall suspended (column 7)
  • A count of the number of tests in the year of women who were suspended from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'Screened while recall suspended'

    A Screening Test is a CLINICAL INTERVENTION where the CLINICAL INTERVENTION TYPE is National Code 'Screening Test'.

    While recall ceased (column 8)
  • A count of the number of tests in the year of women who were ceased from the call and recall system at the time of their Screening Test Date. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification of 'screened while recall ceased'.

    Not Invited by Programme (column 9)
  • A count of the number of opportunistic tests during the year. This includes all women whose Recall Status was "No action", "GP not informed", "GP informed", "ZZZ GP" and those women whose Recall Status was "Final non-responder" where the initial invitation was generated more than 12 months ago. These women will have had a Screening Test with the OPPORTUNISTIC SCREENING TYPE classification 'not invited by programme'.

    Result of test
  • This is classified by the following CYTOLOGY RESULT TYPES:
    Inadequate (cat. 1) (line 0001)
    Negative (cat. 2) (line 0002)
    Borderline changes (cat. 8) (line 0003)
    Mild dyskaryosis (cat. 3) (line 0004)
    Moderate dyskaryosis (cat. 7) (line 0005)
    Severe dyskaryosis (cat. 4) (line 0006)
    Severe dyskaryosis/?invasive carcinoma (cat. 5) (line 0007)
    ?Glandular neoplasia (cat. 6) line 0008)

    Total all results (line 9999)
  • This counts the number of tests in the Screening Programme for all age groups on 31 March (sum of lines 0001 to 0008).

    A Screening Programme is a HEALTH PROGRAMME where the HEALTH PROGRAMME TYPE is National Code 'Screening Programme'.

top


KH12 1

Change to Central Return Form: Changed Description

Central Return Form Guidance
 

KH12 - Diagnostic Departments: Radiology, Nuclear Medicine and Medical Physics Imaging and Radiodiagnostic Examinations or Tests in any Part of a Hospital

  • Contextual Overview
    This return is currently under review. For further information on Annual Imaging and Radiodiagnostics Data, please see the NHS England website.
    • Contextual Overview
    • The Department of Health requires a count of all Imaging or Radiodiagnostic Events carried out in hospital DEPARTMENTS. The data are collected to implement a requirement of the Council of the European Union. Council Directives 80/836/Euratom and 96/29/Euratom require the health surveillance of the population, through assessment of radiation dose. Council Directive 97/43/Euratom takes this further by placing a specific requirement in relation to doses from medical exposures.

    • Information on the return is published annually in the 'Diagnostic Departments' bulletin.

      Completing Return KH12 - Imaging and Radiological Examinations or Tests in any Part of a Hospital
    • The return KH12 requires the following information:

      • numbers of imaging and radiodiagnostic examinations or tests by modality;
      • numbers of imaging events with intervention (success or failed);
      • whether the events take place under the auspices of an imaging department or some other department.
    • The following are excluded:

      • Requests which do not result in the use of an IMAGING MODALITY;
      • Imaging performed as part of radiotherapy planning;
      • Doppler ultrasound examinations without imaging such as is used for peripheral arterial or venous disease or fetal studies;
      • Procedures undertaken as part of the NHS Breast Screening Programme (initial screening and subsequent assessment) but not mammography undertaken for symptomatic women whose referrals are made directly to the imaging department.
    • Providers should collate data from every DEPARTMENT of the hospital which undertakes imaging or radiodiagnostic examinations or tests under its auspices. Imaging Department includes radiology, nuclear medicine and medical physics departments. Any other DEPARTMENT includes DEPARTMENTS other than radiology, nuclear medicine and medical physics undertaking imaging or radiodiagnostic investigations. This would include for instance an obstetric DEPARTMENT with its own ultrasound apparatus or a cardiology department undertaking imaging/interventional procedures.

    • Care needs to be taken to avoid double-counting. For example X-rays undertaken in an OPERATING THEATRE should be counted by either the Radiology Department or the surgery department, but not by both.

    • A KH12 return is required from each NHS Health Care Provider.

    • The return KH12 relates to ACTIVITY taking place over a 12 month period, between 1 April of one year and 31 March of the following year. The return is made annually and submitted within two months of the end of the year to which it relates, by the end of May at the latest.

top


KH12 2

Change to Central Return Form: Changed Description

Central Return Form Guidance
 

KH12 - Imaging and Radiological Examinations or Tests in any Part of a Hospital

top


ABO SYSTEM

Change to Supporting Information: Changed Description

The ABO System is a classification for CLINICAL INVESTIGATION RESULT ITEM.The ABO System is a CLINICAL CLASSIFICATION.

The ABO System is a system of 4 basic types into which human blood may be classified according to the presence or absence of particular antigens:

  • A - Blood group A has A antigens in its red blood cells and anti-B antibodies in its plasma;
  • B - Blood group B has B antigens and anti-A antibodies in its plasma;
  • O - Blood group O blood has no antigens but both anti-A and anti-B antibodies
  • AB - Blood group AB has both A and B antigens but no antibodies, as it would destroy itself.

For further information on the ABO System, see the NHS Choices website.

 

top


ABO SYSTEM

Change to Supporting Information: Changed Description

top


ANAESTHETIC SERVICE

Change to Supporting Information: Changed Description

Anaesthetic Service is a CLINICAL INTERVENTION.An Anaesthetic Service is an Item Of Service Delivery.

An item of Service Delivery.

The administration of a general anaesthetic, other than in connection with a Maternity Medical Service, which requires the services of a second GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.An Anaesthetic Service  is the administration of a general anaesthetic, other than in connection with a Maternity Medical Service, which requires the services of a second GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed. The fee is payable whether the anaesthetic is administered by the GENERAL MEDICAL PRACTITIONER requesting the services of a second GENERAL MEDICAL PRACTITIONER, or by the second GENERAL MEDICAL PRACTITIONER.

Note that Items of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.Note that Items Of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.

References:
Statement of Fees and Allowances Payable to General Medical Practitioners in England and Wales.

 

top


BIRTH LENGTH

Change to Supporting Information: Changed Description

top


BIRTH WEIGHT

Change to Supporting Information: Changed Description

top


BLOOD PRESSURE

Change to Supporting Information: Changed Description

Blood Pressure is a PERSON PROPERTY.Blood Pressure is a CLINICAL INVESTIGATION RESULT ITEM.

Blood Pressure is the the pressure of the blood within the arteries and is comprised of:Blood Pressure is the pressure of the blood within the arteries and is comprised of:

 

top


BLOOD TRANSFUSION

Change to Supporting Information: Changed Description

A Blood Transfusion is a CLINICAL INTERVENTION.A Blood Transfusion is a CLINICAL INTERVENTION.

A Blood Transfusion is a procedure which is undertaken to replace blood that might be lost for example, during surgery or due to a serious injury. It is also performed when the PATIENT is unable to produce blood properly because of an illness.A Blood Transfusion is a procedure which is undertaken to replace blood that might be lost for example, during surgery or due to a serious injury.

 A Blood Transfusion is also performed when the PATIENT is unable to produce blood properly because of an illness.

For further information on Blood Transfusions, see the NHS Choices website.

 

top


BODY MASS INDEX

Change to Supporting Information: Changed Description

Body Mass Index (BMI) is a PERSON PROPERTY.Body Mass Index (BMI) is a CLINICAL INVESTIGATION RESULT ITEM.

Body Mass Index is a measure of body fat based on Height and Weight.

For further information on Body Mass Index, see the NHS Choices website.

 

top


BONE AGE

Change to Supporting Information: Changed Description

Bone Age is a MEASURED PERSON OBSERVATIONBone Age is a CLINICAL INVESTIGATION RESULT ITEM.

Bone Age is the radiological bone age, following an assessment by a radiologist viewing X-rays of the PATIENT's hand and wrist.

 

top


CERVICAL GLANDULAR INTRA-EPITHELIAL NEOPLASIA  renamed from CERVICAL GLANDULAR INTRAEPITHELIAL NEOPLASIA

Change to Supporting Information: Changed Name, Description

Cervical Glandular Intraepithelial Neoplasia is a CLINICAL INVESTIGATION RESULT ITEM.Cervical Glandular Intra-epithelial Neoplasia is a PATIENT DIAGNOSIS.

Cervical Glandular Intraepithelial Neoplasia is used for PATIENTS with cervical cancer to identify the inner glandular CELLS of the cervix.Cervical Glandular Intra-epithelial Neoplasia is used for PATIENTS with cervical cancer to identify the inner glandular CELLS of the cervix.

 

top


CERVICAL INTRA-EPITHELIAL NEOPLASIA  renamed from CERVICAL INTRAEPITHELIAL NEOPLASIA

Change to Supporting Information: Changed Name, Description

Cervical Intraepithelial Neoplasia is a CANCER STAGING.Cervical Intra-epithelial Neoplasia is a CANCER STAGING.

A Cervical Intraepithelial Neoplasia is divided into grades and is used for PATIENTS with cervical cancer and may be used to describe how abnormal the CELLS are and how much of the cervical TISSUE is involved.A Cervical Intra-epithelial Neoplasia is divided into grades and is used for PATIENTS with cervical cancer and may be used to describe how abnormal the CELLS are and how much of the cervical TISSUE is involved.

For further information on Cervical Intraepithelial Neoplasia, see the National Cancer Institute website.For further information on Cervical Intra-epithelial Neoplasia, see the National Cancer Institute website.

 

top


CLINICAL INTERVENTION DATE AND TIME

Change to Supporting Information: New Supporting Information

A Clinical Intervention Date and Time is an ACTIVITY DATE TIME.

A Clinical Intervention Date and Time is the Clinical Intervention Date and Clinical Intervention Time of the occurrence of the CLINICAL INTERVENTION.

 

This supporting information is also known by these names:
ContextAlias
pluralClinical Intervention Dates

top


CLINICAL INTERVENTION TIME

Change to Supporting Information: New Supporting Information

A Clinical Intervention Time is an ACTIVITY DATE TIME.

A Clinical Intervention Time is the time of the occurrence of the CLINICAL INTERVENTION.

 

This supporting information is also known by these names:
ContextAlias
pluralClinical Intervention Times

top


CLINICAL INVESTIGATION

Change to Supporting Information: Changed Description

A Clinical Investigation is a CLINICAL INTERVENTION.

A Clinical Investigation is a clinical test or investigation offered to or carried out on a PERSON.

Clinical Investigations may include blood tests for specific antibodies, scans or physical examinations for specific diseases.

 A Clinical Investigation may include a Patient Procedure, where it is both diagnostic and therapeutic, for example, certain endoscopic procedures.

 

top


CONTRACEPTIVE SERVICE

Change to Supporting Information: Changed Description

Contraceptive Service is a CLINICAL INTERVENTION.A Contraceptive Service is a SERVICE.

An Item of Service Delivery.A Contraceptive Service is the delivery of Contraceptive Services to a PERSON by a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.

The delivery of Contraceptive Services to a PERSON by a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.

Note that Items of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.

References:
Statement of Fees and Allowances Payable to General Medical Practitioners in England and Wales.

 

top


DENTAL HAEMORRHAGE SERVICE

Change to Supporting Information: Changed Description

Dental Haemorrhage Service is a CLINICAL INTERVENTION.A Dental Haemorrhage Service is an Item Of Service Delivery.

An Item of Service Delivery.A Dental Haemorrhage Service is the arresting of a dental haemorrhage or provision of aftercare treatment associated with the dental haemorrhage, delivered by a GENERAL MEDICAL PRACTITIONER to a PATIENT, for which a fee may be claimed.

The arresting of a dental haemorrhage or provision of after care treatment associated with the dental haemorrhage, delivered by a GENERAL MEDICAL PRACTITIONER to a PATIENT, for which a fee may be claimed.Note that Items Of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.

Note that Items of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.

References:
Statement of Fees and Allowances Payable to General Medical Practitioners in England and Wales.

 

top


DENTAL TREATMENT

Change to Supporting Information: Changed Description

Dental Treatment is a CLINICAL INTERVENTION.

A delivery of dental care of a single DENTAL TREATMENT CLASSIFICATIONS given during a Dental Treatment Contact. This includes all treatment given by community dental services outside Oral Health Programme.Dental Treatment is the delivery of dental care of a single DENTAL TREATMENT CLASSIFICATION given during a Dental Treatment Contact. This includes all treatment given by community dental services outside an Oral Health Programme.

 

top


DIAGNOSTICS WAITING TIMES AND ACTIVITY DATA SET OVERVIEW

Change to Supporting Information: Changed Description

The Diagnostic waiting times reporting of the monthly waiting times and activity reporting (DM01).

The Diagnostics Waiting Times and Activity Data Set provides definitions to support the national data collections on DIAGNOSTIC TESTS, a key element towards monitoring waits from referral to treatment. ORGANISATIONS responsible for the DIAGNOSTIC TEST activity report the DIAGNOSTIC TEST waiting times and the number of tests completed.

The distinctions between the data set groups are not absolute and some procedures could be collected under more than one of the clinical groupings. A PATIENT waiting for a diagnostic investigation should be counted only once for each test they are waiting for, wherever the test is to be performed and even if there is any additional therapeutic intervention. Each test should be identified by their OPCS Classification of Interventions and Procedures coding where applicable.

The diagnostic investigations are grouped into categories of Imaging, Physiological Measurement and Endoscopy. The data set is for the monthly return covering 15 key DIAGNOSTIC TESTS as below:

IMAGING

  • Magnetic Resonance Imaging
  • Computer Tomography
  • Non-obstetric ultrasound
  • Barium Enema
  • DEXA Scan (Dual-energy X-ray absorptiometry)

PHYSIOLOGICAL MEASUREMENT

  • Audiology - audiological assessments
  • Cardiology - echocardiography
  • Cardiology - electrophysiology
  • Neurophysiology - peripheral neurophysiology
  • Respiratory physiology - sleep studies
  • Urodynamics - pressures & flows

ENDOSCOPY

  • Colonoscopy
  • Flexible sigmoidoscopy
  • Cystoscopy
  • Gastroscopy
Aggregated numbers of PATIENTS waiting for a DIAGNOSTIC TEST/procedure funded by the NHS should be included. This includes all referral routes (i.e. whether the PATIENT was referred by a GENERAL PRACTITIONER or by a hospital-based clinician or other route) and also all settings (i.e. Out-Patient Clinic, WARD, Imaging Department or a type of LOCATION such as a Health Centre). It is recognised that there will be some overlap between PATIENTS reported in this data set and PATIENTS reported in the other waiting times data sets.

How the data set is transmitted

Information is to be submitted onto the Unify2 database that has been developed and maintained by the Department of Health. Full guidance on Unify2 can be found at: Unify2.

Further guidance

Guidance on extracting the data sets and PATIENT PATHWAYS, including OPCS Classification of Interventions and Procedures, can be found at: Department of Health - Diagnostics.For further guidance on extracting the data sets and PATIENT PATHWAYS, see the NHS England website at: Diagnostics Waiting Times and Activity.

top


DIAGNOSTICS WAITING TIMES CENSUS DATA SET OVERVIEW

Change to Supporting Information: Changed Description

The Diagnostic Census of the waiting times for DIAGNOSTIC TEST REQUESTS.

The Diagnostics Waiting Times Census Data Set provides definitions to support the national data collections on DIAGNOSTIC TESTS, a key element towards monitoring waits from referral to treatment. This is a census of DIAGNOSTIC TEST waiting times.

The diagnostic investigations are grouped into categories of Endoscopy, Imaging, Pathology and Physiological Measurement.

The distinctions between these groups are not absolute and some procedures could be collected under more than one of the clinical groupings. A PATIENT waiting for a diagnostic investigation should be counted only once for each test they are waiting for, wherever the test is to be performed and even if there is any additional therapeutic intervention. Each test should be identified by their OPCS Classification of Interventions and Procedures coding where applicable.

This data set is for the census covering 4 main areas of DIAGNOSTIC TESTS as below:

  • Part 1 - Endoscopy
  • Part 2 - Imaging
  • Part 3 - Pathology
  • Parts 4 to 11 - Physiological Measurement

Patient level information

Information is to be submitted onto the Unify2 database that has been developed and maintained by the Department of Health. All PATIENTS waiting for a DIAGNOSTIC TEST/procedure funded by the NHS should be included. This includes all referral routes (i.e. whether the PATIENT was referred by a GENERAL PRACTITIONER or by a hospital-based clinician or other route) and also all settings (i.e. Out-Patient Clinic, WARD, Imaging Department, GP Practice, one-stop centres etc.). It is recognised that there will be some overlap between PATIENTS reported on this census and PATIENTS reported in the inpatient and outpatient waiting times returns.

How the data set is transmitted

Full guidance on Unify2 can be found at: Unify2.

Further guidance

Guidance on extracting the data sets, including OPCS Classification of Interventions and Procedures, can be found at: Department of Health - Diagnostics.For further guidance on extracting the data sets, see the NHS England website at: Diagnostics Waiting Times and Activity.

top


DIASTOLIC BLOOD PRESSURE

Change to Supporting Information: Changed Description

top


DOMINANT ARM (RETIRED)  renamed from DOMINANT ARM

Change to Supporting Information: Changed Name, Description, status to Retired

Dominant Arm is a PERSON PROPERTY This item has been retired from the NHS Data Model and Dictionary.

Dominant Arm is recorded for the purposes of measuring a PATIENT's Blood Pressure.The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

Blood Pressure differences are common between readings when taken from both PATIENT's arms, and may be slightly higher in the PERSON's Dominant Arm. For example, if the PERSON is  left-handed, the left arm may have a slightly higher reading than the right arm.Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

 

top


DOMINANT ARM (RETIRED)  renamed from DOMINANT ARM

Change to Supporting Information: Changed Name, Description, status to Retired

top


DRY WEIGHT

Change to Supporting Information: Changed Description

Dry Weight is a MEASURED PERSON OBSERVATION.Dry Weight is a CLINICAL INVESTIGATION RESULT ITEM.

Dry Weight is a PATIENT's Weight after a Renal Dialysis session when the extra fluid has been removed.

 

top


EMERGENCY TREATMENT SERVICE

Change to Supporting Information: Changed Description

An Item Of Service Delivery.Emergency Treatment Service is an Item Of Service Delivery.

The delivery of an Emergency Treatment Service by a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.Emergency Treatment Service is the delivery of an Emergency Treatment Service by a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.

Note that Items of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.Note that Items Of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.

References:
Statement of Fees and Allowances Payable to General Medical Practitioners in England and Wales.

 

top


FACE TO FACE CONTACT COMMUNITY CARE

Change to Supporting Information: Changed Description

Face To Face Contact Community Care is a CARE CONTACT.

A contact which is made by one or more nurses or community support workers (nursing) with a PATIENT or his/her proxy during a Community Episode. The contact occurs when a PATIENT or their proxy attends a clinic or when the nurse or community support worker (nursing) makes a domiciliary visit to see the PATIENT.Face To Face Contact Community Care is a contact which is made by one or more NURSES or community support workers (nursing) with a PATIENT or his/her proxy during a Community Episode. The contact occurs when a PATIENT or their proxy attends a clinic or when the NURSE or community support worker (nursing) makes a domiciliary visit to see the PATIENT.

A proxy contact is a single occasion involving contact between a proxy and one or more members of a community nurse staff group within a Nursing In The Community Programme.A proxy contact is a single occasion involving contact between a proxy and one or more members of a COMMUNITY NURSE STAFF GROUP within a Nursing In The Community Programme. Contacts with proxies only count if the contact is in lieu of the contact with the PATIENT, and the proxy is able more effectively than the PATIENT to ensure that the specified advice/treatment devised for the PATIENT is followed. This is most likely to be the case where the PATIENT is unable to communicate effectively say for an infant, or for a PERSON who is mentally ill or has learning disabilities.

One or more nurses or community support workers (nursing) in the same or different Nursing In The Community Programmes may be in contact with a PATIENT at the same time.

Contacts should be recorded as follows:

a.If one or more NURSES or community support workers (nursing) from the same programme are in contact with one PATIENT at the same time, this should be recorded as one face-to-face contact
b.If one or more NURSES or community support workers (nursing) from different programmes are in contact with one PATIENT at the same time, this should be recorded as one contact for each programme involved
c.For contacts at a Day Care Facility, where repeated contacts may occur during the course of a day, this should be recorded as one contact for each programme involved
d.If two NURSES of different disciplines but both classed in the community nurse staff group other community nurses, such as stomatherapist and a continuing care nurse, are in contact with one PATIENT at the same time, this should be recorded as two face-to-face contacts, one for each discipline

Group activity, where, for example, general advice is given to several PATIENTS at the same time should not be recorded as Nurse or Midwife Contacts.

A Face To Face Contact Community Care may involve activities attributable to a structured programme, such as the following:A Face To Face Contact Community Care may involve ACTIVITIES attributable to a structured programme, such as the following:

a.Screening Test 
b.Group Session 
c.Health Promotion Other Activity
d.EDUCATIONAL ASSESSMENT 
e.Test Of Immunity 
e.Test of Immunity
f.Immunisation Dose Given 
g.Face To Face Contact Surveillance 

For such activities they must be recorded as part of the respective structured programmes as well as attributed to the Nursing In The Community Programmes.For such ACTIVITIES they must be recorded as part of the respective structured programmes as well as attributed to the Nursing In The Community Programmes.

If the PATIENT is currently subject to a Mental Health Care Spell and the contact NURSE is also their allocated care programme approach care coordinator then a Face To Face Contact CPA Care Coordinator should also be recorded.

For domiciliary visits, an indication of whether the Face To Face Contact Community Care is the first occasion on which a PATIENT is seen should be recorded as an initial contact.For domiciliary visits, an indication of whether the Face To Face Contact Community Care is the first occasion on which a PATIENT is seen should be recorded as an Initial Contact. A LOCATION type should also be recorded.

Information recorded for a Face To Face Contact Community Care includes:

Contact Date
First Contact In Financial Year
Initial Contact (applies to domiciliary visits only)
LOCATION (applies to domiciliary visits only)
 

top


FORCED EXPIRATORY VOLUME IN 1 SECOND (ABSOLUTE AMOUNT)

Change to Supporting Information: Changed Description

top


FORCED EXPIRATORY VOLUME IN 1 SECOND (PERCENTAGE)

Change to Supporting Information: Changed Description

Forced Expiratory Volume in 1 second (Percentage) is a MEASURED PERSON OBSERVATION.Forced Expiratory Volume in 1 second (Percentage) is a CLINICAL INVESTIGATION RESULT ITEM.

Forced Expiratory Volume in 1 second (Percentage) is the volume of air that can forcibly be blown out in one second, after full inspiration, as a percentage of the predicted value.Forced Expiratory Volume in 1 second (Percentage) is the volume of air that can forcibly be blown out in one second, after full inspiration, as a 'Percentage (%)' of the predicted value.

 

top


GESTATION LENGTH IN DAYS (RETIRED)  renamed from GESTATION LENGTH IN DAYS

Change to Supporting Information: Changed Name, Description, status to Retired

Gestation Length In Days is the gestation length of a Fetus Episode recorded as the total number of days.This item has been retired from the NHS Data Model and Dictionary.

The calculation may be:The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

a)calculated by ultrasound scan measurements according to the trimester of the scan
b)estimated from the LAST MENSTRUAL PERIOD DATE
c)estimated by clinical assessment (in the absence of a or b)

The number of completed whole weeks of gestation and the remaining number of days of an uncompleted whole week should be calculated from the Gestation Length In Days for input and reporting purposes. Where there is no uncompleted whole week, the number of additional days should be recorded as zero.Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

For example:

 

top


GESTATION LENGTH IN DAYS (RETIRED)  renamed from GESTATION LENGTH IN DAYS

Change to Supporting Information: Changed Name, Description, status to Retired

top


HAND GRIP STRENGTH

Change to Supporting Information: Changed Description

top


HBA1C

Change to Supporting Information: Changed Description

HbA1c (Hemoglobin A1c), also known as Glycated Hemoglobin, is a MEASURED PERSON OBSERVATION.HbA1c (Hemoglobin A1c), also known as Glycated Hemoglobin, is a CLINICAL INVESTIGATION RESULT ITEM.

The HbA1c test measures the amount of glucose that is being carried by the red blood cells in the body.The HbA1c test measures the amount of plasma glucose concentration that is being carried by the red blood cells in the body, over a prolonged period of time.

 

top


HEAD CIRCUMFERENCE

Change to Supporting Information: Changed Description

top


HEART RATE

Change to Supporting Information: Changed Description

Heart Rate is a MEASURED PERSON OBSERVATION.Heart Rate is a CLINICAL INVESTIGATION RESULT ITEM.

Heart Rate is the number of heart beats per unit of time. 

 

top


HEIGHT

Change to Supporting Information: Changed Description

Height is a MEASURED PERSON OBSERVATION.Height is a CLINICAL INVESTIGATION RESULT ITEM.

Height is the height of a PATIENT on a given date, where the MEASUREMENT VALUE TYPE CODE is 'Metres (m)' or 'Centimetres (cm)'.Height is the height of a PATIENT on a given date, where the UNIT OF MEASUREMENT is 'Metres (m)' or 'Centimetres (cm)'.

 

top


HIP MEASUREMENT

Change to Supporting Information: Changed Description

top


MANTOUX TEST

Change to Supporting Information: Changed Description

A Mantoux Test is a Test Of Immunity.A Mantoux Test is a Screening Test.

The Mantoux Test is used as a Screening Test for tuberculosis infection or disease and as an aid to diagnosis.

Further information about Mantoux Tests can be found on the NHS Immunisation Information website.For further information on Mantoux Tests, see the NHS Choices website.

 

top


MATERNITY MEDICAL SERVICE

Change to Supporting Information: Changed Description

An Item Of Service Delivery.A Maternity Medical Service is an Item Of Service Delivery.

The delivery of maternity medical services to a PATIENT by a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.A Maternity Medical Service is the delivery of maternity medical services to a PATIENT by a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.

Note that Items of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.Note that Items Of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.

References:
Statement of Fees and Allowances Payable to General Medical Practitioners in England and Wales.

 

top


MID ARM CIRCUMFERENCE

Change to Supporting Information: Changed Description

top


MINOR SURGERY PROCEDURE

Change to Supporting Information: Changed Description

An Item Of Service Delivery.A Minor Surgery Procedure is an Item Of Service Delivery.

A minor surgical procedure performed on a PATIENT by a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.A Minor Surgery Procedure is a surgical procedure performed on a PATIENT by a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.

Note that Items of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.Note that Items Of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.

References:
Statement of Fees and Allowances Payable to General Medical Practitioners in England and Wales.

 

top


NATIONAL DIRECT ACCESS AUDIOLOGY PATIENT TRACKING LIST DATA SET OVERVIEW

Change to Supporting Information: Changed Description

The National Direct Access Audiology Patient Tracking List Data Set collects performance information on a weekly basis, on the Referral To Treatment pathways of PATIENTS who are receiving NHS funded audiology treatment in England, who are not already included in the Referral to Treatment Summary Patient Tracking List Data Set. This includes:

  • both analogue and digital hearing aid fittings
  • services provided directly by NHS Healthcare Providers and also NHS funded PATIENTS treated via the Independent Sector and third sector providers (collected directly or via Primary Care Trusts)
  • both new and existing PATIENTS
  • any other PATIENTS attending Audiology services directly

For the purposes of the National Direct Access Audiology Patient Tracking List Data Set, "Direct Access" means PATIENTS who are not referred via Ear, Nose and Throat (ENT) or other hospital CONSULTANT. Any pathways that are subject to the 18 weeks waiting time target for Referral to Treatment are out of scope. For this reason PATIENTS on Ear, Nose and Throat pathways (or pathways from other specialties) are excluded from this central return data set - information on these PATIENTS is available via the Referral to Treatment Summary Patient Tracking List Data Set data collection.

The National Direct Access Audiology Patient Tracking List Data Set is in two parts, as follows:

Parts 1A and 1B: Untreated Patients

Part 1A should be completed for PATIENTS who have not had an ACTIVITY which ends their REFERRAL TO TREATMENT PERIOD (such as first definitive treatment, or a decision not to treat)

AND

who do not have a future APPOINTMENT for an ACTIVITY with an anticipated REFERRAL TO TREATMENT PERIOD STATUS of 30 before the REFERRAL TO TREATMENT PERIOD EXCEEDS 18 WEEKS DATE.

Part 1B should be completed for PATIENTS who have not had an ACTIVITY which ends their REFERRAL TO TREATMENT PERIOD (such as first definitive treatment, or a decision not to treat)

AND

whose REFERRAL TO TREATMENT PERIOD EXCEEDS 18 WEEKS DATE has passed.

Part 2 should be completed for PATIENTS who have a REFERRAL TO TREATMENT PERIOD END DATE within the last 7 days

Full guidance on the completion and submission of the National Direct Access Audiology Waiting Times Data Set is available from the Department of Health website.For further guidance, see NHS England website at: Direct Access Audiology.

The Department of Health document 'Improving Access to Audiology Service in England' can be found at the  "Direct Access Audiology Waiting Times and PTL collections section" of the Department of Health website.

top


NATIONAL DIRECT ACCESS AUDIOLOGY WAITING TIMES DATA SET OVERVIEW

Change to Supporting Information: Changed Description

The National Direct Access Audiology Waiting Times Data Set collects performance information on a monthly basis on the Referral To Treatment pathways of PATIENTS who are receiving NHS funded audiology treatment in England, who are not already included in the Referral To Treatment Data Set data collection. This includes:

  • both analogue and digital hearing aid fittings
  • services provided directly by NHS Healthcare Providers and also NHS funded PATIENTS treated via the Independent Sector and third sector providers (collected directly or via Primary Care Trusts)
  • both new and existing PATIENTS
  • any other PATIENTS attending Audiology services directly

For the purposes of the National Direct Access Audiology Waiting Times Data Set, "Direct Access" means PATIENTS who are not referred via Ear, Nose and Throat (ENT) specialist or other hospital CONSULTANT. Any pathways that are subject to the 18 week waiting time target for Referral to Treatment are out of scope. For this reason PATIENTS on Ear, Nose and Throat pathways (or pathways from other specialties) are excluded from this central return data set - information on these PATIENTS is available via the Referral To Treatment Data Set data collection.

The National Direct Access Audiology Waiting Times Data Set is in two parts, as follows:

Part 1 - Treated Patients should be completed for PATIENTS who have had an ACTIVITY which ends their REFERRAL TO TREATMENT PERIOD (such as first definitive treatment, or a decision not to treat), within the REPORTING PERIOD.

Part 2 - Untreated Patients should be completed for PATIENTS without a REFERRAL TO TREATMENT PERIOD END DATE within the REPORTING PERIOD.

Full guidance on the completion and submission of the National Direct Access Audiology Waiting Times Data Set is available from the Department of Health website.

The Department of Health document 'Improving Access to Audiology Service in England' can be found at the  "Direct Access Audiology Waiting Times and PTL collections section" of the Department of Health website.For further guidance, see NHS England website at: Direct Access Audiology.

top


ORGANISATIONS INTRODUCTION

Change to Supporting Information: Changed Description

ORGANISATIONS such as the Health and Social Care Information Centre, General Medical Council etc which are included in the NHS Data Model and Dictionary.

Referenced Organisations:

 

 Regulatory Bodies:

 
  
  

top


ORGANISATIONS MENU

Change to Supporting Information: Changed Description



top


PALLIATIVE CARE EPISODE

Change to Supporting Information: Changed Description

top


PATIENT PROCEDURE

Change to Supporting Information: Changed Description

Patient Procedure is a CLINICAL INTERVENTION.A Patient Procedure is a CLINICAL INTERVENTION.

This is the actual procedure performed on an individual PATIENT at a particular time. A PATIENT may undergo a procedure under the direct personal supervision of a medical or dental practitioner, in pregnancy or childbirth or for the prevention, cure, relief or diagnosis of disease. It should be possible to record at least four procedures for each Consultant Episode (Hospital Provider).A Patient Procedure is a procedure performed on a PATIENT by a CARE PROFESSIONAL.

In the case of an electro-convulsive therapy (ECT) treatment procedure, it comprises the PATIENT being given an anaesthetic for the purpose of electro-convulsive therapy and being administered one or more electric stimuli to the head and should be recorded regardless of whether or not the PATIENT has a convulsion.A Patient Procedure may be carried out:

 
  • for the prevention, cure, relief or diagnosis of disease
  • during pregnancy
  • during childbirth.
  • A Patient Procedure may be carried out as part of a Clinical Investigation, where it is both diagnostic and therapeutic, for example, certain endoscopic procedures.

     

    top


    PERCENTAGE WEIGHT LOSS

    Change to Supporting Information: Changed Description

    Percentage Weight Loss is a MEASURED PERSON OBSERVATION.

    Percentage Weight Loss is a CLINICAL INVESTIGATION RESULT ITEM.

    Percentage Weight Loss is the percentage of Weight lost by a PATIENT over a specified period.

    Percentage Weight Loss is used as an indicator of malnutrition.Percentage Weight Loss may be used as an indicator of malnutrition.

     

    top


    PERSON STOP SMOKING EPISODE

    Change to Supporting Information: Changed Description

    A Person Stop Smoking Episode is an ACTIVITY GROUP.

    A Person Stop Smoking Episode is a period of time during which a PERSON attempts to stop smoking as a result of structured stop smoking interventions, delivered by NHS staff or their trained agents. During this time, it is expected that the PERSON will set a SMOKING QUIT DATE.

    The Person Stop Smoking Episode:

    • starts when the PERSON has consented to a programme of treatment and presents themselves to the Stop Smoking Service for a treatment session and has set a SMOKING QUIT DATE
    • ends 28 days after their specified SMOKING QUIT DATE (or within 25 to 42 days of the SMOKING QUIT DATE) when it is confirmed that the PERSON:
      • has stopped smoking
      • has not been successful or
      • are lost to follow up (where the PERSON could not be contacted at four weeks (-3 days or +14 days)).

    A PERSON who has participated in an assessment session but failed to attend for treatment should not be counted as having started a Person Stop Smoking Episode.

    For further information, see the Department of Health NHS Stop Smoking Services: service and monitoring guidance, October 2007/08.For further information, see the Department of Health part of the gov.uk website at Stop Smoking Service: monitoring and guidance update.

     

    top


    POST MORTEM

    Change to Supporting Information: Changed Description

    Post Mortem is a CLINICAL INTERVENTION.A Post Mortem is a CLINICAL INTERVENTION.

    A pathology procedure carried out on NHS premises. This should include post mortem examinations of the viable new born fetus but exclude dissection of the pre-viable fetus.A Post Mortem is the pathological examination of a dead body to determine the cause of death.

     A Post Mortem may include post-mortem examination of a viable new born fetus but excludes dissection of a pre-viable fetus.

     

    top


    RADIOLOGY DEPARTMENT

    Change to Supporting Information: Changed Description

    Radiology Department is a DEPARTMENT.A Radiology Department is a DEPARTMENT.

    A unit based in one or more LOCATIONS which is managed as a separate entity by a CONSULTANT or non-medical scientist of equivalent standing in the MAIN SPECIALTY of radiology which deals with requests for radiological or isotope procedures.A Radiology Department is a unit based in one or more LOCATIONS which is managed as a separate entity by a CONSULTANT or non-medical scientist of equivalent standing in the MAIN SPECIALTY of radiology which deals with requests for radiological or isotope procedures.

    A Radiology Department may produce Radiology Investigation Plans, perform Imaging or Radiodiagnostic Events and provide radiology investigation result items.

     

    top


    RADIOTHERAPY DEPARTMENT

    Change to Supporting Information: Changed Description

    Radiotherapy Department is a DEPARTMENT.A Radiotherapy Department is a DEPARTMENT.

    A Radiotherapy Department is a facility with rooms in which Radiotherapy Machines are housed and operated. A Radiotherapy Department may be responsible for one or more Radiotherapy Treatment Courses.

     

    top


    RH SYSTEM

    Change to Supporting Information: Changed Description

    The Rh System is a classification for a CLINICAL INVESTIGATION RESULT ITEM.The Rh System is a CLINICAL CLASSIFICATION.

    In addition to the antigens present in the ABO System, red blood cells sometimes have another antigen, a protein called the Rh factor.

    • If the Rh factor is present, the PERSON's blood group is RhD positive;
    • If the Rh factor is absent, the PERSON is RhD negative.

    This means that a PERSON can be one of eight blood groups:

    • A RhD positive (A+)
    • A RhD negative (A-)
    • B RhD positive (B+)
    • B RhD negative (B-)
    • O RhD positive (O+)
    • O RhD negative (O-)
    • AB RhD positive (AB+)
    • AB RhD negative (AB-).

    For further information on the Rh System, see the NHS Choices website.

     

    top


    RH SYSTEM

    Change to Supporting Information: Changed Description

    top


    SCREENING TEST

    Change to Supporting Information: Changed Description

    Screening Test is a CLINICAL INTERVENTION.A Screening Test is a Clinical Investigation.

    A test performed on a PERSON to detect a specific disease or impairment, which may be carried out as part of a Screening Programme. It should be noted that individuals may have to be re-tested shortly after an initial test for technical reasons such as the loss of sample, an unsatisfactory test procedure, or an inconclusive result. The Screening Test is not complete until such re-tests have been satisfactorily completed.A Screening Test is a test performed on a PATIENT to detect a specific disease or impairment, which may be carried out as part of a Screening Programme.

     It should be noted that individuals may have to be re-tested shortly after an initial test for technical reasons such as the loss of sample, an unsatisfactory test procedure, or an inconclusive result.

    The Screening Test is not complete until such re-tests have been satisfactorily completed.

     

    top


    SERUM CHOLESTEROL LEVEL

    Change to Supporting Information: Changed Description

    top


    SERUM CREATININE LEVEL

    Change to Supporting Information: Changed Description

    Serum Creatinine Level is a MEASURED PERSON OBSERVATION.Serum Creatinine Level is a CLINICAL INVESTIGATION RESULT ITEM.

    Serum Creatinine Level is the concentration of creatinine in serum (used as an indicator of renal function).

     

    top


    STOP SMOKING SERVICE

    Change to Supporting Information: Changed Description

    A Stop Smoking Service is a SERVICE.

    A Stop Smoking Service is a SERVICE set up by a Primary Care Trust to help people give up smoking.

    For a SERVICE to be designated as an NHS Stop Smoking Service requires that minimum quality standards should be met. To meet these minimum quality standards all advisers should:

    • have received appropriate training for their role,
    • carry out the 4 week follow-up promptly, in accordance with the current guidance,
    • complete the minimum dataset (the individual PERSON data monitoring forms) for each PERSON, fully and accurately, and return the information required to the coordinator in good time,
    • offer weekly support for at least the first four weeks of a quit attempt,
    • attempt to confirm smoking status of all PERSONS self-reporting as having quit at 4 week follow-up by use of a carbon monoxide monitor, except where follow-up is carried out by telephone.

    The majority of Stop Smoking Services will operate broadly on the 'Maudsley' model of a clinic providing intensive support, usually on a group therapy basis, to the most dependent smokers. The Stop Smoking Service should also continue to be supplemented by a range of SERVICES in various settings in primary care, secondary care and the community.

    Central monitoring of data regarding 52 week follow-up is no longer required however, follow-up at 52 week stage is still recommended as good practice to establish long-term success rates and this information should still be collected locally.

     For further information on Stop Smoking Services, see the Department of Health part of the gov.uk website at Stop Smoking Service: monitoring and guidance update.

     

    top


    STOP SMOKING SERVICE QUARTERLY DATA SET OVERVIEW

    Change to Supporting Information: Changed Description


    Collection and Submission
    Synopsis of Data Set Content

    top


    SYSTOLIC BLOOD PRESSURE

    Change to Supporting Information: Changed Description

    top


    TEMPERATURE

    Change to Supporting Information: Changed Description

    top


    TEST OF IMMUNITY  renamed from TEST OF IMMUNITY

    Change to Supporting Information: Changed Name, Description

    top


    URINARY ALBUMIN LEVEL

    Change to Supporting Information: Changed Description

    top


    URINE OUTPUT

    Change to Supporting Information: Changed Description

    Urine Output is a MEASURED PERSON OBSERVATIONUrine Output is a CLINICAL INVESTIGATION RESULT ITEM.

    Urine Output is the output of urine of a PATIENT over a specified period of time (i.e. last hour, last 24 hours).

     

    top


    VACCINATION SERVICE

    Change to Supporting Information: Changed Description

    An Item Of Service Delivery.A Vaccination Service is an Item Of Service Delivery.

    A vaccination or immunisation given to a PERSON in accordance with public policy by or on behalf of a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.A Vaccination Service is a vaccination or immunisation given to a PERSON in accordance with public policy, by or on behalf of a GENERAL MEDICAL PRACTITIONER, for which a fee may be claimed.

    The applicable payment rate for the Vaccination Service delivered is determined by the combination of VACCINE PREVENTABLE DISEASE and IMMUNISATION COURSE TYPE.

    Note that Items of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.Note that Items Of Service Delivery reimbursement cannot be claimed by those GENERAL MEDICAL PRACTITIONERS who hold a Personal Medical Services, as opposed to a General Medical Services, contract.

    References:
    Statement of Fees and Allowances Payable to General Medical Practitioners in England and Wales.

     

    top


    VASECTOMY PERFORMED (RETIRED)  renamed from VASECTOMY PERFORMED

    Change to Supporting Information: Changed Name, Description, status to Retired

    Vasectomy Performed is a CLINICAL INTERVENTION.This item has been retired from the NHS Data Model and Dictionary.

    A vasectomy operative procedure performed, excluding those vasectomies performed on NHS PATIENTS using a Hospital Bed.The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

     Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

     

    top


    VASECTOMY PERFORMED (RETIRED)  renamed from VASECTOMY PERFORMED

    Change to Supporting Information: Changed Name, Description, status to Retired

    top


    VENOUS THROMBOEMBOLISM RISK ASSESSMENT DATA SET OVERVIEW

    Change to Supporting Information: Changed Description

    The purpose of the Venous Thromboembolism Risk Assessment Data Set is to quantify the number of adult PATIENTS (aged 18 and over) admitted to hospital, who are risk assessed for Venous Thromboembolism using the Venous Thromboembolism Risk Assessment Tool to allow appropriate preventative treatment based on guidance from the National Institute for Health and Clinical Excellence.

    Collection and submission of the Venous Thromboembolism Risk Assessment Data Set

    All providers of NHS funded acute hospital care (including foundation trusts and Independent Providers of acute NHS services) must complete this data collection.

    Data on Venous Thromboembolism risk assessments should be uploaded onto UNIFY2 each month no later than 20 working days after the month end. Revisions to the data set before the cut off date are allowed however, revisions made after the cut off date must be made in liaison with the Department of Health.

    Full guidance on the Venous Thromboembolism Risk Assessment Tool  can be be found at: National Institute for Health and Clinical Excellence website and also The Department of Health Venous Thromboembolism website.For further guidance on the Venous Thromboembolism Risk Assessment Data Set, see the:

    top


    VENOUS THROMBOEMBOLISM RISK ASSESSMENT TOOL

    Change to Supporting Information: Changed Description

    top


    WAIST MEASUREMENT

    Change to Supporting Information: Changed Description

    top


    WEIGHT

    Change to Supporting Information: Changed Description

    Weight is a MEASURED PERSON OBSERVATION.Weight is a CLINICAL INVESTIGATION RESULT ITEM.

    Weight is the weight of a PATIENT on a given date, where the MEASUREMENT VALUE TYPE CODE is 'Kilograms (kg)' or 'Grams (g)'.Weight is the weight of a PATIENT on a given date, where the UNIT OF MEASUREMENT is 'Kilograms (kg)' or 'Grams (g)'.

     

    top


    WHAT'S NEW: NOVEMBER 2013  renamed from WHAT'S NEW: SEPTEMBER 2013

    Change to Supporting Information: Changed Name, Description

    Release: November 2013

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1367 (29 November 2013) - ISB 0090 Amd 5/2013 Organisation Data Service – Introduction of New Sub Type Identifier for Private Dental Practices
    • CR1359 (29 November 2013) - ISB 0090 Amd 47/2012 Organisation Data Service - Identification Codes for Local Authorities
    • DDCN 1407 (Immediate) - DDCN 1407/2013 Clinical Investigations
    • DDCN 1415 (Immediate) - DDCN 1415/2013 Area Teams
    • DDCN 1411 (Immediate) - DDCN 1411/2013 Update to Supporting Information: SNOMED CT®

    Release: September 2013

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1348 (1 October 2013) - ISB 1597 Amd 35/2012 Breast Screening Programmes Data Set (KC63 and KC62)
    • CR1403 (Immediate) - DDCN 1403/2013 Religious or Other Belief System Affiliation
    • CR1384 (Immediate) - DDCN 1384/2013 Health and Social Care Information Centre Rebranding of XML Schemas
    • CR1397 (Immediate) - DDCN 1397/2013 Retired Main Specialty Codes

    Release: July 2013

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1377 (Immediate) - ISB 0105 Retirement of Accident and Emergency Quarterly Monitoring Data Set (QMAE)

    Release: May 2013

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:

    Release: April 2013

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1372 (Immediate) - DDCN 1372/2013 Organisation Update: April 2013
    • CR1369 (Immediate) - DDCN 1369/2013 Organisation Codes and Organisation Types
    • CR1347 (1 April 2013) - ISB 1521 Amd 40/2012 Updates to the Cancer Outcomes and Services Data Set and XML Schema

    Release: March 2013

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:

    Release: February 2013

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1336 (Immediate) - DDCN 1336/2013 XML Schema Constraint Pages
    • CR1362 (Immediate) - DDCN 1362/2013 Update to Organisations in the NHS Data Model and Dictionary
    • CR1246 (Immediate) - DDCN 1246/2013 Guidance for Merging Organisations
    • CR1345 (Immediate) - DDCN 1345/2013 e-Government Interoperability Framework (e-GIF) and Government Data Standards Catalogue
    • CR1354 (Immediate) - DDCN 1354/2013 Treatment Function Code - Well Babies

    Release: December 2012

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1155 (Immediate) - ISB 1567 Amd 12/2011 National Joint Registry Data Set Version 5
    • CR1324 (1 December 2012) - ISB 1067 Amd 23/2012 Workforce Data Set Version 2.5
    • CR1196, CR1287 and CR1195 (1 January 2013) - ISB 1521 Amd 64/2010 Cancer Outcomes and Services Data Set, Cancer Outcomes and Services Data Set Message and Retirement of Cancer Registration Data Set and National Cancer Data Set

    The following have been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2013:

    • CR1337 (1 April 2013) - ISB 1072 Amd 30/2012 Update to Child and Adolescent Mental Health Services Secondary Uses Data Set

    Release: November 2012

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1166, CR1167 and CR1306 (1 November 2012) - ISB 0092 Amd-16-2010 Commissioning Data Set Version 6-2, Commissioning Data Set XML Message Version 6-2 and Retirement of CDS 6-0
    • CR1305 (1 April 2013) - ISB 0092 Amd 06/2011 Allied Health Professions Referral to Treatment (AHP RTT) Update - CDS 6-2
    • CR1286 (1 November 2012) - ISB 0028 Amd 17/2012 Treatment Function Codes Update
    • CR1343 (Immediate) - DDCN 1343/2012 Change of name for NHS Commissioning Board Authority
    • CR1342 (Immediate) - DDCN 1342/2012 Overseas Visitors Update
    • CR1341 (Immediate) - DDCN 1341/2012 Discharge Default Code Descriptions
    • CR1323 (Immediate) - National Cancer Waiting Times Monitoring Data Set Update for "Delay Reason To Treatment For Cancer"

    CR1323 is a corrigendum to CR1258 (1 July 2012) - ISB 0147 Amd 23/2011 Changes to the National Cancer Waiting Times Monitoring Data Set published in the June 2012 release

    The following have been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2013:

    • CR1231 and CR1288 (1 April 2013) - ISB 1570 Amd 164/2010 HIV and AIDS Reporting Data Set and HIV and AIDS Related Data Set Message

    Release: September 2012

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1103 (Immediate) - ISB 0066 Amd 43/2010 Renal Data Set - Data Item Addition, Changes and Deletions
    • CR1334 (Immediate) - DDCN 1334/2012 Psychology Definitions
    • CR1331 (Immediate) - DDCN 1331/2012 Activity Date Time Type
    • CR1329 (Immediate) - DDCN 1329/2012 Change of name for "Health and Social Care Information Centre"

    Release: August 2012

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1326 (Immediate) - DDCN 1326/2012 Health and Care Professions Council
    • CR1241 (Immediate) - DDCN 1241/2012 NHS dictionary of medicines and devices
    • CR1292 (Immediate) - ISB 1549 Amd 4/2011 and DDCN 1292/2012 Deprecation and withdrawal of version 3.2 of the Acute Myocardial Infarction Data Set and subsequent retiring of the Data Set from the NHS Data Model and Dictionary

    Release: June 2012

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1314 (Immediate) - DDCN 1314/2012 Reasonable Offer Update
    • CR1282 (29 June 2012) - ISB 0090 Amd 36/2011 Independent Sector Healthcare Provider (ISHP) Codes extended for ISHPs and Sites
    • CR1258 (1 July 2012) - ISB 0147 Amd 23/2011 Changes to the National Cancer Waiting Times Monitoring Data Set

    Release: May 2012

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1215 (1 June 2012) - ISB 1067 Amd 30/2011 National Workforce Data Set

      The following have been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2013:

    • CR1028 (1 April 2013) - ISB 1069 Amd 14/2012 Children and Young People's Health Services Data Set
    • CR1029 (1 April 2013) - ISB 1072 Amd 12/2012 Child and Adolescent Mental Health Services (CAMHS) Data Set
    • CR1104 (1 April 2013) - ISB 1513 Amd 13/2012 Maternity Secondary Uses Data Set

    Release: March 2012

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:

    Release: January 2012

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:

    Release: November 2011

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1264 (Immediate) - ISB 1077 Amd 3/2012 Automatic Identification and Data Capture (AIDC) for Patient Identification Data Set
    • CR1274 (Immediate) - DDCN 1274/2011 CDS Prime Recipient Identity Update

      The following have been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2012:

    • CR1265 (1 April 2012) - ISB 1520 Amd 29/2011 Changes to the Improving Access to Psychological Therapies Data Set

    Release: October 2011

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1271 (Immediate) - DDCN 1271/2011 Commissioning Data Set Addressing Grid Update
    • CR1268 (Immediate) - DDCN 1268/2011 Sexual Orientation Code
    • The following has been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2012:

    • CR1158 and CR1260 (1 April 2012) - ISB 1533 Amd 63/2010 Systemic Anti-Cancer Therapy Data Set and Systemic Anti-Cancer Therapy Data Set Message Schema

      The following have been incorporated early to allow users to see the changes, but please note that the implementation date is 1 July 2012:

    • CR1270 (1 July 2012) - ISB 1080 Amd 25/2011 Amendments to NHS Health Check Data Set
    • CR1250 (1 July 2012) - ISB 1080 Amd 25/2011 NHS Health Checks Data Set Message Schema Version 2.0.0

    Release: August 2011

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1232 (Immediate) - ISB 0034 Amd 26/2006 Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) - NHS Data Model and Dictionary Overview
    • CR1222 (1 April 2012) - ISB 0021 Amd 86/2010 Introduction of the International Classification of Diseases Tenth Revision 4th Edition
    • CR1190 (1 September 2011) - ISB 1538 Amd 131/2010 Chlamydia Testing Activity Data Set
    • CR1188 (Immediate) - Amd 85/2010 Genitourinary Medicine Clinic Activity Data Set (GUMCAD) Extension to include Enhanced Sexual Health Services (ESHS)

    The following data set is initially being introduced for local use only. A future Information Standards Notice will be published to notify providers and system suppliers of the requirement to flow the data set nationally:

    Release: July 2011

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1249 (Immediate) - DDCN 1249/2011 General Pharmaceutical Council Registration Changes

    The following has been incorporated early to allow users to see the changes, but please note that the implementation date is 1 July 2012:

    Release: June 2011

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1256 (Immediate) - DDCN 1256/2011 School Definitions
    • CR1117 (26 August 2011) - ISB 0090 Amd 94/2010 Organisation Data Service Identification Codes for Local Authorities in England and Wales
    • CR1251 (Immediate) - DDCN 1251/2011 Change to the Format/Length of Weekly Hours Worked
    • CR1243 (Immediate) - DDCN 1243/2011 National Interim Clinical Imaging Procedure (NICIP) Code Set

    Release: April 2011

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1154 (1 April 2011) - ISB 0011 Amd 87/2010 Mental Health Minimum Data Set Version 4.0
    • CR1234 (Immediate) - DDCN 1234/2011 Technology Reference Data Update Distribution Service (TRUD)
    • CR1168 (Immediate) - ISB 0097 Amd 140/2010 Genitourinary Medicine Access Monthly Monitoring Data Set Amendments - Removal of Human Immunodeficiency Virus data

    The following has been incorporated early to allow users to see the changes, but please note that the implementation date is 1 April 2012:

    Release: March 2011

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:

    Release: January 2011

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:
    • CR1116 (1 April 2010) - ISB 0003 Amd 79/2010 Immunisation Programmes Activity Data Set (KC50)
    • CR1112 (1 April 2010) - ISB 1511 Amd 26/2010 NHS Continuing Healthcare and NHS Funded Nursing Care
    • CR1068 (Immediate) - ISB 0133 Amd 161/2010 Change To Central Return: Human Papillomavirus (HPV) Immunisation Programme - Vaccine Monitoring Minimum Data Set
    • CR1211 (Immediate) - DDCN 1211/2010 Commissioning Data Set Addressing Grid / Organisation Code (Code of Commissioner) Update

    Release: December 2010

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:

    Release: November 2010

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1119 (Immediate) - DDCN 1119/2010 Organisation Codes Update 
    • CR1192 (Immediate) - DDCN 1192/2010 Change of name for "Health Solution Wales"
    • CR1199 (Immediate) - DDCN 1199/2010 General Pharmaceutical Council and Royal Pharmaceutical Society of Great Britain Update
    • CR1189 (Immediate) - DDCN 1189/2010 National Institute for Health and Clinical Excellence
    • CR1187 (Immediate) - DDCN 1187/2010 Introduction of the Department for Education

    Release: September 2010

    Information Standards Notices and Data Dictionary Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1128 (Immediate) - DDCN 1128/2010 Changes to reporting procedures for Overseas Visitors from the European Economic Area and Switzerland
    • CR1173 (Immediate) - DDCN 1173/2010 Care Quality Commission Update
    • CR1143 (Immediate) - DDCN 1143/2010 General Pharmaceutical Council
    • CR1061 (1 October 2010) - ISB 0092/2010 CDS Type 20: Out-patient: Retirement of Default Codes for Out-patient Procedures
    • CR1133 (Immediate) - ISB 00289/2010 National Specialty List

    Release: August 2010

    • The August 2010 Release introduces the NHS Data Model and Dictionary Help Pages.

    Release: July 2010

    Information Standards Notices and Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    Release: May 2010

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    Release: March 2010

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1123 (1 April 2010) - DSCN 18/2010 Information Standards Notice (ISN)
    • CR1139 (Immediate) - DSCN 16/2010 Person Weight
    • CR1130 (Immediate) - DSCN 15/2010 Change of name for "The NHS Information Centre for health and social care"
    • CR1013 (April 2010) - DSCN 14/2010 Sexual and Reproductive Health Activity Dataset (SRHAD)
    • CR1125 (Immediate) - DSCN 13/2010 NHS Data Model and Dictionary Maintenance Update - Policy Definitions
    • CR1122 (Immediate) - DSCN 11/2010 Changes to Family Planning References

    Release: January 2010

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1115 (Immediate) - DSCN 10/2010 Data Standards: Updating of e-Government Interoperability Framework and Government Data Standards Catalogue References

    Release: December 2009

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1100 (Immediate) - DSCN 25/2009 NHS Prescription Services Update
    • CR1045 (1 December 2009) - DSCN 17/2009 Referral to Treatment Clock Stop Administrative Event
    • CR1003 (1 December 2009) - DSCN 16/2009 Commissioning Data Sets: Mandation of 18 Week Referral To Treatment Data Items

    Release: November 2009

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1113 (Immediate) - DSCN 24/2009 Information Standards Board for Health and Social Care Update
    • CR1087 (Immediate) - DSCN 23/2009 Health Professions Council Update
    • CR1081 (Immediate) - DSCN 22/2009 Data Standards: NHS Data Model and Dictionary Maintenance Update
    • CR1019 (27 November 2009) - DSCN 21/2009 Data Standards: Organisation Data Service (ODS) - Optical Sites and Optical Headquarters
    • CR1034 (27 November 2009) - DSCN 20/2009 Data Standards: Organisation Data Service (ODS) - Care Homes in England and Wales and their Headquarters

    Release: September 2009

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1065 (1 October 2009) - DSCN 15/2009 Data Standards: Organisation Data Service, Local Health Boards

    Release: June 2009

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1014 (1 June 2009) - DSCN 13/2009 Religious and Other Belief System Affiliation
    • CR1074 (Immediate) - DSCN 12/2009 Data Standards: Care Quality Commission
    • CR1056 (Immediate) - DSCN 11/2009 Data Standards: NHS Data Model and Dictionary Maintenance Update
    • CR1072 (1 December 2009) - DSCN 10/2009 Data Standards: National Radiotherapy Data Set
    • CR1073 (Immediate) - DSCN 09/2009 Central Returns: Diagnostic Waiting Times and Activity Data Set
    • CR1066 (Immediate) - DSCN 08/2009 Data Standards: NHS Prescription Services and NHS Dental Services
    • CR1047 (1 April 2011) - DSCN 07/2009 Data Standards: Diabetic Retinopathy Screening Dataset v3.6 
    • CR1059 (Immediate) - DSCN 06/2009 Data Standard: National Workforce Data Set v2.1
    • CR914 (April 2008 (Retrospective)) - DSCN 05/2009 NHS Stop Smoking Services Quarterly Monitoring Return
    • CR899 (Immediate) - DSCN 02/2009 NHS Data Model and Dictionary Maintenance Update

    Release: March 2009

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1001 (1 April 2009) - DSCN 03/2009 Introduction of Commissioning Data Set Schema Version 6-1 (2008-04-01) and update to Commissioning Data Set Schema Version 6-0 (2008-01-14)
    • CR976 (31 March 2009) - DSCN 26/2008 Subject: KP90 - Admissions, Changes in Status and Detentions under the Mental Health Act
    • CR1017 (1 April 2009) - DSCN 25/2008 Critical Care Minimum Data Set
    • CR1002 (1 April 2009) - DSCN 24/2008 Data Standards: Introduction of Commissioning Dataset Version 6.1
    • CR1016 (Immediate) - DSCN 23/2008 4 Byte Version of the Read Codes - Withdrawal

    Release: December 2008

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1022 (1 January 2009) - DSCN 29/2008 Data Standards: 18 Weeks Referral to Treatment (RTT) Time, Performance Sharing
    • CR901 (Immediate) - DSCN 28/2008 Removal of references to EDIFACT and the NHS Wide Clearing Service (NWCS) 
    • CR843 (1 April 2009) - DSCN 22/2008 Data Standards: National Radiotherapy Data Set
    • CR1011 (1 January 2009) - DSCN 20/2008 Data Standards: National Cancer Waiting Times Minimum Data Set 

    Release: November 2008

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1026 (3 November 2008) - DSCN 21/2008 Information Standard: Mental Health Act 2007 Mental Category

    Release: August 2008

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR1018 (Immediate) - DSCN 19/2008 Data Standards: Change of Name for National Administrative Code Services (NACS) to Organisation Data Service (ODS)
    • CR956 (1 September 2008) - DSCN 18/2008 Central Return: Human Papillomavirus (HPV) Immunisation Programme, Vaccine Monitoring Minimum Dataset
    • CR861 (Immediate) - DSCN 16/2008 Central Return:  Hospital and Community Services Complaints and General Practice (including Dental) Complaints - KO41(a) and KO 41(b)
    • CR964 (Immediate) - DSCN 14/2008 Central Return: 18 Weeks ‘Adjusted’ Referral to Treatment (RTT) Dataset
    • CR965 (Immediate) - DSCN 13/2008 Data Standards: Organisation Data Service (ODS) - Change to the Default Codes Set to Support Changes to GMS Contract
    • CR879 (Immediate) - DSCN 12/2008 Data Standards: Quarterly Monitoring: Cancelled Operations Data Set (QMCO)

    Release: May 2008

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR502 (Immediate) - DSCN 10/2008 Data Standards: National Workforce Data Definitions (v2.0)
    • CR910 (1 April 2008) - DSCN 08/2008 Data Standards: National Direct Access Audiology Patient Tracking List (PTL) and Waiting Times (WT) data sets
    • CR900 (Immediate) - DSCN 07/2008 Data Standards: Inter-Provider Transfer Administrative Minimum Data Set
    • CR934 (1 April 2008) - DSCN 06/2008 Data Standards: Mental Health Minimum Data Set (version 3.0)
    • CR935 (Immediate) - DSCN 05/2008 Data Standards: 18 Weeks Rules Suite
    • CR925 (1 September 2008) - DSCN 04/2008 Genitourinary Medicine Clinic Activity Data Set Change to an Information Standard
    • CR942 (1 June 2008) - DSCN 03/2008 General Practice and General Medical Practitioner (GMP) - changes resulting from the introduction of the General Medical Services (GMS) Contract

    Release: February 2008

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR812 (Immediate) - DSCN 01/2008 Central Return: Diagnostics Waiting Times Census Data Set
    • CR881 (31 December 2007) - DSCN 42/2007 Central Return: Referral To Treatment Summary Patient Tracking List
    • CR904 (Immediate) - DSCN 41/2007 Data Standards: Admission Intended Procedure Update
    • CR824 (1 February 2008) - DSCN 39/2007 Data Standards: 48 Hour Genitourinary Medicine Access Monthly Monitoring (GUMAMM)

    Release: November 2007

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR919 (Immediate) - DSCN 38/2007 Data Standards: Mental Health Minimum Data Set Schema
    • CR814 (1 April 2008) - DSCN 37/2007 Data Standards: Introduction of Mental Health Minimum Data Set version 2.1
    • CR930 (31 December 2007) - DSCN 35/2007 Data Standards: A correction to the version 6 Commissioning Data Set schema
    • CR834 (Immediate) - DSCN 34/2007 Data Standards: Referral Request Received Date
    • CR875 (Immediate) - DSCN 33/2007 Data Standards: National Administrative Codes Service: Introduction of codes for the new Pan SHAs
    • CR880 (Immediate) - DSCN 29/2007 Data Standards: Amendments to Doctor Index Number (DIN) Description

    Release: August 2007

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR845 (Immediate) - DSCN 28/2007 Data Standards: Treatment Function Code (Referral to Treatment Period)
    • CR831 (1 October 2007) - DSCN 27/2007 Data Standards: Update to Commissioning Data Set XML Schema v5
    • CR825 (1 October 2007) - DSCN 16/2007 Data Standards: Source of Referral for Outpatients (18 Weeks)

    Release: June 2007

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR799 (31 December 2007) - DSCN 18/2007 Data Standards: Introduction of Commissioning Data Set Version 6
    • CR833 (Immediate) - DSCN 17/2007 Data Standards: Introduction of Commissioning Data Set validation table
    • CR801 (Immediate) - DSCN 15/2007 Data Standards: Cover of Vaccination Evaluated Rapidly (COVER) Return

    Release: May 2007

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR800 (31 December 2007) - DSCN 14/2007 Commissioning Data Set Schema Version 6-0
    • CR856 (1 October 2007) - DSCN 13/2007 Data Standards: Discharge Ready Date
    • CR869 (Immediate) - DSCN 12/2007 Data Standards: Update to Clinical Coding Introduction
    • CR827 (1 October 2007) - DSCN 09/2007 Data Standards: Earliest Reasonable Offer Date
    • CR817 (1 October 2007) - DSCN 08/2007 Data Standards: Introduction of Age into Commissioning Data Sets
    • CR849 (May 2007) - DSCN 07/2007 National Administrative Codes Service: Introduction of new identification codes for Dental Consultants
    • CR822 (Immediate) - DSCN 06/2007 Data Standards: Update to Organisation Codes
    • CR850 (Immediate) - DSCN 05/2007 National Administrative Codes Service: Amendments to Default Codes
    • CR786 (1 April 2007) - DSCN 04/2007 Quarterly Monitoring Accident and Emergency Services (QMAE) Central Return

    Release: February 2007

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR811 (Immediate) - DSCN 03/2007 Diagnostic Waiting Times and Activity
    • CR826 (1 October 2007) - DSCN 02/2007 Extension of Treatment Function to Support the Measurement of 18 Week Referral to Treatment Periods
    • CR813 (1 April 2007) - DSCN 01/2007 Paediatric Critical Care Minimum Data Set
    • CR768 (1 January 2007) - DSCN 18/2006 Changes to the NHS Data Dictionary to support the measurement of 18 week referral to treatment periods
    • CR798 (6 November 2006) - DSCN 19/2006 Commissioning Data Set (CDS) Version 5 XML Message Schema
    • CR776 (1 October 2006) - DSCN 05/2006 Data Standards: Accident and Emergency Enhancements to Investigation and Treatment Codes

    Release: September 2006

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR795 (31 October 2006) - DSCN 22/2006 Organisation Codes / Organisation Site Codes
    • CR792 (1 April 2007) - DSCN 15/2006 Neonatal Critical Care
    • CR719 (1 April 2006) - DSCN 09/2006 Measuring and Recording of Waiting Times
    • CR791 (1 April 2007) - DSCN 13/2006 Priority Type
    • CR774 (1 September 2006) - DSCN 12/2006 Person Marital Status

    Release: May 2006

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR764 (1 April 2006) - DSCN 08/2006 Diagnostics waiting times and activity
    • Correction to menu structure to include Critical Care Minimum Data Set

    Release: April 2006

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR608 (1 October 2006) - DSCN 07/2006 Introduction of Commissioning Data Set Version 5 and its associated XML schema into the NHS Data Dictionary.
    • CR756 (1 September 2005) - DSCN 19/2005 PbR Commissioning for Out of Area Treatments (OATs) and Charge-Exempt Overseas Visitors
    • CR724 (1 April 2006) - DSCN 13/2005 Critical Care Minimum Data Set
    • CR754 (1 April 2006) - DSCN 17/2005 Treatment Function and Main Specialty Code Revisions
    • CR763 (1 April 2006) - DSCN 20/2005 New Treatment Functions for therapy services and anticoagulant service
    • CR767 (Immediate) - DSCN 02/2006 Referral Request Received Date
    • CR690 (1 September 2005) - DSCN 16/2005 Marital Status

    Release: August 2005

    Data Set Change Notices incorporated into the NHS Data Model and Dictionary:

    • CR555 (1 April 2005) - DSCN 11/2005 Data Standards: COVER - Hepatitis B immunisation for babies
    • CR715 (Immediate) - DSCN 10/2005 Data Standards: Treatment Function Codes - correction and clarification of names and descriptions
    • CR706 (1 April 2005) - DSCN 09/2005 Data Standards: Cancer Registration Data Set
    • CR691 (1 July 2005) - DSCN 06/2005 Data Standards: NSCAG Commissioner Code

    For all Information Standards Notices and Data Set Change Notices, see the Information Standards Board for Health and Social Care Website.

    top


    ACTIVITY GROUP

    Change to Class: Changed Attributes

    Attributes of this Class are:
    A and E INCIDENT LOCATION TYPE
    A and E PATIENT GROUP
    ACTIVITY GROUP TYPE
    ADMISSION METHOD
    BABY FIRST FEED BREAST MILK STATUS
    BREASTFEEDING STATUS
    BROAD PATIENT GROUP
    CANCER OR SYMPTOMATIC BREAST REFERRAL PATIENT STATUS
    CANCER REFERRAL TO TREATMENT PERIOD START DATE
    CANCER SCREENING STATUS
    CANCER TREATMENT INTENT
    CANCER TREATMENT PERIOD START DATE
    CARE PROGRAMME APPROACH LEVEL
    CHILDREN TEENAGERS AND YOUNG ADULTS AGE CATEGORY
    DELIVERY FACILITIES ONLY USED
    DELIVERY PLACE CHANGE REASON
    DISCHARGE DESTINATION
    DISCHARGED TO HOSPITAL AT HOME SERVICE INDICATOR
    DISCHARGE FROM MENTAL HEALTH SERVICE REASON
    DISCHARGE METHOD
    FIRST REGULAR DAY OR NIGHT ADMISSION
    FULL POSTNATAL EXAMINATION DATE
    GENERAL DENTAL SERVICE INDICATOR
    IMPROVING ACCESS TO PSYCHOLOGICAL THERAPIES CARE SPELL END CODE
    INCIDENT TYPE
    INTRAVESICAL CHEMOTHERAPY RECEIVED INDICATOR
    INTRAVESICAL IMMUNOTHERAPY RECEIVED INDICATOR
    KEY WORKER SEEN INDICATOR
    LENGTH OF STAY ADJUSTMENT
    LENGTH OF STAY ADJUSTMENT REASON
    MONITORING INTENT
    NON SMOKING CONFIRMATION STATUS AT 4 WEEKS
    OUTCOME AT 4 WEEK FOLLOW-UP
    PAEDIATRIC NEPHROLOGY REGISTRY STATUS CODE
    PALLIATIVE CARE SPECIALIST SEEN INDICATOR
    PALLIATIVE TREATMENT REASON CODE FOR UPPER GASTROINTESTINAL
    PHARMACOTHERAPY STOP SMOKING AID RECEIVED
    PREGNANCY OUTCOME CODE
    PREGNANCY TOTAL PREVIOUS LOSSES LESS THAN 24 WEEKS
    PREVIOUS NEGATIVE HIV TEST IN UNITED KINGDOM INDICATOR
    RADIOTHERAPY INTENT
    RENAL DIALYSIS SCHEDULE TYPE
    SMOKING QUIT DATE
    SOURCE OF ADMISSION
    SUPERVISED COMMUNITY TREATMENT END REASON
    SUPERVISION REGISTER RISK
    TELEPHONE CONTACT INDICATOR
    TREATMENT START DATE FOR CANCER
    WARD STAY TERMINATION REASON

    top


    CATEGORY VALUED PERSON OBSERVATION

    Change to Class: Changed Description

    A subtype of PERSON PROPERTY.

    Observations made regarding a PERSON. These observations do not include information about a treatment or intervention. CATEGORY VALUED PERSON OBSERVATIONS do not include information about a treatment or intervention.

    CATEGORY VALUED PERSON OBSERVATION TYPE provides coded classifications of observations about a PERSON.

    Note: MEASURED PERSON OBSERVATION allows for recording of measurements about a PERSON and OTHER PERSON OBSERVATION is where the PERSON states, for example, when they first experienced symptoms, the number of days on which alcohol has been consumed etc.Note: CLINICAL INVESTIGATION RESULT ITEM captures measurements about a PERSON and OTHER PERSON OBSERVATION is where the PERSON states, for example, when they first experienced symptoms, the number of days on which alcohol has been consumed etc.

     

    top


    CLINICAL INVESTIGATION RESULT ITEM

    Change to Class: Changed Attributes, Description

    A result of a single Clinical Investigation including all essential or useful relevant data.The result of a Clinical Investigation.

    Note: A CLINICAL INVESTIGATION RESULT ITEM includes all useful information in connection with an investigation result (e.g. numerical value, date and time of Clinical Investigation etc.); this corresponds to what is normally called a 'line' on a paper report.CLINICAL INVESTIGATION RESULT ITEM TYPE provides a list of CLINICAL INVESTIGATION RESULT ITEMS.

    References:
    The Version 1.0 Trial NHS Standard EDIFACT Messages for Radiology Requests and Reports, 14.3.95
    The Version 1.0 Trial NHS Standard EDIFACT Messages for GP-Hospital Communications - 17.5.95

     

    top


    CLINICAL INVESTIGATION RESULT ITEM

    Change to Class: Changed Attributes, Description

    Attributes of this Class are:
    KINVESTIGATION RESULT DATE
    KINVESTIGATION RESULT TIME
    ABNORMALITY DETECTED INDICATOR
    ALBUMINURIA STAGE
    ALK 1 STATUS
    ANKLE DORSIFLEXION CODE
    ANKLE PLANTARFLEXION CODE
    ARITHMETIC COMPARATOR
    BIOPSY REFERRAL OUTCOME
    BREAST BIOPSY REFERRAL OUTCOME
    BREAST CANCER HISTOLOGICAL TYPE
    BREAST SCREENING MAMMOGRAPHY OUTCOME CODE
    CANCER VASCULAR OR LYMPHATIC INVASION
    CERVICAL GLANDULAR INTRAEPITHELIAL NEOPLASIA PRESENCE AND GRADE
    CERVICAL NODE STATUS
    CERVICAL SMEAR EXAMINED DATE
    CHLAMYDIA TEST RESULT
    CLINICAL ASSESSMENT RESULT CODE FOR BREAST CANCER
    CLINICAL INVESTIGATION ITEM TYPE
    CLINICAL INVESTIGATION ITEM UNIT OF MEASURE
    CLINICAL INVESTIGATION RESULT CODE FOR RENAL CARE
    CLINICAL INVESTIGATION RESULT CODE FOR RENAL TRANSPLANT
    CLINICAL INVESTIGATION RESULT VALUE
    CYTOGENETIC ANALYSIS CODE
    CYTOGENETIC PRESENCE TYPE FOR RHABDOMYOSARCOMA
    CYTOGENETIC RISK CODE
    CYTOLOGY RESULT TYPE
    CYTOLOGY SMEAR REASON
    DEGREES OF FIXED FLEXION DEFORMITY
    DEGREES OF FLEXION RANGE
    DETRUSOR MUSCLE PRESENCE INDICATION CODE
    DEVIATING RESULT INDICATOR
    DIPSTICK TEST RESULT CODE
    EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONAL STATUS
    EXCISION MARGIN
    GENETIC CONFIRMATION INDICATOR
    GRADE OF DIFFERENTIATION
    HbA1C ASSAY MEASUREMENT METHOD
    HEPATOMEGALY INDICATOR
    HORMONE EXPRESSION TYPE
    INVASIVE CANCER SPECIAL TYPE INDICATOR
    INVESTIGATION EXAMINATION RESULT CODE
    INVESTIGATION HAEMOGLOBINOPATHY RESULT CODE
    INVESTIGATION RESULT STATUS CODE
    INVESTIGATION RESULT TEXT
    INVESTIGATION RISK RATIO RESULT CODE
    INVESTIGATION RUBELLA RESULT INDICATOR
    INVESTIGATION SENSITISED RESULT INDICATOR
    KARYOTYPE TEST OUTCOME
    LACTATE DEHYDROGENASE LEVEL
    LYMPH NODE STATUS
    MAMMOGRAM RESULT CODE
    METASTASIS EXTENT CODE
    NEWBORN BLOOD SPOT TEST OUTCOME STATUS CODE
    NEWBORN HEARING SCREENING OUTCOME
    NUMBER OF FETUSES
    NUMERICAL VALUE
    PATHOLOGICAL RISK CLASSIFICATION CODE AFTER NEPHRECTOMY
    PATHOLOGICAL RISK CLASSIFICATION CODE AFTER PREOPERATIVE CHEMOTHERAPY
    PERSON BLOOD GROUP
    PERSON RHESUS FACTOR
    PREOPERATIVE THERAPY RESPONSE TYPE
    RADIOLOGICAL RESULT VERIFIED DATE
    RADIOLOGICAL RESULT VERIFIED TIME
    RESULT ITEM STATUS
    S CATEGORY CODE
    SCREENING TEST RESULT
    SERUM CALCIUM CONCENTRATION CORRECTION CODE
    SMEAR INFECTION TYPE
    SPECIMEN NATURE
    SPLEEN BELOW COSTAL MARGIN
    SPLENOMEGALY INDICATOR
    SUBTALAR JOINT MOVEMENT CODE
    TIBIA HINDFOOT ALIGNMENT CODE
    TUMOUR NECROSIS
    ULTRASOUND RESULT CODE FOR BREAST CANCER

    top


    MEASURED PERSON OBSERVATION (RETIRED)  renamed from MEASURED PERSON OBSERVATION

    Change to Class: Changed Attributes, Supertype, Name, Description, status to Retired

    A subtype of PERSON PROPERTY.This item has been retired from the NHS Data Model and Dictionary.

    MEASURED PERSON OBSERVATION allows for recording of measurements about a PERSON.The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    MEASURED PERSON OBSERVATION TYPE CODE provides a list of MEASURED PERSON OBSERVATIONS.Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

    Note: CATEGORY VALUED PERSON OBSERVATION allows coded classifications of observations about a PERSON and OTHER PERSON OBSERVATION is where the PERSON states, for example, when they first experienced symptoms, the number of days on which alcohol has been consumed etc.

     

    top


    MEASURED PERSON OBSERVATION (RETIRED)  renamed from MEASURED PERSON OBSERVATION

    Change to Class: Changed Attributes, Supertype, Name, Description, status to Retired

    Attributes of this Class are:
    ALBUMINURIA STAGE
    MEASURED OBSERVATION VALUE
    This class has no attributes.

    top


    MEASURED PERSON OBSERVATION (RETIRED)  renamed from MEASURED PERSON OBSERVATION

    Change to Class: Changed Attributes, Supertype, Name, Description, status to Retired

    top


    MEASURED PERSON OBSERVATION TYPE (RETIRED)  renamed from MEASURED PERSON OBSERVATION TYPE

    Change to Class: Changed Attributes, Relationships, Name, Description, status to Retired

    Identifies the type of MEASURED PERSON OBSERVATION being recorded, for example Height and Weight.This item has been retired from the NHS Data Model and Dictionary.

     The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

     

    top


    MEASURED PERSON OBSERVATION TYPE (RETIRED)  renamed from MEASURED PERSON OBSERVATION TYPE

    Change to Class: Changed Attributes, Relationships, Name, Description, status to Retired

    Attributes of this Class are:
    KMEASURED PERSON OBSERVATION TYPE CODE
    This class has no attributes.

    top


    MEASURED PERSON OBSERVATION TYPE (RETIRED)  renamed from MEASURED PERSON OBSERVATION TYPE

    Change to Class: Changed Attributes, Relationships, Name, Description, status to Retired

    Each MEASURED PERSON OBSERVATION TYPE
    must be validated by one or more OBSERVATION MEASUREMENT VALIDATION
    may be the type for one or more MEASURED PERSON OBSERVATION

    top


    MEASURED PERSON OBSERVATION TYPE (RETIRED)  renamed from MEASURED PERSON OBSERVATION TYPE

    Change to Class: Changed Attributes, Relationships, Name, Description, status to Retired

    top


    MEASUREMENT VALUE TYPE (RETIRED)  renamed from MEASUREMENT VALUE TYPE

    Change to Class: Changed Attributes, Relationships, Name, Description, status to Retired

    Identifies the unit of measurement used to record a MEASURED PERSON OBSERVATION, for example Metres, kilograms etc.This item has been retired from the NHS Data Model and Dictionary.

     The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

     

    top


    MEASUREMENT VALUE TYPE (RETIRED)  renamed from MEASUREMENT VALUE TYPE

    Change to Class: Changed Attributes, Relationships, Name, Description, status to Retired

    Attributes of this Class are:
    KMEASUREMENT VALUE TYPE CODE
    This class has no attributes.

    top


    MEASUREMENT VALUE TYPE (RETIRED)  renamed from MEASUREMENT VALUE TYPE

    Change to Class: Changed Attributes, Relationships, Name, Description, status to Retired

    Each MEASUREMENT VALUE TYPE
    must be validated by one or more OBSERVATION MEASUREMENT VALIDATION
    may be the type for one or more MEASURED PERSON OBSERVATION

    top


    MEASUREMENT VALUE TYPE (RETIRED)  renamed from MEASUREMENT VALUE TYPE

    Change to Class: Changed Attributes, Relationships, Name, Description, status to Retired

    top


    OBSERVATION MEASUREMENT VALIDATION (RETIRED)  renamed from OBSERVATION MEASUREMENT VALIDATION

    Change to Class: Changed Name, Description, status to Retired

    Identifies the valid MEASUREMENT VALUE TYPE that is used for a particular MEASURED PERSON OBSERVATION TYPE. Examples would be Height measured in metres or Weight measured in kilograms.This item has been retired from the NHS Data Model and Dictionary.

     The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

     

    top


    OBSERVATION MEASUREMENT VALIDATION (RETIRED)  renamed from OBSERVATION MEASUREMENT VALIDATION

    Change to Class: Changed Name, Description, status to Retired

    top


    ORGANISATION SITE BED AVAILABILITY

    Change to Class: Changed Attributes

    Attributes of this Class are:
    KBROAD PATIENT GROUP CODE
    KORGANISATION BED AVAILABILITY START DATE
    AVAILABLE BED DAYS NHS PATIENTS
    AVAILABLE BED DAYS NON-NHS PATIENTS
    ORGANISATION BED AVAILABILITY END DATE

    top


    ORGANISATION SITE BED OCCUPANCY

    Change to Class: Changed Attributes

    Attributes of this Class are:
    KBROAD PATIENT GROUP
    KORGANISATION SITE BED OCCUPANCY START DATE
    OCCUPIED BED DAYS NHS PATIENTS
    OCCUPIED BED DAYS NON-NHS PATIENTS
    ORGANISATION SITE BED OCCUPANCY END DATE

    top


    OTHER PERSON OBSERVATION

    Change to Class: Changed Description

    A subtype of PERSON PROPERTY.

    Observations made by a PERSON which are not coded or measured.

    These observations do not include information about a treatment or intervention. These observations may be where the PERSON states, for example, when they first experienced symptoms, the number of days on which alcohol has been consumed etc.

    Note: CATEGORY VALUED PERSON OBSERVATION allows coded classifications of observations about a PERSON and MEASURED PERSON OBSERVATION allows for the recording of measurements about a PERSON.Note: CATEGORY VALUED PERSON OBSERVATION allows coded classifications of observations about a PERSON and CLINICAL INVESTIGATION RESULT ITEM captures measurements about a PERSON. 

     

    top


    PERSON PROPERTY

    Change to Class: Changed Attributes, Description

    top


    PERSON PROPERTY

    Change to Class: Changed Attributes, Description

    Attributes of this Class are:
    KPERSON PROPERTY IDENTIFIER
    ATTEMPTED SUICIDE WITH INTENT INDICATOR
    DOMINANT ARM CODE
    FAMILIAL CANCER SYNDROME INDICATOR
    FREE PRESCRIPTIONS INDICATOR
    LAST MENSTRUAL PERIOD DATE
    PERSON BLOOD GROUP
    PERSON PROPERTY EFFECTIVE DATE
    PERSON PROPERTY EFFECTIVE END DATE
    PERSON PROPERTY EFFECTIVE END TIME
    PERSON PROPERTY EFFECTIVE TIME
    PERSON PROPERTY OBSERVED DATE
    PERSON PROPERTY OBSERVED TIME
    PERSON PROPERTY RECORDED DATE
    PERSON PROPERTY RECORDED TIME
    PERSON RHESUS FACTOR
    PREGNANCY STATUS
    SURGICAL VOICE RESTORATION COMMUNICATION METHOD FOR PLANNED POST OPERATIVE
    SURGICAL VOICE RESTORATION COMMUNICATION METHOD FOR PRIMARY
    YOUNG CARER INDICATOR

    top


    PERSON PROPERTY QUALIFIER

    Change to Class: Changed Attributes

    Attributes of this Class are:
    ANATOMICAL AREA
    ANATOMICAL SIDE
    ANATOMICAL SIDE FOR IMAGING
    ANATOMICAL SITE
    BONE SARCOMA LOCATION
    HYDRONEPHROSIS CODE
    PERSON PROPERTY QUALIFIER IDENTIFIER
    PERSON PROPERTY QUALIFIER TYPE
    PERSON PROPERTY QUALIFIER VALUE
    PERSON PROPERTY RELATIONSHIP TYPE
    PRIMARY EXTRANODAL SITE
    RADIOTHERAPY TREATMENT REGION
    SOFT TISSUE SARCOMA LOCATION

    top


    REGISTRABLE BIRTH

    Change to Class: Changed Attributes

    Attributes of this Class are:
    APGAR SCORE 1 MINUTE
    APGAR SCORE 5 MINUTE
    BCG ADMINISTERED
    BIRTH HEAD CIRCUMFERENCE
    BIRTH ORDER
    DELIVERY METHOD
    DELIVERY PLACE TYPE
    DELIVERY TIME
    EXAMINATION OF HIPS
    FOLLOW UP CARE
    GESTATION LENGTH
    GESTATION LENGTH IN DAYS
    GESTATION LENGTH IN WEEKS
    LIVE OR STILL BIRTH
    METABOLIC SCREENING
    NUMBER OF BABIES IDENTIFIER
    PRESENCE OF JAUNDICE
    PRESENTATION AT ONSET OF LABOUR
    RESUSCITATION METHOD DRUGS
    RESUSCITATION METHOD POSITIVE PRESSURE
    STATUS OF PERSON CONDUCTING DELIVERY

    top


    UNIT OF MEASUREMENT

    Change to Class: New Class

    The unit of measurement.

    This could be, for example, for a CLINICAL INVESTIGATION RESULT ITEMPRESCRIBED ITEM, PERSON PROPERTY.

     

    This class is also known by these names:
    ContextAlias
    pluralUNITS OF MEASUREMENT

    top


    UNIT OF MEASUREMENT

    Change to Class: New Class

    Attributes of this Class are:
    UNIT OF MEASUREMENT

    top


    UNIT OF MEASUREMENT

    Change to Class: New Class

    Each UNIT OF MEASUREMENT
    may be recorded for one or more CLINICAL INVESTIGATION RESULT ITEM
    may be recorded for one or more MALIGNANT ABNORMALITY
    may be recorded for one or more PERSON PROPERTY
    may be recorded for one or more PRESCRIBED ITEM

    top


    WARD BED AVAILABILITY

    Change to Class: Changed Attributes

    Attributes of this Class are:
    KBED AVAILABILITY START DATE
    KBROAD PATIENT GROUP
    AUGMENTED CARE LOCATION CODE
    BED AVAILABILITY END DATE
    IC OR HD BEDS INDICATOR
    WARD AVAILABLE BED

    top


    WARD OPERATIONAL PLAN

    Change to Class: Changed Attributes

    Attributes of this Class are:
    KWARD OPERATIONAL PLAN START DATE
    AGE GROUP INTENDED
    BROAD PATIENT GROUP
    CLINICAL CARE INTENSITY
    PLANNED WARD LISTING TIME
    SEX OF PATIENTS
    WARD DAY NIGHT INDICATOR
    WARD DAY PERIOD AVAILABILITY
    WARD NIGHT PERIOD AVAILABILITY
    WARD OPERATIONAL PLAN END DATE
    WARD PLAN TOTAL BED CONSULTANT CARE
    WARD PLAN TOTAL BED MIDWIFE ACCESS
    WARD PLAN TOTAL BED NURSING CARE

    top


    ACTIVITY DATE AND TIME TYPE

    Change to Attribute: Changed Description

    top


    ACTIVITY TIME TYPE

    Change to Attribute: Changed Description

    The type of TIME that defines the usage with regard to the ACTIVITY.

    An ACTIVITY may have many TIMES associated with it but may only have one TIME of a particular type.

    National Codes:

    50Accident and Emergency Attendance Conclusion Time
    51Accident and Emergency Departure Time
    52Accident and Emergency Initial Assessment Time
    53Accident and Emergency Time Seen For Treatment
    54Arrival At Hospital Time (Retired April 2012)
    55ARRIVAL TIME (Retired April 2012)
    56End Time
    57Event Time (Retired July 2012)
    58Initial Patient Contact Time (Retired July 2012)
    59Last Dosage Time
    60Pathology Result Due Time
    61Start Time
    62Theatre Case Time In To Theatre Suite (Retired September 2012)
    63Theatre Case Time Out Of Theatre (Retired September 2012)
    64Theatre Case Time Out Of Theatre Suite (Retired September 2012)
    65Time Seen
    66Discharge Ready Time (Retired April 2012)
    67Arrival Time At Accident and Emergency Department
    68Arrival Time For Transport Requests
    69Discharge Time
    70Clinical Intervention Time

    Note: This list is not in alphabetical order.

     

    top


    CANCER TREATMENT MODALITY

    Change to Attribute: Changed Description

    The type of treatment or care which was delivered in a Cancer Treatment Period.

    National Codes:

    01Surgery
    02Anti-Cancer Drug Regimen (Cytotoxic Chemotherapy)
    03Anti-Cancer Drug Regimen (Hormone Therapy)
    04Chemoradiotherapy 
    05Teletherapy (Beam Radiation excluding Proton Therapy)
    06Brachytherapy 
    07Specialist Palliative Care 
    08Active Monitoring (excluding Non-Specialist Palliative Care)
    09Non-Specialist Palliative Care (excluding Active Monitoring)
    10Radiofrequency Ablation (RFA)
    11High Intensity Focused Ultrasound (HIFU)
    12Cryotherapy 
    13Proton Therapy 
    14Anti-Cancer Drug Regimen (other)
    15Anti-Cancer Drug Regimen (Immunotherapy)
    16Light Therapy (including Photodynamic Therapy and Psoralen and Ultraviolet A Therapy (PUVA))
    17Hyperbaric Oxygen Therapy 
    18 Other Treatment (Retired 1 July 2012) 
    19Radioisotope Therapy (including Radioiodine)
    20Laser Treatment (including Argon Beam therapy)
    21Biological Therapies (excluding Immunotherapy)
    22Radiosurgery 
    97Other treatment
    98All treatment declined

    Notes:

     

    top


    CLINICAL INTERVENTION TYPE

    Change to Attribute: Changed Description

    The type of CLINICAL INTERVENTION.

    National Codes:

    01Anaesthetic Service 
    01Anaesthetic Service (Retired November 2013)
    02Anti-Cancer Drug Cycle 
    03Anti-Cancer Drug Fraction (Retired 1 January 2013) 
    04Anti-Cancer Drug Programme 
    05Anti-Cancer Drug Regimen 
    06Brachytherapy Treatment Course 
    07Contraceptive Service 
    08Dental Haemorrhage Service 
    07Contraceptive Service (Retired November 2013)
    08Dental Haemorrhage Service (Retired November 2013)
    09Dental Treatment 
    10Drug Dosage and Administration (Retired 1 January 2013) 
    11Drug Treatment 
    12Emergency Treatment Service 
    12Emergency Treatment Service (Retired November 2013)
    13Endocrine Therapy (Retired 1 January 2013) 
    14Fraction 
    15Primary Hip Replacement Surgery 
    16Imaging or Radiodiagnostic Event 
    17Immunisation Dose Given 
    18Joint Replacement Surgery 
    19Primary Knee Replacement Surgery 
    20Labour and Delivery 
    21Lithotripsy Course Attendance 
    22Maternity Medical Service 
    23Minor Surgery Procedure 
    22Maternity Medical Service (Retired November 2013)
    23Minor Surgery Procedure (Retired November 2013)
    24Pathology Laboratory Investigation 
    25Patient Procedure 
    26Post Mortem 
    27Radiotherapy Treatment Course 
    28Screening Test 
    28Screening Test (Retired November 2013)
    29Teletherapy Treatment Course 
    30Test Of Immunity 
    30Test Of Immunity (Retired November 2013)
    31Therapy After Discharge (Retired July 2012)
    32Thrombo Prophylaxis Regime 
    33Unsealed Source Treatment Course 
    34Vaccination Service 
    35Vasectomy Performed 
    34Vaccination Service (Retired November 2013)
    35Vasectomy Performed (Retired November 2013)
    36Clinical Investigation 
    37Systemic Anti-Cancer Drug Cycle 
    38Systemic Anti-Cancer Drug Programme 
    39Systemic Anti-Cancer Drug Regimen 
    40Chemotherapy 
    41Cytotoxic Chemotherapy 
    42Hormone Therapy 
    43Immunotherapy 
    44Diagnostic Imaging 
    456 - 8 Week Physical Examination 
    46Ultrasound Scan In Pregnancy 
    47Newborn Physical Examination 
    48Biological Therapy 
    49Brachytherapy 
    50Chemoradiotherapy 
    51Cryotherapy 
    52High Intensity Focused Ultrasound 
    53Hyperbaric Oxygen Therapy 
    54Laser Treatment 
    55Light Therapy 
    56Photodynamic Therapy 
    57Proton Therapy 
    58Psoralen and Ultraviolet A Therapy 
    59Radiofrequency Ablation 
    60Radioisotope Therapy 
    61Radiosurgery 
    62Radiotherapy 
    63Teletherapy
    64Tissue Typing
    65Blood Transfusion
    65Blood Transfusion
    66Renal Dialysis
    67Antiretroviral Therapy
    68Drug Regimen
    69Ablative Therapy 
    70Laparoscopy 
    71Primary Ankle Replacement Surgery
    72Revision Ankle Replacement Surgery
    73Primary Elbow Replacement Surgery
    74Revision Elbow Replacement Surgery
    75Revision Hip Replacement Surgery
    76Revision Knee Replacement Surgery
    77Primary Shoulder Replacement Surgery
    78Revision Shoulder Replacement Surgery
     

    top


    CLINICAL INVESTIGATION RESULT ITEM TYPE

    Change to Attribute: New Attribute

    top


    CLINICAL INVESTIGATION RESULT VALUE

    Change to Attribute: New Attribute

    The recorded value for a CLINICAL INVESTIGATION RESULT ITEM.

    A UNIT OF MEASUREMENT may be recorded for a CLINICAL INVESTIGATION RESULT VALUE.

     

    This attribute is also known by these names:
    ContextAlias
    pluralCLINICAL INVESTIGATION RESULT VALUES

    top


    CLINICAL INVESTIGATION RESULT VALUE

    Change to Attribute: New Attribute

    CLINICAL INVESTIGATION RESULT VALUE
     
    Data Elements:
    ALANINE AMINOTRANSFERASE CONCENTRATION
    ALBUMIN LEVEL
    ALKALINE PHOSPHATASE CONCENTRATION
    ALPHA FETOPROTEIN
    ALPHA FETOPROTEIN (CEREBROSPINAL FLUID)
    ALPHA FETOPROTEIN (MAXIMUM AT DIAGNOSIS)
    ANTENATAL OBSERVATION (MATERNAL HEIGHT)
    ANTENATAL OBSERVATION (MATERNAL WEIGHT)
    ASPARTATE AMINOTRANSFERASE CONCENTRATION
    BASE EXCESS CONCENTRATION
    BETA2 MICROGLOBULIN LEVEL
    BETA HUMAN CHORIONIC GONADOTROPIN
    BETA HUMAN CHORIONIC GONADOTROPIN (CEREBROSPINAL FLUID)
    BETA HUMAN CHORIONIC GONADOTROPIN (MAXIMUM AT DIAGNOSIS)
    BICARBONATE CONCENTRATION
    BILIRUBIN CONCENTRATION
    BIRTH WEIGHT
    BLOOD BASOPHILS PERCENTAGE
    BLOOD EOSINOPHILS PERCENTAGE
    BLOOD MYELOBLASTS PERCENTAGE
    BLOOD PRESSURE AVERAGED
    BLOOD PRESSURE HIGHEST
    BLOOD PRESSURE LOWEST
    BLOOD PRESSURE SITTING
    BLOOD UREA CONCENTRATION
    BLOOD UREA CONCENTRATION (DONOR ON ADMISSION)
    BLOOD UREA CONCENTRATION (DONOR ON RETRIEVAL)
    BONE AGE (RENAL PAEDIATRIC)
    BONE MARROW BLAST CELLS PERCENTAGE
    BRESLOW THICKNESS
    CALCULATED CREATININE CLEARANCE
    CD4 CELL COUNT
    CHOLESTEROL HIGH DENSITY LIPOPROTEIN CONCENTRATION
    CHOLESTEROL LOW DENSITY LIPOPROTEIN CONCENTRATION
    CHOLESTEROL TOTAL CONCENTRATION
    CYCLOSPORINE A 12 HOUR TROUGH LEVEL (RECIPIENT)
    CYCLOSPORINE A 2 HOUR TROUGH LEVEL C2 (RECIPIENT)
    DIALYSATE 24 HOUR CREATININE CONCENTRATION
    DIALYSATE 24 HOUR PROTEIN LOSS
    DIALYSATE 24 HOUR UREA CONCENTRATION
    DIALYSATE 24 HOUR VOLUME
    DIALYSATE EFFLUENT VOLUME (4 HOUR)
    DIALYSATE GLUCOSE END OF DWELL (4 HOUR)
    DIALYSATE GLUCOSE START OF DWELL (4 HOUR)
    DIASTOLIC BLOOD PRESSURE
    DIASTOLIC BLOOD PRESSURE (POST HAEMODIALYSIS)
    DIASTOLIC BLOOD PRESSURE (PRE-HAEMODIALYSIS)
    DISTANCE BEYOND MUSCULARIS PROPRIA
    DISTANCE FROM DENTATE LINE
    DISTANCE TO CIRCUMFERENTIAL EXCISION MARGIN
    DISTANCE TO CLOSEST NON PERITONEALISED RESECTION MARGIN
    DISTANCE TO DISTAL RESECTION MARGIN
    DISTANCE TO MARGIN
    DISTANCE TO SEROSA
    ESTIMATED GLOMERULAR FILTRATION RATE
    FORCED EXPIRATORY VOLUME IN 1 SECOND (ABSOLUTE AMOUNT)
    FORCED EXPIRATORY VOLUME IN 1 SECOND (PERCENTAGE)
    GAMMA GLUTAMYL TRANSFERASE CONCENTRATION
    HAEMOGLOBIN CONCENTRATION
    HAEMOGLOBIN CONCENTRATION (PRE-DIALYSIS)
    HAEMOGLOBIN CONCENTRATION (PRIOR END STAGE RENAL FAILURE)
    HAND GRIP STRENGTH
    HbA1c CONCENTRATION (DCCT)
    HbA1c CONCENTRATION (IFCC)
    HEAD CIRCUMFERENCE (RENAL PAEDIATRIC)
    HEART RATE
    HEIGHT IN CENTIMETRES FIRST VISIT
    HIP MEASUREMENT
    HYPOCHROMIC RED CELLS PERCENTAGE
    INVASIVE THICKNESS
    ISOTOPIC GLOMERULAR FILTRATION RATE (LIVING DONOR)
    LACTATE DEHYDROGENASE CONCENTRATION
    MEASURED 24HR CREATININE CLEARANCE
    MEASURED CREATININE CLEARANCE
    MEASURED GLOMERULAR FILTRATION RATE
    MID ARM CIRCUMFERENCE
    MITOTIC RATE
    MYCOPHENOLIC ACID TROUGH LEVEL (RECIPIENT)
    NEUTROPHIL COUNT
    NORMALISED PROTEIN CATABOLIC RATE (DIALYSIS)
    NORMALISED WEEKLY PERITONEAL CREATININE CLEARANCE
    PARTIAL PRESSURE CARBON DIOXIDE
    PARTIAL PRESSURE OXYGEN
    PERCENTAGE WEIGHT LOSS
    PERITONEAL DIALYSIS TOTAL WEEKLY FLUID VOLUME
    PERSON HEIGHT IN CENTIMETRES
    PERSON HEIGHT IN METRES
    PERSON OBSERVATION (HbA1c LEVEL)
    PERSON OBSERVATION (SERUM CHOLESTEROL LEVEL)
    PERSON OBSERVATION (SERUM CREATININE LEVEL)
    PERSON OBSERVATION (URINARY ALBUMIN LEVEL)
    PERSON WEIGHT
    PERSON WEIGHT (POST DIALYSIS)
    PERSON WEIGHT (PRE-DIALYSIS)
    PERSON WEIGHT (RENAL CARE)
    PHOSPHATE CONCENTRATION
    PHOSPHATE CONCENTRATION (DONOR)
    PLATELETS COUNT
    POSITIVE END-EXPIRATORY PRESSURE
    POTASSIUM CONCENTRATION (DONOR ON ADMISSION)
    POTASSIUM CONCENTRATION (DONOR ON RETRIEVAL)
    PROSTATE SPECIFIC ANTIGEN (DIAGNOSIS)
    PROSTATE SPECIFIC ANTIGEN (PRE-TREATMENT)
    PROTEIN CREATININE RATIO
    RED CELL FOLATE CONCENTRATION
    RESIDUAL RENAL CREATININE CLEARANCE
    SATURATION PERCENTAGE
    SERUM ALBUMIN CONCENTRATION
    SERUM ALBUMIN CONCENTRATION (DONOR)
    SERUM ALUMINIUM CONCENTRATION
    SERUM B12 CONCENTRATION
    SERUM BICARBONATE CONCENTRATION
    SERUM CALCIUM CONCENTRATION
    SERUM CALCIUM CONCENTRATION (DONOR)
    SERUM C-REACTIVE PROTEIN CONCENTRATION
    SERUM CREATININE CONCENTRATION
    SERUM CREATININE CONCENTRATION (DONOR)
    SERUM CREATININE CONCENTRATION (DONOR ON ADMISSION)
    SERUM CREATININE CONCENTRATION (DONOR ON RETRIEVAL)
    SERUM CREATININE CONCENTRATION (PRE-DIALYSIS)
    SERUM CREATININE CONCENTRATION (PRIOR END STAGE RENAL FAILURE)
    SERUM CREATININE KtV
    SERUM FERRITIN CONCENTRATION
    SERUM INTACT PARATHYROID HORMOME CONCENTRATION
    SERUM MAGNESIUM CONCENTRATION
    SERUM POTASSIUM CONCENTRATION
    SERUM UREA CONCENTRATION (POST DIALYSIS)
    SERUM UREA CONCENTRATION (PRE-DIALYSIS)
    SIROLIMUS TROUGH LEVEL (RECIPIENT)
    SYSTOLIC BLOOD PRESSURE
    SYSTOLIC BLOOD PRESSURE (POST HAEMODIALYSIS)
    SYSTOLIC BLOOD PRESSURE (PRE-HAEMODIALYSIS)
    TACROLIMUS 12 HOUR TROUGH LEVEL (RECIPIENT)
    TEMPERATURE
    TRANSFERRIN SATURATION
    TRIGLYCERIDES CONCENTRATION
    TUMOUR HEIGHT ABOVE ANAL VERGE
    URIC ACID CONCENTRATION
    URINE CREATININE CONCENTRATION
    URINE KtV
    URINE OUTPUT LAST 24 HOURS
    URINE OUTPUT LAST HOUR
    URINE UREA CONCENTRATION
    URINE VOLUME
    VIRAL LOAD COUNT
    VITAMIN D CONCENTRATION
    WAIST MEASUREMENT
    WHITE BLOOD CELL COUNT
    WHITE BLOOD CELL COUNT (HIGHEST PRETREATMENT)
    WHITE BLOOD CELL COUNT (PERITONEAL FLUID)
    WHOLE BLOOD MEAN CELL VOLUME (DIALYSIS)
    WHOLE BLOOD MEAN CORPUSCULAR HAEMOGLOBIN (DIALYSIS)

    top


    DELAY REASON REFERRAL TO FIRST SEEN FOR CANCER OR BREAST SYMPTOMS

    Change to Attribute: Changed Description

    The reason why a delay occurred between the CANCER REFERRAL TO TREATMENT PERIOD START DATE and the DATE FIRST SEEN, when the PRIORITY TYPE of the SERVICE REQUEST was National Code 3 'Two Week Wait'.

    This is the reason why the Health Care Provider was unable to provide an APPOINTMENT DATE within the service standard of two weeks.

    National Codes:

    01Clinic cancellation
    02Out-patient capacity inadequate (i.e. no cancelled clinic, but not enough slots for this PATIENT)
    03Administrative delay
    04 Referral not received within 24 hours (Retired 1 July 2012) 
    05PATIENT unavailable (the PATIENT has declined the opportunity to be seen within two weeks prior to any APPOINTMENT being offered)
    06PATIENT declines (the PATIENT declines all APPOINTMENT dates offered within two weeks)
    07PATIENT cancellation (the PATIENT cancels their booked APPOINTMENT)
    08PATIENT care not commissioned by the English NHS (waiting time standard does not apply)
    98Other reason
    99 Other reason (Retired 1 July 2012) 

    Notes:

    • National Code 03 ‘Administrative delay’ should not be used to record delays linked to a ‘Did Not Attend’ (DNA) event where a waiting time adjustment has been entered into the PATIENT record.
    • If National Code 98 'Other reason' is used, further detail must be recorded for the precise cause of the delay, within DELAY REASON COMMENT (FIRST SEEN).
    • National Code 08 'PATIENT care not commissioned by the English NHS (waiting time standard does not apply)' should only be used in instances where the non-English administration has commissioned a two week wait service, i.e. the PRIORITY TYPE of the SERVICE REQUEST was National Code 03 'Two Week Wait', but the PATIENT was not seen within two weeks. This is to allow for different commissioning arrangements to be supported by local administrative and clinical systems.
     

    top


    DELAY REASON TO TREATMENT FOR CANCER

    Change to Attribute: Changed Description

    The reason why a Cancer Care Spell Delay was experienced with regard to a Cancer Care Spell.

    The national codes to be used are the same for delays between:

    This is the reason why the Health Care Provider was unable to offer a DATE within the service standard (31 days between DECISION TO TREAT DATE and TREATMENT START DATE FOR CANCER, and CONSULTANT UPGRADE DATE and TREATMENT START DATE FOR CANCER; or 62 days between the CANCER REFERRAL TO TREATMENT PERIOD START DATE and TREATMENT START DATE FOR CANCER).

    National Codes:

    Delays relating to diagnostic and pre-treatment events

     Delays relating to diagnostic and pre-treatment events 
    01Clinic cancellation
    02Out-patient capacity inadequate (i.e. no cancelled clinic, but not enough slots for this PATIENT)
    03Administrative delay
    07Complex diagnostic pathway (many, or complex, diagnostic tests required)
    08 Delay due to referral between Trusts (Retired 1 July 2012) 
    11Diagnosis delayed for medical reasons (PATIENT unfit for diagnostic episode, excluding planned recovery period following diagnostic test)
    13Delay due to recovery after an invasive test (PATIENT DIAGNOSIS or treatment delayed due to planned recovery period following an invasive diagnostic test)
    17PATIENT choice delay relating to first outpatient APPOINTMENT 
    18Health Care Provider initiated delay to diagnostic test or treatment planning
    19PATIENT initiated (choice) delay to diagnostic test or treatment planning, advance notice given
    20PATIENT Did Not Attend an APPOINTMENT for a diagnostic test or treatment planning event (no advance notice)
    98Other reason
     Delays relating to treatment in an admitted care setting 
    04Elective cancellation (for non-medical reason)
    05Elective capacity inadequate (PATIENT unable to be scheduled for treatment within standard time)
    06 Delay to diagnostic test or treatment planning (Retired 1 July 2012) 
    10Treatment delayed for medical reasons (PATIENT unfit for treatment episode, excluding planned recovery period following diagnostic test)
    21PATIENT failed to present for elective treatment (choice)
    22PATIENT care not commissioned by the English NHS (waiting time standard does not apply)
    98Other reason
     Delays relating to treatment in a non-admitted care setting 
    01Clinic cancellation
    02Out-patient capacity inadequate (i.e. no cancelled clinic, but not enough slots for this PATIENT)
    10Treatment delayed for medical reasons (PATIENT unfit for treatment episode, excluding planned recovery period following diagnostic test)
    14PATIENT Did Not Attend treatment APPOINTMENT 
    16PATIENT Choice (PATIENT declined or cancelled an offered APPOINTMENT DATE for treatment)
    22PATIENT care not commissioned by the English NHS (waiting time standard does not apply)
    98Other reason
    99 Other reason (Retired 1 July 2012) 

    Notes:

     

    top


    DOMINANT ARM CODE

    Change to Attribute: Changed Description

    The PERSON's Dominant Arm.The PERSON's dominant arm.

    National Codes:

    01Right
    02Left
     

    top


    GESTATION LENGTH IN DAYS

    Change to Attribute: New Attribute

    The gestation length of a Fetus Episode recorded as the total number of days.

    The calculation may be:

    a)calculated by ultrasound scan measurements according to the trimester of the scan
    b)estimated from the LAST MENSTRUAL PERIOD DATE
    c)estimated by clinical assessment (in the absence of a or b)


    The number of completed whole weeks of gestation and the remaining number of days of an uncompleted whole week should be calculated from the GESTATION LENGTH IN DAYS for input and reporting purposes. Where there is no uncompleted whole week, the number of additional days should be recorded as zero.

    For example:

     

    This attribute is also known by these names:
    ContextAlias
    pluralGESTATION LENGTHS IN DAYS

    top


    GESTATION LENGTH IN DAYS

    Change to Attribute: New Attribute

    top


    GESTATION LENGTH IN WEEKS  renamed from GESTATION LENGTH

    Change to Attribute: Changed Name

    top


    LARGEST METASTASIS

    Change to Attribute: Changed Description

    Where the neck has been dissected during a Head and Neck Cancer Care Spell, the size of the largest metastasis, in 'Millimetres (mm)'.Where the neck has been dissected during a Head and Neck Cancer Care Spell, the size of the largest metastasis, where the UNIT OF MEASUREMENT is 'Millimetres'.

     

    top


    MAXIMUM DEPTH OF INVASION

    Change to Attribute: Changed Description

    The maximum depth of invasion of the Tumour, in 'Millimetres (mm)'.The maximum depth of invasion of the Tumour, where the UNIT OF MEASUREMENT is 'Millimetres' . 

     

    top


    MEASURED OBSERVATION VALUE (RETIRED)  renamed from MEASURED OBSERVATION VALUE

    Change to Attribute: Changed Name, Description, status to Retired

    The recorded value for the MEASURED PERSON OBSERVATION observed associated with a MEASURED PERSON OBSERVATION TYPE CODE and MEASUREMENT VALUE TYPE CODE.This item has been retired from the NHS Data Model and Dictionary.

     The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

     

    top


    MEASURED OBSERVATION VALUE (RETIRED)  renamed from MEASURED OBSERVATION VALUE

    Change to Attribute: Changed Name, Description, status to Retired

    top


    MEASURED PERSON OBSERVATION TYPE CODE (RETIRED)  renamed from MEASURED PERSON OBSERVATION TYPE CODE

    Change to Attribute: Changed Name, Description, status to Retired

    The type of MEASURED PERSON OBSERVATION.This item has been retired from the NHS Data Model and Dictionary.

    Each MEASURED PERSON OBSERVATION TYPE CODE must have an associated MEASUREMENT VALUE TYPE.The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    National Codes:Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

    01Weight 
    02Height 
    03Body Surface Area (Retired 1 January 2013)
    04Diastolic Blood Pressure 
    05Systolic Blood Pressure 
    06Forced Expiratory Volume in 1 second (Percentage) 
    07Forced Expiratory Volume in 1 second (Absolute Amount) 
    08HbA1c 
    09Serum Cholesterol Level 
    10Serum Creatinine Level 
    11Urinary Albumin Level 
    12Heart Rate 
    13Gestation Length In Days 
    14Percentage Weight Loss 
    15Mid Arm Circumference 
    16Waist Measurement 
    17Hip Measurement 
    18Bone Age 
    19Head Circumference 
    20Hand Grip Strength 
    21Temperature 
    22Urine Output 
    23Dry Weight 
     

    top


    MEASURED PERSON OBSERVATION TYPE CODE (RETIRED)  renamed from MEASURED PERSON OBSERVATION TYPE CODE

    Change to Attribute: Changed Name, Description, status to Retired

    top


    MEASUREMENT VALUE TYPE CODE (RETIRED)  renamed from MEASUREMENT VALUE TYPE CODE

    Change to Attribute: Changed Name, Description, status to Retired

    The type of measurement used for the MEASURED PERSON OBSERVATION being recorded.This item has been retired from the NHS Data Model and Dictionary.

    National Codes:The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    01Millimoles per litre (mmol/L)
    02Micromoles per litre (µmol/L)
    03Micrograms per litre (µg/Ll)
    04Micrograms per millimole (µg/mmol)
    05Microgram albumin per hour (µg/ml/hr)
    06Microgram albumin per minute (µg/min)
    07Microgram albumin per 24 hours (µg/24hr)
    08Number (Retired September 2013)
    09Percentage (%)
    10Kilograms (kg)
    11Metres (m)
    13Square Metres (m2)
    14Millilitres per Minute (ml/min)
    15Millimetres of mercury (mmHg)
    16Litres (l)
    17Beats per minute (bpm)
    18Centimetres (cm)
    19Milligrams (mg)
    20Millilitres (ml)
    21Minutes
    22Celsius (ºC)
    23Millimetres (mm)
    24Grams per decilitre (g/dl)
    25Grams per litre (g/l)
    26Milligrams per litre (mg/l)
    27Nanograms per millilitre (ng/ml)
    28International Units per litre (IU/L)
    29Decilitres (d/l)
    30Square Millimetres (mm2)
    31Millilitres (ml) (Retired September 2013)
    32Grays (Gy)
    33International Units per kilogram (IU/kg)
    34Grams (g)
    35Kilocalories (kcal)
    36Millimoles (mmol)
    37Millimoles per mole (mmol/mol)
    38Picomoles per litre (pmol/L)
    39Milligrams per millimole (mg/mmol)
    40Nanograms per litre (ng/l)
    41Micrograms per millilitre (µg/ml)
    42Millimetres of water (mmH2O)
     Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

     

    top


    MEASUREMENT VALUE TYPE CODE (RETIRED)  renamed from MEASUREMENT VALUE TYPE CODE

    Change to Attribute: Changed Name, Description, status to Retired

    top


    ORGANISATION DEPARTMENT CODE

    Change to Attribute: Changed Description

    An ORGANISATION DEPARTMENT CODE is a code which identifies an ORGANISATION DEPARTMENT uniquely.

    For NHS ORGANISATIONS it is a code that is managed by either the:

    Notes:

    ORGANISATION DEPARTMENT CODING FRAMES

    Character
    Position

     

    1

     

    2

     

    3

     

    4

     

    5

     

    6

     

    7

     

    8

     

    Format

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    A Frame

     

    Department Type Identifier

     

    Department Identifier

     
       

    B Frame

     

    Department Type Identifier

     

    Department Identifier

     

    C Frame

     

    Department Type Identifier

     

    Department Identifier

     
         

    A Frame:

    Example
    Pathology Laboratory e.g. 69010

    • 69 = Department Type Identifier
    • 010 = Department Identifier

    B Frame:

    Example
    Local Authority Department e.g. V002AC01

    • V = Department Type Identifier
    • 002AC01 = Department Identifier

    C Frame:

    Example
    Isle of Man Government Department e.g. YJ1

    • YJ = Department Type Identifier
    • 1 = Department Identifier

    The structure and format of ORGANISATION DEPARTMENT CODES maintained by the Organisation Data Service, NHS Prescription Services and other agencies are detailed in the tables below.

    ORGANISATION CODES TABLES

    Table 1: CODING FORMATS FOR ORGANISATION DEPARTMENTS IN ENGLAND AND WALES

    Organisation Department Type

    Frame Type

    Character Position

    Code allocated by:

    Notes/Comments

     

    See Coding Frames Table

     

    1

     

    2

     

    3

     

    4

     

    5

     

    6

     

    7

     

    8

     
      

    Executive Agency Programme Department

     

    N/A

    See Note

     

    X

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     

    A-Y

     

    A-Y

     

    ODS

     

    First six characters denote Executive Agency Programme

    e.g. X09001AA

     

    Local Authority Department

     

    B

     

    V

     

    A-9

     

    A-9

     

    A-9

     

    A-Y

     

    A-Y

     

    A-9

     

    A-9

     

    ODS

     

    e.g. V002AC01

    Pathology Laboratory 

    A

     

    6

     

    9

     

    A-9

     

    A-9

     

    A-9

     
       

    ODS

     

    e.g. 69010

     

    Note: Codes for Executive Agency, Executive Agency Programme, Executive Agency Site and Executive Agency Programme Department do not easily fit into the coding frames as shown above and are therefore not included. This is due to their unusual structure in that there are more hierarchical 'tiers' than with other organisations. 

    Executive Agency and Executive Agency Programme are both considered Organisation level entities, although each Programme does have a relationship to an Executive Agency. Executive Agency codes are three characters long. Executive Agency Programme codes are six, and their first three characters are the same as the Executive Agency they are associated to. 

    Department codes of eight characters long can then be allocated underneath a Programme code (sharing the first six characters). Executive Agency Site codes of five characters long can be allocated under an Executive Agency code (and share the first three characters). 

     

    Table 2: CODING FORMATS FOR ORGANISATION SITES IN OTHER HOME COUNTRIES

    Organisation Department Type

    Frame Type

    Character Position

    Code allocated by:

    Notes/Comments

     

    See Coding Frames Table

     

    1

     

    2

     

    3

     

    4

     

    5

     

    6

     

    7

     

    8

     
      

    Isle of Man Government Department

     

    C

     

    Y

     

    J

     

    A-9

     

     

     
        

    ODS

     

    e.g. YJ1

     


    Note: A-9 indicates that characters A-Z and 0-9 are valid: except B, I, O, S, U and Z (to avoid ambiguity). 

     

    top


    ORGANISATION SITE CODE

    Change to Attribute: Changed Description

    An ORGANISATION SITE CODE is a code which identifies an ORGANISATION SITE uniquely.

    Note: Only ORGANISATION SITE CODES which have been notified to and issued by the Organisation Data Service may be used.

    Notes:

    ORGANISATION SITE CODING FRAMES

    Character
    Position

    1

    2

    3

    4

    5

    6

    7

    8

    9

    Format

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    a/n

     

    A Frame

     

    Organisation Type Identifier

     

    Organisation Identifier

     

    Site or Sub-Division Identifier

     
      

    B Frame

     

    Organisation Type Identifier

     

    Organisation Identifier

     

    Site or Sub-Division Identifier

     
        

    C Frame

     

    Organisation Type Identifier

     

    Organisation Identifier

     

    Site or Sub-Division Identifier

     
        

    D Frame

     

    Organisation Type
    Identifier

     

    Practice Identifier

     

    Branch Surgery Identifier

     

    E Frame

     

    Organisation Type Identifier

     

    Organisation Identifier

     

    Site or Sub-Division Identifier

     
        

    F Frame

     

    Organisation Type
    Identifier

     

    Organisation Identifier

     
        

    H Frame

     

    Organisation Type Identifier

     

    Organisation Identifier

     
        

    I Frame

     

    Organisation Type Identifier

     

    Organisation Identifier

     
        

    J Frame

     

    Organisation Type Identifier

     

    Organisation Identifier

     
        

    K Frame

     

    Organisation and Organisation Type Identifier

     

    Organisation Site Identifier

     
        

    A Frame:

    Example
    Local Service Provider Site e.g. LSP0101

    • LSP = Org Type Identifier
    • 01 = Organisation Identifier
    • 01 = Site or Sub-Division Identifier

    B Frame:

    Example
    Care Trust Site e.g. TAK01

    • T = Organisation Type Identifier
    • AK = Organisation Identifier
    • 01 = Site or Sub-Division Identifier

    Also:

    Government Department Sitee.g. XDA01
    High Level Health Geography Site, e.g. Area Team sitee.g. Q4401
    Local Authority Sitee.g. 000AA
    Local Health Board (Wales) Sitee.g. 7A101 
    NHS Trust Sitee.g. RH802 
    Other Statutory Authority (OSA) Site e.g. X1601 
     e.g. Q3001

    C Frame:

    Example
    Independent Sector Healthcare Provider (ISHP) Site e.g. NV701

    • NV = Organisation Site Type Identifier
    • 7 = Organisation Identifier
    • 01 = Site or Sub-Division Identifier

    D Frame

    Example
    GP Practice Branch Surgery: e.g. H81010002

    • H (and length of code) = Organisation Identifier
    • 81010 = Organisation Identifier (parent GP Practice)
    • 002 = Branch Surgery Identifier

    E Frame

    Example
    Special Health Authority (SpHA) Site: e.g. T115A

    • T1 = Organisation Type Identifier
    • 15 = Organisation Identifier
    • A = Site or Sub-Division Identifier

    F Frame

    Example
    Commissioning Support Unit Site: e.g. 0AA01

    • 0 = Organisation Type Identifier
    • AA01 = Organisation Identifier

    H Frame

    Example
    Prison: e.g. YDE01

    • YDE = Organisation Type Identifier
    • 01 = Site or Sub-Division Identifier

    I Frame

    Example
    Optical Site: e.g. TP01A

    • TP = Organisation Type Identifier
    • 01A = Site or Sub-Division Identifier

    J Frame

    Example
    Care Home Site: e.g. VN01A

    • VN = Organisation Type Identifier
    • 01A = Site or Sub-Division Identifier

    Also:

    Health Observatorye.g. XP001
    Primary Healthcare Directorate (Isle of Man) Sitee.g. YK101



    K Frame

    Example
    Clinical Commissioning Group (CCG) Site e.g. 11AAA - 99YZZ

    • 11A = Organisation and Organisation Type Identifier
    • AA = Organisation Site Identifier

    The structure and format of ORGANISATION SITE CODES maintained by the Organisation Data Service, NHS Prescription Services and other agencies are detailed in the tables below.

    NHS ORGANISATION SITE CODES TABLES

    Coding Formats

    Table 1: CODING FORMATS FOR ORGANISATION SITES IN ENGLAND AND WALES

    Organisation Site Type

    Frame Type

    Character Position

    Code allocated by:

    Notes/Comments

     

    See Coding Frames Table

     

    1

     

    2

     

    3

     

    4

     

    5

     

    6

     

    7

     

    8

     

    9

     
      

    Care Home Site

     

    J

     

    V

     

    L, M or N

     

    A-9

     

    A-9

     

    A-9

     
        

    ODS

     

    e.g. VN01A, VM01A, VL01A

     

    Care Trust Site

     

    B

     

    T

     

    A-Y

     

    A-Y

     

    A-9

     

    A-9

     
        

    ODS

     

    First three characters denote owning Care Trust

    e.g. TAK01

     
    Clinical Commissioning Group (CCG) Site  

    K

     

    0-9

     

    0-9

     

    A-Y

     

    A-Y

     

    A-Y

     
        

    ODS

     

    First three characters denote owning Clinical Commissioning Group

    e.g. 11AAA - 99YZZ

     

    Commissioning Support Unit (CSU) Site

     

    F

     

    0

     

    A-Y

     

    A-Y

     

    A-9

     

    A-9

     
        

    ODS

     

    e.g. 0AA01

     

    Executive Agency Site

     

    N/A

    See Note

     

    X

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     
        

    ODS

     

    First three characters denote Executive Agency

    e.g. X0901

     

    Government Department Site

     

    B

     

    X

     

    A-Y

     

    A-Y

     

    0-9

     

    0-9

     
        

    ODS

     

    First three characters denote Government Department

    e.g. XDA01

     

    GP Practice Branch Surgery - England and Wales

     

    D

     

    A-H,
    J-N,
    P,
    W &
    Y

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     

    ODS

     

    First 6 characters denote parent practice. Char 1 = W for Welsh GP Practice.

    All other values represent English GP Practices

    e.g. H81010002

     
    Health Observatory

    J

     

    X

    P

     

    0-9

     

    0-9

     

    0-9

     
        

    ODS

     

    e.g. XP001

     

    High Level Health Geography Site, e.g. Area Team site

     

    B

     

    Q

     

    A-9

     

    A-9

     

    A-9

     

    A-9

     
        

    ODS

     

    e.g. Q4401

     

    Independent Sector Healthcare Provider (ISHP) Site

     

    C

     

    A, B, D, G, I, K, L, M , N, O, S, U, V, W

     

    A-Y

     

    A-Y, 0-9

     

    A-Y, 0-9

     

    A-Y, 0-9

     
        

    ODS

     

    First three characters denote owning Independent Sector Healthcare Provider (ISHP)

    e.g. NV701

    Note: The A-Y range includes all letters except Z

     

    Local Authority (LA) Site

     

    B

     

    0-9

     

    0-9

     

    0-9

     

    A-Z

     

    A-Z

     
        

    ODS

     

    First three characters denote parent Local Authority

    e.g. 000AA

     
    Local Health Board (Wales) Site

    B

     

    7

     

    A-9

     

    A-9

     

    A-9

     

    A-9

     
        

    ODS

     

    First three characters denote owning NHS Trust

    e.g. 7A101

     

    Local Service Provider Site

     

    A

     

    L

     

    S

     

    P

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     
      

    ODS

     

    First five characters denote owning Local Service Provider

    e.g. LSP0101

     

    NHS Trust Site

     

    B

     

    R

     

    A-9

     

    A-9

     

    A-9

     

    A-9

     
        

    ODS

     

    First three characters denote owning NHS Trust

    e.g. RH802

     

    Optical Site

     

    I

     

    T

     

    P or Q

     

    0-9

     

    A-9

     

    A-9

     
        

    ODS

     

    e.g. TP01A, TQ01A

     

    Other Statutory Authority (OSA) Site

     

    B

     

    X

     

    0-9

     

    0-9

     

    0-9

     

    0-9

     
        

    ODS

     

    First three characters denote owning Other Statutory Authority

    e.g. X1601 

     

    Primary Care Trust (PCT) Site

     

    B

     

    5

     

    A-9

     

    A-9

     

    A-9

     

    A-9

     
        

    ODS

     

    First three characters denote owning Primary Care Trust

    e.g. 5CT49

    All Primary Care Trusts closed 31 March 2013

    Special Health Authority (SpHA) Site

     

    E

     

    T

     

    1

     

    0-9

     

    0-9

     

    A-Y, 1-9

     
        

    ODS

     

    First three characters denote owning SpHA

    e.g. T115A

     

    Strategic Health Authority (SHA) Site

     

    B

     

    Q

     

    A-9

     

    A-9

     

    A-9

     

    A-9

     
        

    ODS

     

    First three characters denote owning SHA Trust

    e.g. Q3001

    All Strategic Health Authorities closed 31 March 2013 - from 1 April 2013 referred to High Level Health Geography Site

    Note: Codes for Executive Agency, Executive Agency Programme, Executive Agency Site and Executive Agency Programme Department do not easily fit into the coding frames as shown above and are therefore not included. This is due to their unusual structure in that there are more hierarchical 'tiers' than with other organisations. 

    Executive Agency and Executive Agency Programme are both considered Organisation level entities, although each Programme does have a relationship to an Executive Agency. Executive Agency codes are three characters long. Executive Agency Programme codes are six, and their first three characters are the same as the Executive Agency they are associated to. 

    Department codes of eight characters long can then be allocated underneath a Programme code (sharing the first six characters). Executive Agency Site codes of five characters long can be allocated under an Executive Agency code (and share the first three characters). 


    Note: A-9 indicates that characters A-Z and 0-9 are valid: except B, I, O, S, U and Z (to avoid ambiguity). This applies to all ORGANISATION SITE CODES in the Coding Format Table above except Independent Sector Healthcare Provider (ISHP) sites.

      

    Table 2: CODING FORMATS FOR ORGANISATION SITES IN OTHER HOME COUNTRIES

    Organisation Site Type

    Frame Type

    Character Position

    Code allocated by:

    Notes/Comments

     

    See Coding Frames Table

     

    1

     

    2

     

    3

     

    4

     

    5

     

    6

     

    7

     

    8

     

    9

     
      

    Primary Healthcare Directorate (Isle of Man) Site

    J

     

    Y

     

    K

     

    A-9

     

    A-9

     

    A-9

     
      

     

     
     

    ODS

     

    e.g. YK101

     

    Note: A-9 indicates that characters A-Z and 0-9 are valid: except B, I, O, S, U and Z (to avoid ambiguity). 

     

    top


    PERSON PROPERTY QUALIFIER TYPE (RETIRED)  renamed from PERSON PROPERTY QUALIFIER TYPE

    Change to Attribute: Changed Name, Description, status to Retired

    Identifies the type of qualifier intrinsic to the PERSON PROPERTY.This item has been retired from the NHS Data Model and Dictionary.

     The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

     

    top


    PERSON PROPERTY QUALIFIER TYPE (RETIRED)  renamed from PERSON PROPERTY QUALIFIER TYPE

    Change to Attribute: Changed Name, Description, status to Retired

    top


    PERSON PROPERTY QUALIFIER VALUE (RETIRED)  renamed from PERSON PROPERTY QUALIFIER VALUE

    Change to Attribute: Changed Name, Description, status to Retired

    The value of the qualifier intrinsic to the PERSON PROPERTY. The appropriate value is determined by the PERSON PROPERTY QUALIFIER TYPE.This item has been retired from the NHS Data Model and Dictionary.

     The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

     

    top


    PERSON PROPERTY QUALIFIER VALUE (RETIRED)  renamed from PERSON PROPERTY QUALIFIER VALUE

    Change to Attribute: Changed Name, Description, status to Retired

    top


    PERSON PROPERTY RELATIONSHIP TYPE (RETIRED)  renamed from PERSON PROPERTY RELATIONSHIP TYPE

    Change to Attribute: Changed Name, Description, status to Retired

    Identifies the type of association from one PERSON PROPERTY to another.This item has been retired from the NHS Data Model and Dictionary.

     The last live version of this item is available in the September 2013 release of the NHS Data Model and Dictionary.

    Access to this version can be obtained by emailing information.standards@hscic.gov.uk with "NHS Data Model and Dictionary - Archive Request" in the email subject line.

     

    top


    PERSON PROPERTY RELATIONSHIP TYPE (RETIRED)  renamed from PERSON PROPERTY RELATIONSHIP TYPE

    Change to Attribute: Changed Name, Description, status to Retired

    top


    REHABILITATION ASSESSMENT TEAM TYPE

    Change to Attribute: Changed Description

    An indication of whether the CARE PROFESSIONAL TEAM undertaking a Rehabilitation Assessment, is specialised or non-specialised.  This information is recorded for the purposes of Payment by Results

    National Codes:

    1Specialised Rehabilitation Team
    2Non-specialised Rehabilitation Team
    1Specialised Rehabilitation Team
    2Non-specialised Rehabilitation Team

    Note:
    This data item is included in Commissioning Data Set version 6-2, but should not be submitted until further development by the Department of Health has been undertaken.This data item is included in Commissioning Data Set version 6-2, but should not be submitted until further development by the Department of Health has been undertaken.

     

    top


    SERVICE TYPE

    Change to Attribute: Changed Description

    top


    SERVICE TYPE FOR CHLAMYDIA TESTING

    Change to Attribute: Changed Description

    The type of SERVICE providing chlamydia testing.

    National Codes:

    01Genitourinary Medicine ServicesIncludes testing done in Genitourinary Medicine clinics reported to Genitourinary Medicine Clinic Activity Data Set (GUMCAD).
    02Community Sexual Health ServicesIncludes testing carried out in Sexual and Reproductive Health Services/Contraception and Sexual Health (CASH) services/Community Contraceptive Services excludes Contraceptive Services within GP Practices. Includes young PERSON's sexual health services e.g. Brook clinics and SexSense. It also includes pre-instrumentation screening e.g. Intrauterine Devices where undertaken at CASH services and postal kits handed out at community sexual health services.
    02Community Sexual Health ServicesIncludes testing carried out in Sexual and Reproductive Health Services/Contraception and Sexual Health (CASH) services/Community Contraceptive Services excludes Contraceptive Services within GP Practices. Includes young PERSON's sexual health services e.g. Brook clinics and SexSense. It also includes pre-instrumentation screening e.g. Intrauterine Devices where undertaken at CASH services and postal kits handed out at community sexual health services.
    03GP PracticeIncludes post kits handed out at the GP Practice.
    04PharmacyIncludes testing carried out in community pharmacies, including post kits handed out at the pharmacy.
    05Termination of Pregnancy (TOP) ServicesIncludes testing undertaken in TOP services at all stages including medical and surgical. Includes all NHS and private providers including British Pregnancy Advice Service (BPAS), Marie Stopes and Pregnancy Crisis Centre. It also includes post kits handed out in TOP Services.
    XXOtherAny other testing service type which does not fit into categories 01 - 05 e.g. chlamydia screening offices, antenatal and obstetric services, military,education, occupational health, prison, youth services, outreach, accident and emergency, minor injuries, NHS walk-in centres and Hospitals.
     

    top


    SKIN CANCER LESION NUMBER

    Change to Attribute: Changed Description

    The SKIN CANCER LESION identification number used to identify the specimen within a Pathology Laboratory Service Report during a Skin Cancer Care Spell.The identification number used to identify the specimen within a Pathology Laboratory Service Report during a Skin Cancer Care Spell.

    Note: where more than one primary skin cancer is reported on the same Pathology Laboratory Service Report, the Lesion number as specified on the Pathology Laboratory Service Report should be recorded. 

    top


    TUMOUR PROXIMITY TO CARINA

    Change to Attribute: Changed Description

    The proximity of the Tumour to the carina (ridge at the base of the trachea that separates the openings of the right and left main bronchi), in 'Millimetres (mm)'.The proximity of the Tumour to the carina (ridge at the base of the trachea that separates the openings of the right and left main bronchi), where the UNIT OF MEASUREMENT is 'Millimetres'. 

    National Codes:

    1Less than or equal to 20mm
    2Greater than 20mm
     

    top


    TUMOUR SIZE

    Change to Attribute: Changed Description

    The size of the Tumour, in 'Millimetres (mm)'.The size of the Tumour.

     

    top


    UNIT OF MEASUREMENT  renamed from CLINICAL INVESTIGATION RESULT ITEM UNIT OF MEASURE

    Change to Attribute: Changed Name, Description

    The identification of the unit of measurement for a CLINICAL INVESTIGATION RESULT ITEM.The unit of measurement.

    National Codes:

    01Millimoles per litre (mmol/L)
    02Micromoles per litre (µmol/L)
    03Micrograms per litre (µg/L)
    04Micrograms per millimole (µg/mmol)
    05Microgram albumin per hour (µg/ml/hr)
    06Microgram albumin per minute (µg/min)
    07Microgram albumin per 24 hours (µg/24hr)
    08Number (Retired September 2013)
    09Percentage (%)
    10Kilograms (kg)
    11Metres (m)
    12Picograms (pg)
    13Square Metres (m2)
    14Millilitres per Minute (ml/min)
    15Millimetres of mercury (mmHg)
    16Litres (l)
    17Beats per minute (bpm)
    18Centimetres (cm)
    19Milligrams (mg)
    20Millilitres (ml)
    21Minutes
    22Celsius (ºC)
    23Millimetres (mm)
    24Grams per decilitre (g/dl)
    25Grams per litre (g/l)
    26Milligrams per litre (mg/l)
    27Nanograms per millilitre (ng/ml)
    28International Units per litre (IU/L)
    29Decilitres (d/l)
    30Square Millimetres (mm2)
    31Millilitres (ml) (Retired September 2013)
    32Grays (Gy)
    33International Units per kilogram (IU/kg)
    34Grams (g)
    35Kilocalories (kcal)
    36Millimoles (mmol)
    37Millimoles per mole (mmol/mol)
    38Picomoles per litre (pmol/L)
    39Milligrams per millimole (mg/mmol)
    40Nanograms per litre (ng/l)
    41Micrograms per millilitre (µg/ml)
    42Millimetres of water (mmH2O)
    43Cubic Millimetres (mm3)
    44Litres per week per 1.73 metres squared (l/week/1.73²)
    45Millilitres per Minute divided by 1.73 Square Metres (ml/min/1.73m2)
    46number times ten raised to the power of nine per litre (x109/l)
    475 Millimetres Squared
    48Grams per kilogram per day (g/kg/day)
    49Kilopascals (KPa)
    50Femtolitres (fl)
    51Megavolts

    References:
    The Version 1.1 NHS Standard EDIFACT Messages for Pathology Requests and Reports, 2001
    The Version 1.0 Trial NHS Standard EDIFACT Messages for GP-Hospital Communications - 17.5.95

     

    top


    UNIT OF MEASUREMENT  renamed from CLINICAL INVESTIGATION RESULT ITEM UNIT OF MEASURE

    Change to Attribute: Changed Name, Description

    top


    ABLATIVE THERAPY TYPE

    Change to Data Element: Changed Description

    Format/Length:an1
    HES Item: 
    National Codes:See ABLATIVE THERAPY TYPE
    Default Codes:9 - Not Known (Not Recorded)

    Notes:
    ABLATIVE THERAPY TYPE is the same as attribute ABLATIVE THERAPY TYPE

    top


    ABNORMALITY DETECTED (DATING ULTRASOUND SCAN)

    Change to Data Element: Changed Description

    Format/Length:an1
    HES Item: 
    National Codes:See ABNORMALITY DETECTED INDICATOR
    Default Codes: 


    Notes:
    ABNORMALITY DETECTED (DATING ULTRASOUND SCAN) is the same as the attribute ABNORMALITY DETECTED INDICATOR for a Dating Ultrasound Scan.

     

    top


    ACCIDENT AND EMERGENCY ATTENDANCE CONCLUSION DATE

    Change to Data Element: Changed Description

    Format/Length:See DATE 
    HES Item: 
    National Codes: 
    Default Codes: 


    Notes:
    ACCIDENT AND EMERGENCY ATTENDANCE CONCLUSION DATE is the same as attribute ACTIVITY DATE where the ACTIVITY DATE TYPE is National Code 'Accident and Emergency Attendance Conclusion Date'.

     

    top


    ACCIDENT AND EMERGENCY DIAGNOSIS - FIRST

    Change to Data Element: Changed Description

    Format/length:an6
    HES item: 
    Format/Length:an6
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    The first recorded ACCIDENT AND EMERGENCY DIAGNOSIS of PATIENT DIAGNOSIS for an Accident and Emergency Attendance.ACCIDENT AND EMERGENCY DIAGNOSIS - FIRST is the first recorded ACCIDENT AND EMERGENCY DIAGNOSIS of PATIENT DIAGNOSIS for an Accident and Emergency Attendance. This is required for recording within an Accident and Emergency Attendance Commissioning Data Set.

    See Accident and Emergency Diagnosis Tables for clinical coding and classification structure.

    Accident and Emergency Attendance is a CARE CONTACT where the CARE CONTACT TYPE is National Code 01 'Accident And Emergency Attendance'.For Commissioning Data Set and XML schema version 6 onwards, ACCIDENT AND EMERGENCY DIAGNOSIS - FIRST will be recognised as Primary Diagnosis (Accident and Emergency)

    For Commissioning Data Set and XML schema version 6, this Data Element will be recognised as Primary Diagnosis (Accident and Emergency)

     

    top


    ACCIDENT AND EMERGENCY DIAGNOSIS - SECOND

    Change to Data Element: Changed Description

    Format/length:an6
    HES item: 
    Format/Length:an6
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    The second or subsequent recorded ACCIDENT AND EMERGENCY DIAGNOSIS of PATIENT DIAGNOSIS for an Accident and Emergency Attendance.ACCIDENT AND EMERGENCY DIAGNOSIS - SECOND is the second or subsequent recorded ACCIDENT AND EMERGENCY DIAGNOSIS of PATIENT DIAGNOSIS for an Accident and Emergency Attendance. This is required for recording within an Accident and Emergency Attendance Commissioning Data Set.

    See Accident and Emergency Diagnosis Tables for clinical coding and classification structure.

    Accident and Emergency Attendance is a CARE CONTACT where the CARE CONTACT TYPE is National Code 01 'Accident And Emergency Attendance'.For Commissioning Data Set and XML Schema version 6 onwards, ACCIDENT AND EMERGENCY DIAGNOSIS - SECOND will be recognised as Secondary Diagnosis (Accident and Emergency).

    For Commissioning Data Set and XML Schema version 6, this Data Element will be recognised as Secondary Diagnosis (Accident and Emergency).

    For Commissioning Data Set version 6 onwards, there are no restrictions on the number of Secondary Diagnoses (Accident and Emergency) recorded.

     

    top


    ACCIDENT AND EMERGENCY INVESTIGATION - FIRST

    Change to Data Element: Changed Description

    Format/length:an6
    HES item: 
    Format/Length:an6
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    The first recorded ACCIDENT AND EMERGENCY INVESTIGATION of a CLINICAL INTERVENTION for an Accident and Emergency Attendance.ACCIDENT AND EMERGENCY INVESTIGATION - FIRST is the first recorded ACCIDENT AND EMERGENCY INVESTIGATION of a CLINICAL INTERVENTION for an Accident and Emergency Attendance. This is required for recording within an Accident and Emergency Attendance Commissioning Data Set.

    See Accident and Emergency Investigation Table for clinical coding and classification structure.

    Accident and Emergency Attendance is a CARE CONTACT where the CARE CONTACT TYPE is National Code 01 'Accident And Emergency Attendance'.For Commissioning Data Set and XML Schema version 6 onwards, ACCIDENT AND EMERGENCY INVESTIGATION - FIRST will be recognised as Primary Investigation (Accident and Emergency).

    For Commissioning Data Set and XML Schema version 6, this Data Element will be recognised as Primary Investigation (Accident and Emergency).

     

    top


    ACCIDENT AND EMERGENCY INVESTIGATION - SECOND

    Change to Data Element: Changed Description

    Format/length:an6
    HES item: 
    Format/Length:an6
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    The second or subsequent recorded ACCIDENT AND EMERGENCY INVESTIGATION of a CLINICAL INTERVENTION for an Accident and Emergency Attendance.ACCIDENT AND EMERGENCY INVESTIGATION - SECOND is the second or subsequent recorded ACCIDENT AND EMERGENCY INVESTIGATION of a CLINICAL INTERVENTION for an Accident and Emergency Attendance. This is required for recording within an Accident and Emergency Attendance Commissioning Data Set.

    See Accident and Emergency Investigation Table for clinical coding and classification structure.

    Accident and Emergency Attendance is a CARE CONTACT where the CARE CONTACT TYPE is National Code 01 'Accident And Emergency Attendance'.

    For Commissioning Data Set and Schema version 6 onwards, ACCIDENT AND EMERGENCY INVESTIGATION - SECOND will be recognised as Secondary Investigation (Accident and Emergency).
    For Commissioning Data Set and Schema version 6, this Data Element will be recognised as Secondary Investigation (Accident and Emergency).

    For Commissioning Data Set version 6 onwards there are no restrictions on the number of Secondary Investigations (Accident and Emergency) recorded.

     

    top


    ACCIDENT AND EMERGENCY TREATMENT - FIRST

    Change to Data Element: Changed Description

    Format/length:an6
    HES item: 
    Format/Length:an6
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    The first recorded ACCIDENT AND EMERGENCY TREATMENT of a CLINICAL INTERVENTION for an Accident and Emergency Attendance.ACCIDENT AND EMERGENCY TREATMENT - FIRST is the first recorded ACCIDENT AND EMERGENCY TREATMENT of a CLINICAL INTERVENTION for an Accident and Emergency Attendance. This is required for recording within an Accident and Emergency Attendance Commissioning Data Set.

    See Accident and Emergency Treatment Tables for clinical coding and classification structure.

    Accident and Emergency Attendance is a CARE CONTACT where the CARE CONTACT TYPE is National Code 01 'Accident And Emergency Attendance'.For Commissioning Data Set and XML Schema version 6 onwards, ACCIDENT AND EMERGENCY TREATMENT - FIRST will be recognised as Primary Treatment (Accident and Emergency).

    For Commissioning Data Set and XML Schema version 6 this Data Element will be recognised as Primary Treatment (Accident and Emergency).

     

    top


    ACCIDENT AND EMERGENCY TREATMENT - SECOND

    Change to Data Element: Changed Description

    Format/length:an6
    HES item: 
    Format/Length:an6
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    The second or subsequent recorded ACCIDENT AND EMERGENCY TREATMENT of a CLINICAL INTERVENTION for an Accident and Emergency Attendance.ACCIDENT AND EMERGENCY TREATMENT - SECOND is the second or subsequent recorded ACCIDENT AND EMERGENCY TREATMENT of a CLINICAL INTERVENTION for an Accident and Emergency Attendance. This is required for recording within an Accident and Emergency Attendance Commissioning Data Set.

    See Accident and Emergency Treatment Tables for clinical coding and classification structure.

    Accident and Emergency Attendance is a CARE CONTACT where the CARE CONTACT TYPE is National Code 01 'Accident And Emergency Attendance'.

    For Commissioning Data Set and XML Schema version 6 this Data Element will be recognised as Secondary Treatment (Accident and Emergency).For Commissioning Data Set and XML Schema version 6 onwards, ACCIDENT AND EMERGENCY TREATMENT - SECOND will be recognised as Secondary Treatment (Accident and Emergency).

    For Commissioning Data Set version 6 onwards there are no restrictions on the number of Secondary Treatment (Accident and Emergency) recorded.

     

    top


    ALANINE AMINOTRANSFERASE CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ALANINE AMINOTRANSFERASE CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's alanine aminotransferase concentration in 'iu/L'.ALANINE AMINOTRANSFERASE CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's alanine aminotransferase concentration, where the UNIT OF MEASUREMENT is 'International Units per litre (IU/L)'. 

    top


    ALANINE AMINOTRANSFERASE CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    ALANINE AMINOTRANSFERASE CONCENTRATION
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    ALBUMIN LEVEL

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:n2
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ALBUMIN LEVEL is the result of the Clinical Investigation which measures the PATIENT's concentration of albumin in serum in 'Grams per litre (g/l)'.ALBUMIN LEVEL is the result of the Clinical Investigation which measures the PATIENT's concentration of albumin in serum, where the UNIT OF MEASUREMENT is 'Grams per litre (g/l)'. 

    The value is presented in the range 10-80.

    For the Cancer Outcomes and Services Data Set, ALBUMIN LEVEL is measured pre-treatment.

     

    top


    ALBUMIN LEVEL

    Change to Data Element: Changed linked Attribute, Description

    ALBUMIN LEVEL
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    ALKALINE PHOSPHATASE CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ALKALINE PHOSPHATASE CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's alkaline phosphatase concentration in 'iu/L'.ALKALINE PHOSPHATASE CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's alkaline phosphatase concentration, where the UNIT OF MEASUREMENT is 'International Units per litre (IU/L)'. 

    top


    ALKALINE PHOSPHATASE CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    ALKALINE PHOSPHATASE CONCENTRATION
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    ALLELE DRB3 DONOR

    Change to Data Element: Changed Description

    Format/Length:max an200
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ALLELE DRB3 DONOR is the ORGAN OR TISSUE DONOR's  'DRB3 alleles', as contained in the Human Leukocyte Antigen report for Tissue Typing

    top


    ALLELE DRB4 DONOR

    Change to Data Element: Changed Description

    Format/Length:max an200
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ALLELE DRB4 DONOR is the ORGAN OR TISSUE DONOR's  'DRB4 alleles', as contained in the Human Leukocyte Antigen report for Tissue Typing

    top


    ALLELE DRB5 DONOR

    Change to Data Element: Changed Description

    Format/Length:max an200
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ALLELE DRB5 DONOR is the ORGAN OR TISSUE DONOR's  'DRB5 alleles', as contained in the Human Leukocyte Antigen report for Tissue Typing

    top


    ALPHA FETOPROTEIN

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n6
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ALPHA FETOPROTEIN is the result of the Clinical Investigation to determine the PATIENT's serum Tumour markers for alpha fetoprotein (AFP) (a protein found in abnormal amounts in the blood of PATIENTS with cancer) in 'Nanograms per millilitre (ng/ml)'.ALPHA FETOPROTEIN is the result of the Clinical Investigation to determine the PATIENT's serum Tumour markers for alpha fetoprotein (AFP) (a protein found in abnormal amounts in the blood of PATIENTS with cancer), where the UNIT OF MEASUREMENT is 'Nanograms per millilitre (ng/ml)'. 

    top


    ALPHA FETOPROTEIN

    Change to Data Element: Changed linked Attribute, Description

    ALPHA FETOPROTEIN
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    ALPHA FETOPROTEIN (CEREBROSPINAL FLUID)

    Change to Data Element: Changed linked Attribute

    ALPHA FETOPROTEIN (CEREBROSPINAL FLUID)
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    ALPHA FETOPROTEIN (MAXIMUM AT DIAGNOSIS)

    Change to Data Element: Changed linked Attribute

    ALPHA FETOPROTEIN (MAXIMUM AT DIAGNOSIS)
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    ANTENATAL OBSERVATION (MATERNAL HEIGHT)

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:n1.max n2
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ANTENATAL OBSERVATION (MATERNAL HEIGHT) is the same as data element PERSON HEIGHT IN METRES, where the MEASUREMENT VALUE TYPE CODE is 'Metres (m)' .ANTENATAL OBSERVATION (MATERNAL HEIGHT) is the same as data element PERSON HEIGHT IN METRES, where the UNIT OF MEASUREMENT is 'Metres (m)' .

    ANTENATAL OBSERVATION (MATERNAL HEIGHT) is the Height of the mother measured during an Antenatal period.

     

    top


    ANTENATAL OBSERVATION (MATERNAL HEIGHT)

    Change to Data Element: Changed linked Attribute, Description

    ANTENATAL OBSERVATION (MATERNAL HEIGHT)
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    ANTENATAL OBSERVATION (MATERNAL WEIGHT)

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3.max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ANTENATAL OBSERVATION (MATERNAL WEIGHT) is the same as data element PERSON WEIGHT, where the MEASUREMENT VALUE TYPE CODE is 'Kilograms (kg)'.ANTENATAL OBSERVATION (MATERNAL WEIGHT) is the same as data element PERSON WEIGHT, where the UNIT OF MEASUREMENT is 'Kilograms (kg)'.

    ANTENATAL OBSERVATION (MATERNAL WEIGHT) is the Weight of the mother measured during an Antenatal period.

     

    top


    ANTENATAL OBSERVATION (MATERNAL WEIGHT)

    Change to Data Element: Changed linked Attribute, Description

    ANTENATAL OBSERVATION (MATERNAL WEIGHT)
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    ASPARTATE AMINOTRANSFERASE CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    ASPARTATE AMINOTRANSFERASE CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's aspartate aminotransferase concentration in 'iu/L'.ASPARTATE AMINOTRANSFERASE CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's aspartate aminotransferase concentration, where the UNIT OF MEASUREMENT is 'International Units per litre (IU/L)'. 

    top


    ASPARTATE AMINOTRANSFERASE CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    ASPARTATE AMINOTRANSFERASE CONCENTRATION
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BASE EXCESS CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n2.max n1
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BASE EXCESS CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's base excess concentration in 'Millimoles per litre (mmol/L)'.BASE EXCESS CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's base excess concentration, where the UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)'.

    top


    BASE EXCESS CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    BASE EXCESS CONCENTRATION
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BETA2 MICROGLOBULIN LEVEL

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n2.n1
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BETA2 MICROGLOBULIN LEVEL is the result of the Clinical Investigation which measures the PATIENT's beta2 microglobulin (protein found on the surface of many CELLS) in serum in 'Milligrams per litre (mg/l)'.BETA2 MICROGLOBULIN LEVEL is the result of the Clinical Investigation which measures the PATIENT's beta2 microglobulin (protein found on the surface of many CELLS) in serum, where the UNIT OF MEASUREMENT is 'Milligrams per litre (mg/l)'. 

    For the Cancer Outcomes and Services Data SetBETA2 MICROGLOBULIN LEVEL is measured pre-treatment.

     

    top


    BETA2 MICROGLOBULIN LEVEL

    Change to Data Element: Changed linked Attribute, Description

    BETA2 MICROGLOBULIN LEVEL
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BETA HUMAN CHORIONIC GONADOTROPIN

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BETA HUMAN CHORIONIC GONADOTROPIN is the result of the Clinical Investigation to determine the PATIENT's serum Tumour markers for beta human chorionic gonadotropin (bHCG) (a hormone normally found in the blood and urine during pregnancy), in 'International Units per Litre (IU/L)'.BETA HUMAN CHORIONIC GONADOTROPIN is the result of the Clinical Investigation to determine the PATIENT's serum Tumour markers for beta human chorionic gonadotropin (bHCG) (a hormone normally found in the blood and urine during pregnancy), where the UNIT OF MEASUREMENT is 'International Units per Litre (IU/L)'.

    BETA HUMAN CHORIONIC GONADOTROPIN may also be produced by some Tumour CELLS. An increased level of beta-human chorionic gonadotropin may be a sign of cancer of the testis, uterus, ovary, liver, stomach, pancreas, or lungs.

     

    top


    BETA HUMAN CHORIONIC GONADOTROPIN

    Change to Data Element: Changed linked Attribute, Description

    BETA HUMAN CHORIONIC GONADOTROPIN
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BETA HUMAN CHORIONIC GONADOTROPIN (CEREBROSPINAL FLUID)

    Change to Data Element: Changed linked Attribute

    BETA HUMAN CHORIONIC GONADOTROPIN (CEREBROSPINAL FLUID)
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BETA HUMAN CHORIONIC GONADOTROPIN (MAXIMUM AT DIAGNOSIS)

    Change to Data Element: Changed linked Attribute

    BETA HUMAN CHORIONIC GONADOTROPIN (MAXIMUM AT DIAGNOSIS)
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BICARBONATE CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n2.max n2
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BICARBONATE CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's bicarbonate concentration (HCO3) in 'Millimoles per litre (mmol/L)'.BICARBONATE CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's bicarbonate concentration (HCO3), where the UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)'. 

    top


    BICARBONATE CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    BICARBONATE CONCENTRATION
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BILIRUBIN CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BILIRUBIN CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's bilirubin concentration in 'Micromoles per litre (µmol/L)'.BILIRUBIN CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's bilirubin concentration, where the UNIT OF MEASUREMENT is 'Micromoles per litre (µmol/L)'. 

    top


    BILIRUBIN CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    BILIRUBIN CONCENTRATION
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BIRTH WEIGHT

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:n4
    HES Item:BIRWEIT
    National Codes: 
    Default Codes:9999 - Not known

    Notes:
    BIRTH WEIGHT is the Birth Weight, where the MEASUREMENT VALUE TYPE CODE is 'Grams (g)'.BIRTH WEIGHT is the Birth Weight, where the UNIT OF MEASUREMENT is 'Grams (g)'. 

    The range is 0001 to 9998.

     

    top


    BIRTH WEIGHT

    Change to Data Element: Changed linked Attribute, Description

    BIRTH WEIGHT
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD BASOPHILS PERCENTAGE

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD BASOPHILS PERCENTAGE is the result of the Clinical Investigation which measures the PATIENT's basophils (part of the immune system that normally protects the body from infection) as a percentage of total white CELLS.BLOOD BASOPHILS PERCENTAGE is the result of the Clinical Investigation which measures the PATIENT's basophils (part of the immune system that normally protects the body from infection) as a percentage of total white CELLS, where the UNIT OF MEASUREMENT is 'Percentage (%)'. 

    top


    BLOOD BASOPHILS PERCENTAGE

    Change to Data Element: Changed linked Attribute, Description

    BLOOD BASOPHILS PERCENTAGE
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD EOSINOPHILS PERCENTAGE

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD EOSINOPHILS PERCENTAGE is the result of the Clinical Investigation which measures the PATIENT's eosinophils (a type of white blood CELL) as a percentage of total white CELLS.BLOOD EOSINOPHILS PERCENTAGE is the result of the Clinical Investigation which measures the PATIENT's eosinophils (a type of white blood CELL) as a percentage of total white CELLS, where the UNIT OF MEASUREMENT is 'Percentage (%)'. 

    top


    BLOOD EOSINOPHILS PERCENTAGE

    Change to Data Element: Changed linked Attribute, Description

    BLOOD EOSINOPHILS PERCENTAGE
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD FLOW RATE (DIALYSIS)

    Change to Data Element: Changed Description

    Format/Length:max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD FLOW RATE (DIALYSIS) is the result of the Clinical Investigation which measures the PATIENT's blood flow rate during Haemodialysis, in 'Millilitres per Minute (ml/min)'.BLOOD FLOW RATE (DIALYSIS) is the same as attribute BLOOD FLOW RATE, where the UNIT OF MEASUREMENT is 'Millilitres per Minute (ml/min)'. 

    top


    BLOOD MYELOBLASTS PERCENTAGE

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD MYELOBLASTS PERCENTAGE is the result of the Clinical Investigation which measures the PATIENT's myeloblasts (immature CELL found in the bone marrow) as a percentage of total white CELLS.BLOOD MYELOBLASTS PERCENTAGE is the result of the Clinical Investigation which measures the PATIENT's myeloblasts (immature CELLS found in the bone marrow) as a percentage of total white CELLS, where the UNIT OF MEASUREMENT is 'Percentage (%)'. 

    top


    BLOOD MYELOBLASTS PERCENTAGE

    Change to Data Element: Changed linked Attribute, Description

    BLOOD MYELOBLASTS PERCENTAGE
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD PRESSURE AVERAGED

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3/max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD PRESSURE AVERAGED is the result of the Clinical Investigation which measures the average Blood Pressure of the PATIENT in 'Millilitres of mercury (mmHg)'.BLOOD PRESSURE AVERAGED is the result of the Clinical Investigation which measures the average Blood Pressure of the PATIENT, where the UNIT OF MEASUREMENT is 'Millimetres of mercury (mmHg)'. 

    top


    BLOOD PRESSURE AVERAGED

    Change to Data Element: Changed linked Attribute, Description

    BLOOD PRESSURE AVERAGED
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD PRESSURE HIGHEST

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3/max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD PRESSURE HIGHEST is the result of the Clinical Investigation which measures the highest Blood Pressure of the PATIENT in 'Millilitres of mercury (mmHg)'.BLOOD PRESSURE HIGHEST is the result of the Clinical Investigation which measures the highest Blood Pressure of the PATIENT, where the UNIT OF MEASUREMENT is 'Millimetres of mercury (mmHg)'. 

    top


    BLOOD PRESSURE HIGHEST

    Change to Data Element: Changed linked Attribute, Description

    BLOOD PRESSURE HIGHEST
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD PRESSURE LOWEST

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3/max n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD PRESSURE LOWEST is the result of the Clinical Investigation which measures the lowest Blood Pressure of the PATIENT in 'Millilitres of mercury (mmHg)'.BLOOD PRESSURE LOWEST is the result of the Clinical Investigation which measures the lowest Blood Pressure of the PATIENT, where the UNIT OF MEASUREMENT is 'Millimetres of mercury (mmHg)'. 

    top


    BLOOD PRESSURE LOWEST

    Change to Data Element: Changed linked Attribute, Description

    BLOOD PRESSURE LOWEST
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD PRESSURE SITTING

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:n3/n3
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD PRESSURE SITTING is the result of the Clinical Investigation which measures the Blood Pressure of the PATIENT whilst sitting, in 'Millilitres of mercury (mmHg)'.BLOOD PRESSURE SITTING is the result of the Clinical Investigation which measures the Blood Pressure of the PATIENT whilst sitting, where the UNIT OF MEASUREMENT is 'Millimetres of mercury (mmHg)'. 

    top


    BLOOD PRESSURE SITTING

    Change to Data Element: Changed linked Attribute, Description

    BLOOD PRESSURE SITTING
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD UREA CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n3.max n1
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD UREA CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's blood urea concentration in 'Millimoles per litre (mmol/L)'.BLOOD UREA CONCENTRATION is the result of the Clinical Investigation which measures the PATIENT's blood urea concentration, where the UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)'. 

    top


    BLOOD UREA CONCENTRATION

    Change to Data Element: Changed linked Attribute, Description

    BLOOD UREA CONCENTRATION
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD UREA CONCENTRATION (DONOR ON ADMISSION)

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n2.max n1
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD UREA CONCENTRATION (DONOR ON ADMISSION) is the result of the Clinical Investigation which measures the ORGAN OR TISSUE DONOR's blood urea concentration on admission in 'Millimoles per litre (mmol/L)'.BLOOD UREA CONCENTRATION (DONOR ON ADMISSION) is the result of the Clinical Investigation which measures the ORGAN OR TISSUE DONOR's blood urea concentration on admission, where the UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)'. 

    top


    BLOOD UREA CONCENTRATION (DONOR ON ADMISSION)

    Change to Data Element: Changed linked Attribute, Description

    BLOOD UREA CONCENTRATION (DONOR ON ADMISSION)
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BLOOD UREA CONCENTRATION (DONOR ON RETRIEVAL)

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n2.max n1
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BLOOD UREA CONCENTRATION (DONOR ON RETRIEVAL) is the result of the Clinical Investigation which measures the ORGAN OR TISSUE DONOR's blood urea concentration on retrieval in 'Millimoles per litre (mmol/L)'.BLOOD UREA CONCENTRATION (DONOR ON RETRIEVAL) is the result of the Clinical Investigation which measures the ORGAN OR TISSUE DONOR's blood urea concentration on retrieval, where the UNIT OF MEASUREMENT is 'Millimoles per litre (mmol/L)'.

    top


    BLOOD UREA CONCENTRATION (DONOR ON RETRIEVAL)

    Change to Data Element: Changed linked Attribute, Description

    BLOOD UREA CONCENTRATION (DONOR ON RETRIEVAL)
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BONE AGE (RENAL PAEDIATRIC)

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:yy.mm
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BONE AGE (RENAL PAEDIATRIC) is the radiological Bone Age as assessed by a radiologist viewing X-rays of the PATIENT's hand and wrist.BONE AGE (RENAL PAEDIATRIC) is the result of the Clinical Investigation which measures the PATIENT's Bone Age.

    For the National Renal Data Set, BONE AGE (RENAL PAEDIATRIC) is the radiological Bone Age as assessed by a radiologist viewing X-rays of the PATIENT's hand and wrist. The age is reported in years and months.   

     

    top


    BONE AGE (RENAL PAEDIATRIC)

    Change to Data Element: Changed linked Attribute, Description

    BONE AGE (RENAL PAEDIATRIC)
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BONE MARROW BLAST CELLS PERCENTAGE

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n2
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BONE MARROW BLAST CELLS PERCENTAGE is the result of the Clinical Investigation which measures the PATIENT's blast CELLS in bone marrow aspirate as a percentage of all nucleated CELLS.BONE MARROW BLAST CELLS PERCENTAGE is the result of the Clinical Investigation which measures the PATIENT's blast CELLS in bone marrow aspirate as a percentage of all nucleated CELLS, where the UNIT OF MEASUREMENT is 'Percentage (%)'.

    The value is presented in the range 0-20%.

     

    top


    BONE MARROW BLAST CELLS PERCENTAGE

    Change to Data Element: Changed linked Attribute, Description

    BONE MARROW BLAST CELLS PERCENTAGE
     
    Attribute:
    CLINICAL INVESTIGATION RESULT VALUE

    top


    BRESLOW THICKNESS

    Change to Data Element: Changed linked Attribute, Description

    Format/Length:max n2.max n2
    HES Item: 
    National Codes: 
    Default Codes: 

    Notes:
    BRESLOW THICKNESS is the result of the Clinical Investigation which measures the PERSON's Breslow Thickness, in 'Millimetres (mm)', to the nearest 0.BRESLOW THICKNESS is the result of the Clinical Investigation which measures the PERSON's Breslow Thickness, where the UNIT OF MEASUREMENT is 'Millimetres (mm)', to the nearest 0.01mm. 

    top


    BRESLOW THICKNESS